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The microbial enzymes that depolymerize complex carbohydrates are of industrial significance 
particularly in the biofuels and biorefinery sectors. In the human large bowel glycan utilization plays a 
critical role in defining the composition of the human gut microbial community (microbiota) which, in 
turn, has a significant impact on health. A central feature of these processes is the specificity of the 
enzymes and the non-catalytic carbohydrate binding modules (CBMs) that contribute to glycan 
degradation. This thesis describes research designed to understand the mechanisms by which CBMs 
and glycoside hydrolases contribute to glycan degradation and how this impacts on the structure of 
the microbiota.  
The first results chapter describes the biochemical properties and structural basis for the specificity 
displayed by two CBMs appended to the glucanase of a rumen bacterium. The sequence of the two 
CBMs are >75% identical and display essentially identical ligand specificities. Isothermal titration 
calorimetry revealed that the two proteins bound to a range of β1,4-glucans (cellulose) and, β1,3-
β1,4-mixed linked glucans, displaying highest affinity for xyloglucan, a β1,4-glucan decorated with 
α1,6-xylose residues. The structures of the two CBMs reveal a β-sandwich fold. The ligand binding 
site comprises the β-sheet that forms the concave surface of the proteins. Binding to the backbone 
chains of β-glucans is mediated primarily by five aromatic residues that also make hydrophobic 
interactions with the xylose side chains of xyloglucan, conferring the distinctive specificity of the CBMs 
for the decorated polysaccharide. Significantly, and in contrast to other CBMs that recognize β-
glucans, CBM65A utilizes different polar residues to bind cellulose and mixed linked glucans. Thus, 
Gln106 is central to cellulose recognition, but is not required for binding to mixed linked glucans. This 
chapter reveals the mechanism by which β-glucan-specific CBMs can distinguish between linear and 
mixed linked glucans, and show how these CBMs can exploit an extensive hydrophobic platform to 
target the side chains of decorated β-glucans.  
In the second chapter the enzymes that contribute to the degradation of α-mannan, a prominent 
component of yeast cell walls, were studied. These enzymes were derived from Bacteroides 
thetaiotaomicron, a member of the microbiota. The data showed that the GH76 endo-α1,6-
mannanases presented on the bacterial surface displayed significantly less activity against small 
mannooligosaccharides compared to the equivalent periplasmic enzymes. All the endo-α1,6-
mannanases were only active on the linear backbone of a-mannan, the enzymes were unable to 
accommodate any side chains. These decorations were partially removed by a poorly expressed and 
slow acting surface GH92 α-mannosidase. In contrast, in the periplasm a highly active GH38 α-
mannosidase rapidly debranched the imported yeast mannan oligosaccharides. The 
manooligosaccharides generated by the GH76 enzymes were then depolymerized into mannose by a 
pair of periplasmic exo-acting α1,6-mannosidases that contained only two substrate binding subsites. 
The biochemical characterization of these enzymes led to the selfish hypothesis in which B. 
thetaiotaomicron maximises deconstruction of yeast mannan in the periplasm, ensuring that the 
mannose generated will not be available to other organisms in the microbiota. This hypothesis were 
verified by showing that B. thetaiotaomicron was unable to support the growth of other Bacteroides 
sp. (that were able to grow on mannose and, in the case of B. xylanisolvens, also on debranched α-
mannan) on yeast α-mannan.  
In the final results chapter the mechanism by which B. thetaiotaomicron utilized β1,6-glucan, a 
component of the yeast wall, was analysed. Transcriptomic analysis identified a Polysaccharide 
Utilization Locus (PUL) that was transcribed in response to β1,6-glucan. The PUL encoded two 
enzymes and two surface glycan binding proteins (SGBPs), one of which was a SusD homologue. 
The two SGBPs displayed tight specificity for β1,6-glucan over other β-glucans, displaying a 
preference for ligands that contained >3 glucose units. The surface GH30 enzyme, BT3312, was 
shown to be an endo-β1,6-glucanase, while the periplasmic GH3 exo-acting β-glucosidase displayed 
a preference for β1,6-linkages. B. thetaiotaomicron accumulated β1,6-glucobiose, which was due to 
the low activity of the GH3 enzyme against the disaccharide and poor expression of the β-
glucosidase. The crystal structure of BT3312 revealed a deep pocket that mirrored the U-shaped 
typology of β1,6-glucan, revealing the mechanism of substrate specificity. Finally the catalytic amino 
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Chapter 1: Introduction  
 
Carbohydrates, consisting of carbon, oxygen and hydrogen, are extremely diverse 
molecules, the existence of which is absolutely vital to life and a number of biological 
processes. Carbohydrates possess hydroxyl groups and an aldehyde or ketone group. 
Individual monosaccharides (single sugars), can adopt a ring conformation, which 
usually consists of a carbon chain of five or above atoms, existing as a six membered 
or five membered ring. These cyclic conformations are known as pyranose and 
furanose respectively. Individual monosaccharides can be connected by glycosidic 
linkages via the anomeric carbon to the hydroxyl group of another monosaccharide, 
forming oligosaccharides with varying degrees of polymerisation. Extensive 
polymerisation of monosaccharides results in polysaccharides - large molecules, the 
composition, structure and stereochemistry of which can be highly complex.  
The eluded to biological roles that carbohydrates facilitate include cell metabolism and 
cell signalling, as well as acting as potential energy stores. Indeed, the innate 
biophysical properties of many polysaccharides endow the polysaccharide with 
functional characteristics, and so polysaccharides are often observed  fulfilling a 
structural role in nature, such as in the cell walls of plants, bacterial cells and 
eukaryotes. 
In addition to biological roles, carbohydrates also have extensive industrial 
applications and are exploited in a number of key processes and industries 
(pharmaceutical and food). Indeed, cellulose, the major constituent of the plant cell 
wall, is the most abundant source of hydrocarbons on the planet. The saccharification 
of cellulose is therefore of extreme relevance to the biofuel sector. Despite the 
recalcitrance of cellulose to enzymatic degradation, a number of bacteria exploit 
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cellulose as an energy source and encode for enzymes capable of deconstructing the 
polysaccharide.  
The aforementioned example emphasises that the acquiring of knowledge of microbial 
exploitation of carbohydrates, mediated by the enzymes they encode, can be of 
extreme industrial and health (see Section 1.4.4) importance. 
1.1 Glycoside Hydrolases 
Glycoside hydrolases catalyse the hydrolysis of the glycosidic bonds linking 
saccharide residues or glyco-conjugates. The hydrolysis of glycosides results in the 
generation of a saccharide hemiacetal or hemiketal as well as the appropriate aglycon. 
Glycoside hydrolases possess the ability to catalyse glycosidic bonds where the 
linking atom is generally oxygen.  
Glycoside hydrolases are often assigned a prefix of exo or endo, reflecting their ability 
to  cleave terminal (most often at the non-reducing end) or internal  glycosidic linkages, 
respectively.  Substrate binding within the glycosidase active site is described using 
sub-sites, with the site of enzymatic cleavage as a reference point. Catalytic sub-sites 
accommodating sugar moieties in the direction of the non-reducing end (from the point 
of enzymatic cleavage) are denoted by sequential negative numbers (-1, -2, -3, etc.), 
with the active site located at -1 and the scissle bond between sugars located at -1 
and +1 (Davies and Henrissat, 1995). Sub-sites of the enzyme interacting with glycan 
residues towards the reducing end are indicated with a positive number (+1, +2, +3, 
etc.).  
1.1.1 Catalytic mechanisms  
 The hydrolysis of glycosidic linkages, catalysed by glycoside hydrolases, most 
commonly proceeds via a single or double displacement acid-base assisted 
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mechanism. Reactions which proceed with a single displacement mechanism results 
in a net inversion of anomeric configuration at C1 post-catalysis, at the site of bond 
cleavage. Conversely, bond cleavage which operates via a double displacement mode 
of catalysis results in an overall net retention of anomeric configuration. Glycoside 
hydrolases which operate with either a single or double displacement mechanism are 
therefore deemed ‘inverting’ or ‘retaining’ enzymes respectively. Irrespective of the 
mechanism, both modes of catalysis require two carboxylate amino acids for 
hydrolysis, an acid/acid-base and a base/nucleophile respectively. In inverting 
glycoside hydrolases the two catalytic residues, the general acid and general base, 
are generally aspartate and/or glutamate and are situated 6 – 11 Ǻ apart (McCarter 
and Withers, 1994). The reaction proceeds via an oxocarbenium ion-like transition 
state. Hydrolysis by retaining glycoside hydrolases, occurring via a two-step, double 
displacement mechanism, involves a covalent glycosyl-enzyme intermediate, 
proceeding via oxocarbenium ion-like transition states. Acid/base and nucleophile 
assistance is given by two amino acid side chains (glutamate or aspartate) which are 
typically situated 5.5 Ǻ apart. Phase one of the retaining process of catalysis is referred 
to as the glycosylation step. The catalytic nucleophile displaces the aglycon by 
attacking the anomeric centre. A glycosyl enzyme intermediate is thereby formed. The 
acid/base residue acts as an acid and provides protonic assistance by protonating the 
glycosidic oxygen encouraging leaving group departure. Phase two entails a 
deglycosylation step, whereby the glycosyl-enzyme is hydrolysed by a water molecule 
which is deprotonated by the acid/base amino acid now functioning as a general base 
(Rye and Withers, 2000; Zechel and Withers, 2000). A schematic of both the inverting 





1.1.2 Glycoside Hydrolase sequence based families 
Glycoside hydrolases (GHs) are classified into sequence based families (defined as 
GHXX where XX is a number) in the CAZy database (www.cazy.org) (Cantarel et al., 
2009).  Family members display the same fold, catalytic mechanism and catalytic 
apparatus (an exception to this general rule occurs in GH97). Such classification 
provides predicted activities of respective hypothetical glycoside hydrolases. There 
are currently 135 families of glycoside hydrolases on the CAZy database (as of 
January 2016). Members of the same glycoside hydrolase family can display the same 
Figure 1.1. Catalytic mechanisms of (A) single displacement, inverting mechanism 
and (B) double displacement, retaining mechanism. The transition state of the 
reactions is highlighted in brackets. Taken from Rye and Withers, 2010.  
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specificity, however, this is not always the case although the stereochemistry of the 
target glycosidic bond is conserved (Henrissat and Davies, 1997). GH families can be 
grouped into larger groups, known as clans. Clans possess extensive similarities in 
protein structure, catalytic residues and mechanism and help to provide structural and 
functional assignments to GHs. 
The exo/endo mode of action of glycoside hydrolases is complementary to the 
topology of the active site of the enzyme. Three topologies are consistently observed 
in glycoside hydrolases. The open cleft topology accommodates the internal regions 
of the substrate and is indicative of an endo-mode of hydrolysis, cleaving sugar 
polymers internally. The pocket topology usually accommodates single saccharide 
residues (usually at the non-reducing end) and liberates monosaccharides from 
oligosaccharides/polysaccharides. Tunnel topology is most prevalent in exo-
processive enzymes, where the polysaccharide/oligosaccharide is transported 
through the ‘tunnel’ of the enzyme, and subsequently cleaved in an exo-acting 
manner, liberating disaccharides (Davies and Henrissat, 1995)  
1.1.3 GH families which target α-mannan  
1.1.3.1 α-mannosidases  
α-mannosidases are glycoside hydrolases which liberate mannose from 
polysaccharides/oligosaccharides containing accessible α-mannosidic linkages in an 
exo-mode of action. As this thesis focusses on α-mannosidases encoded by the α-
mannan and high mannose N-glycan degrading systems of Bacteroides 
thetaiotaomicron (B. theta), the α-mannosidases encoded by the genome of B. theta 
are described here.  
1.1.3.1.1 GH92 
GH92 α-mannosidases display variation in α-mannosidic link preference, with activity 
observed against α1,2, α1,3, α1,4 and α1,6 linkages (Zhu et al., 2010). NMR 
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experiments revealed that GH92s which hydrolyse either an  α1,2, α1,3 or α1,4 
mannosidic linkage, generated β-mannose, indicating that an inverting mechanism of 
hydrolyse is utilized by members of GH92. The GH92 α-mannosidases are Ca2+ 
dependent, being one of three glycoside hydrolase families requiring a metal ion for 
catalytic activity. Interestingly all three families (GH38, 47 and 92) contain only α-
mannosidases. Metal ion interacts with O2 and O3 of the mannose bound in the -1 
active site, possibly providing the conformational flexibility required for the enzyme to 
recognise the ground state and transition state of the substrate, most likely due to the 
lack of distorting binding energy provided by the -2 sub-site as these enzymes are 
exo-acting (Zhu et al., 2010) 
The three-dimensional structure of the GH92 family of α-mannosidases reveals a two 
domain structure. The small N-terminal domain of the enzyme is comprised of a β-
sandwich, whilst the larger C-terminal domain consists of an α/α6 barrel fold. The active 
site of the GH92 family adopts a pocket topology which is formed by both the N- and 
C-terminal domains.  
A number of GH92 α-mannosidases are encoded by the genome of B. theta (23), with 
23 encoded by the α-mannan targeting apparatus of the bacterium (Cuskin et al., 
2015b). The GH92 enzymes encoded by B. theta have been previously characterised 
by Zhu et al. (2010), demonstrating activity against a variety of α-mannosidase 
linkages present in yeast mannan and mammalian high mannose N-glycans.  Around 
50% of the GH92 α-mannosidases encoded by B. theta were up-regulated when the 
bacterium was cultured on yeast α-mannan or mammalian glycans, indicating the 





GH38 α-mannosidases utilize a retaining, double displacement mechanism of 
hydrolysis and require a Zn2+ ion for catalysis. The crystal structure of a GH38 derived 
from Streptococcus pyogenes (SpGH38) in complex with a transition state mimic 
shows that the zinc ion is coordinated at the active site of the enzyme in an overall T6 
octrahedral coordination configuration and interacts with the mannose residue bound 
in the active site, most likely enabling the distortion of the substrate towards the 
transition state (1S5 ‘skew-boat’), reminiscent of the role of Ca2+ in GH92 α-
mannosidases. GH38 enzymes display variation in specificity with respect to the α-
mannosidic linkage and the substrate bound at the positive subsites (Suits et al., 2010) 
1.1.3.1.3 GH125 
GH125 enzymes derived from Clostridium perfringens (CpGH125) and Streptococcus 
pneumoniae (SpGH125) hydrolyse α1,6-mannobiose with a net inversion of 
stereochemistry, indicating a single displacement mechanism of hydrolysis. Catalysis 
mediated by GH125 enzymes is metal-independent. This demonstrates that there is 
no a prior reason why the enzyme mediated exo cleavage of α-mannosidic linkages 
requires divalent metal ions. The three dimensional structure of SpGH125 and Cp125 
demonstrates the family consists of an (α/α)6 fold. Ligand recognition in the -1/+1 
catalytic sub-sites of SpGH125 has been explored using thio-mannobiose, a non-
cleavable substrate, revealing that aspartate 218 and glutamate 391 are the catalytic 
general acid and base of the enzyme respectively. The catalytic residues are 
structurally conserved in CpGH125 as well as the other clan members, GH15 and 
GH65. The resolved crystal structure of SpGH125 shows that O1 of the mannose 
bound at +1 is solvent exposed indicating that the enzyme can accommodate 
extended α1,6-mannooligosaccharides (Gregg et al., 2011). A crystal structure of a 
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GH125 B. theta enzyme has been solved by a structural genomics consortium and its 
comparison to SpGH125 is described in Chapter 4, Discussion. 
1.1.3.2 α-mannanases 
α-mannases are endo-acting enzymes cleave internal α-mannosidic linkages. There 
are currently two families of endo-α-mannanases featured on the CAZy database, 
GH76 and GH99.  
1.1.3.2.1 GH76 
GH76 enzymes have been shown to be endo-α1,6-mannanases. It has recently been 
elucidated that the GH76 family act with an overall retention of stereochemistry, 
utilizing a double displacement method of hydrolysis. The GH76 enzymes are metal 
independent. The resolved crystal structure of a GH76 endo-α1,6-mannanase derived 
from Bacillus circulans (BcGH76) reveals an (α/α)6 helical barrel fold. 3D structures of 
enzyme-substrate complexes show a solvent accessible, long, curved cleft like 
structure constituting the active site of the Bacillus circulans enzyme to which α1,6-
mannopentaose is bound in the -4 to +1 sub-sites of the enzyme. The mannose 
residue bound to the -1 sub-site of the enzyme adopts a OS5 conformation. 
Interestingly, an enzyme-inhibitor complex revealed that the azasugar of α-mannosyl-
1,6-isofagamine was distorted to a B2,5 conformation in the same sub-site, therefore 
suggesting catalysis proceeds through a boat-conformation in the GH76 family. 
BcGH76 displays endo-mannanase activity against α1,6-mannooligosaccharides with 
a degree of polymerisation (DP) ≥3 (Thompson et al., 2015).  
1.1.3.2.2 GH99 
GH99 mammalian and bacterial enzymes display endo-α1,2-mannanase activity 
(bacterial). The mammalian Golgi enzymes target glucose substituted mannosyl 
moieties found in the structure of immature mammalian high-mannose N-glycans, 
cleaving the α1,2-mannoside linkage internally and accommodating up to three 
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glucose substitutions  proximal to the site of enzymatic cleavage. The bacterial GH99 
enzymes release α1,3-mannobiose from the chain termini of Saccharomyces 
cerevisiae yeast α-mannan through the cleavage of an α1,2-linkage. Both bacterial 
enzymes show a strong preference for D-mannose at the -2 subsite reflecting steric 
clashes with an equatorial O2 (O2 is axial in mannose).  Interestingly, eukaryote 
derived GH99s which display a preference for glucose in the -2 subsite possess a 
tyrosine residue capable of interacting with the equatorial O2 of glucose, conveying 
specificity that is complementary to the biological activity of the eukaryotic enzymes 
(Hakki et al., 2015) 
The GH99 family of endo-α-mannosidases act with a net retention of anomeric 
configuration and utilize a double, displacement mechanism of hydrolysis. 
Interestingly, the catalytic nucleophile of the family is yet to be elucidated. Instead, a 
catalytic process whereby catalysis is assisted by substrate has been proposed, 
involving the 2OH residue which is deprotonated by the general acid/base of the 
enzyme and proceeds via a 1,2 anhydrosugar intermediate with neighbouring group 
participation (Hakki et al., 2015) 
1.1.4 GH families which target β1,6-glucans 
Reflecting the presence of β1,6-glucans in the yeast cell wall, glycoside hydrolase 
families which may potentially target β1,6-glycosidic linkages, are also encoded by the 
genome of B. theta and are described here.   
1.1.4.1 β-glucosidases  





GH3 contains enzymes with an plethora of functions that include β-glucosidases, β1,4-
xylosidases. Members of this family often have an array of specificities. GH3 enzymes 
cleave β-glycosidic linkages through a retaining, double-displacement mechanism of 
catalysis (Paal et al., 2004).  Characterised GH3 enzymes that target β-glucans are 
exo-hydrolases, which act at the non-reducing termini of β-D-glucan polymers and 
glucooligosaccharides. Characterised GH3 β-glucosidases target β1,3, β1,4 and β1,6 
linkages, with some enzymes capable of cleaving both β1,3 and β1,4 glucosidic bonds 
(Hrmova et al., 1998). 
The three-dimensional structure of GH3 enzymes reveals significant diversity in 
domain number/arrangement, as well as seemingly low sequence identity amongst 
some family members. However, structural overlays of crystallised GH3 β-
glucosidases has shown that the architecture and amino acids in the active site are 
conserved, despite low sequence identity (Bohlin et al., 2013) 
1.1.4.2 β-glucanases 
β-glucanases are endo-acting glycoside hydrolases that cleave β-linked glucosidic 
linkages. Described in this thesis is a representative of GH30 subfamily 3. Previously 
characterised members of this subfamily display β1,6-glucanase activity. 
1.1.4.2.1 GH30 
The GH30 family utilizes a retaining mechanism of hydrolysis. Crystal structures of 
GH30 members revealed a TIM barrel (α/β)8 fold. Currently, no 3D structure of a GH30 
subfamily 3 β1,6-glucanase has been reported.   
GH30 β1,6-glucanase of eukaryotic origin have been investigated, but not extensively 
characterised.  The GH30 subfamily 3 fungal enzymes display endo-β1,6-glucanase 
activity. These enzymes target fungal cell wall β-D-glucans liberating small amounts 
of glucooligosaccharides (Oyama et al., 2002)  
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1.2 Carbohydrate Binding Modules 
Glycoside hydrolases that target complex recalcitrant substrates such as the plant cell 
wall often contain non-catalytic carbohydrate binding modules (CBMs).  CBMs 
potentiate the catalytic activity of their cognate catalytic domains through targeting or 
proximity effects (Bolam et al., 1998). CBMs that bind to single glycan chains often 
share the same specificity as their cognate enzyme, and direct the biocatalyst to its 
substrate. In heterogeneous complex structures, such as the plant cell wall, targeting 
enables efficient protein-substrate interactions. CBMs that bind insoluble 
carbohydrates increase the concentration of enzymes in the vicinity of these complex 
glycan superstructures leading to more efficient degradation. A third proposed 
mechanism by which CBMs potentiate the degradative capacity of their cognate 
enzyme is through non-catalytic disruption of the target substrate. This mechanism, 
however, has recently been questioned. This mechanism was founded primarily by 
the observation that CBP21, a member of CBM33, although not tethered to enzymes 
was able to substantially increase the efficiency of chitin degradation by endo-acting 
chitinases. CBP21 was later shown not to be a CBM but was an enzyme (lytic 
polysaccharide monooxygenase) that attacked chitin. Thus the poster boy of the CBM 
disruption school of thought has been discredited (Vaaje-Kolstad et al., 2010) .    
CBMs, Like glycoside hydrolases, are grouped in 71 sequence-based families on the 
CAZy database. The binding specificities of CBMs have been elucidated via 
biochemical and structural studies, with CBMs being observed to bind to a number of 
major plant cell wall polymers (cellulose, xylans, β-mannans, pectins) (Zhang et al., 




CBM ligand binding site topography is generally complementary to the conformation 
adopted by the target glycan and can often indicate the preference of the CBM for 
crystalline or soluble carbohydrates. As such, CBMs are grouped into three types 
based on binding site topology, A, B or C respectively, in attempts to provide functional 
classification. Type A CBMs bind to crystalline substrates. The ligand binding site of 
type A is planar and houses three aromatic amino acid residues. The hydrophobic 
surface presents a platform-like architecture, complementary to the crystalline surface 
presented by insoluble cellulose and chitin (Kraulis et al., 1989). Ligand binding in type 
A CBMs is entropy driven, believed to result from the release of trapped water 
molecules from the hydrophobic faces of crystalline ligands and the CBM itself 
(Creagh et al., 1996). Example CBM families which feature type A CBMs include 1,2, 
3, 5 and 10.  
The binding site of type B CBMs presents a cleft like topology that targets the internal 
regions of individual glycan chains (>15 Ǻ in length) (Charnock et al., 2002).  Type B 
CBM-ligand interactions are predominantly achieved through extensive polar contacts 
formed between ligand and polar amino acid residues housed within the binding cleft 
of the CBM. Additional specificity is conferred by aromatic amino acids, which most 
frequently form parallel hydrophobic stacking interactions with the sugar rings of the 
ligand, but can also adopt a sandwich conformation (Boraston et al., 2002). Such 
hydrophobic residues are often orientated to accommodate the target ligand. For 
example, CBMs that bind to xylan (which adopts a 3-fold screw axis conformation), 
often have two tryptophan residues located in the ligand binding cleft that are 
orientated 120o degrees to each other, thereby conferring xylan specificity (Simpson 
et al., 2000). Examples of CBM families which included type B CBMs are 4, 15, 16, 
20, 28 and 36. 
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The ligand binding site of exo-acting type C CBMs display a pocket topology and target 
the termini (primarily the non-reducing terminus) of glycan chains. The binding sites of 
type C CBMs accommodate 1 to 3 sugars.  Interestingly, appending a type C CBM 
(CBM66) which binds to the non-reducing termini of fructans, significantly enhanced 
the activity of its parent, non-specific β-fructosidase enzyme (GH32) against the highly 
branched fructan, levan, but not inulin, a linear fructose polymer. This example 
demonstrates how CBMs can confer enzymatic substrate specificity (Fujimoto et al., 
2013). Examples of the three functional topologies demonstrated by CBMs are shown 

















Whilst usually a more prevalent feature of lectins, binding proteins which are not too 
dissimilar to CBMs with regards to ligand binding mechanisms, avidity effects have 
been observed in enzymes that possess more than one CBM. The CBMs of these 
Figure 1.2. Examples of type A, ,B and C CBMs. (A) Structure of CBM1 from Hypocrea 
jecorina (B) Structure of CBM2 from Cellulomonas fimi. (C) Structure of CBM29 from 
Piromyces equii in complex with mannohexaose (D) Structure of CBM4 from Cellulomonas 
fimi in complex with cellopentaose (E) Structure of CBM9 from Themotoga maritima in complex 
with cellobiose, recognising the non-reducing terminus of the sugar molecule. (F) Structure of 
CBM6 from Bacillus halodurans in complex with laminarihexaose, recognising the non-
reducing termini of the sugar molecule. Structures are continuously colour ramped with 
aromatic amino acid residues contributing to binding shown as sticks.  Solvent accessible 
surface is coloured gray, whilst surfaces contributed to by aromatic amino acid residues is 
coloured purple. Co-complexed ligands are shown as blue sticks. Figure taken from Gilbert et 
al., 2013.  
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enzymes can demonstrate different binding specificities respectively, and can result in 
a greater degradative capacity of the parent enzyme (Cuskin et al., 2012) 
Calcium has been increasingly shown to play significant roles in CBM-ligand binding, 
mediating direct ligand recognition. The divalent metal ion can stabilize the 
conformation of residues that play a key role in ligand recognition, it can play a direct 
role in glycan binding or it can cause increased affinity through avidity effects by 
mediating CBM dimerization (Montanier et al., 2011).  
1.3 Complex polysaccharide – structure and function 
1.3.1 Major plant cell wall polysaccharides  
The plant cell wall is rich in polysaccharides and presents a complex and 
heterogeneous structure which is extremely recalcitrant to enzymatic degradation. The 
major components of plant cell wall are cellulose, hemicellulose, pectin and lignin, 
which form a network of polysaccharides, providing mechanical support to the plant 
cell.  
Cellulose consists of linear, undecorated β1,4-glucan chains, comprised of repeating 
cellobiose units (each sequential glucose monomer is orientated 180o to one another). 
Such glycan chains are arranged in parallel and from contacts via hydrogen bonding 
and van der Waals forces, resulting in crystalline structures known as microfibrils, 
comprising 36 or 24 cellulose molecules (Fernandes et al., 2011).  
Hemicellulose polysaccharides most commonly consist of β1,4-linked backbones 
which are extensively decorated, thereby preventing the formation of crystalline 
structures. Such glycan chains interact with cellulose microfibrils via hydrogen bonding 
and function to provide strength to the plant cell wall. The major polysaccharide 
components of hemicellulose are xyloglucan, xylan, mannan and mixed-linked 
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glucans, with the branching and abundance of each polysaccharide varying 
dramatically between differing plant species and cell types. The polysaccharide 
xyloglucan, consisting of a β1,4-linked glucan backbone substituted with α1,6-xylose 
residues, constitutes the most abundant glycan in dicot primary cell walls (20-25 % of 
cell wall) (Scheller and Ulvskov, 2010). Up to 70 % of the xyloglucan backbone can be 
substituted. Xyloglucans of the XXXG classification have three decorated glucose 
residues, with a fourth unbranched backbone residue. The XXXG motif repeats 
regularly in the polysaccharide. The structure of xyloglucan is not ubiquitous amongst 
species however, with permutations of the XXXG type of xyloglucan being observed 
which harbour additional mono or disaccharide residues capping the canonical xylose 
side chains such as galactose, arabinose and fucose (Larsbrink et al., 2014) . Within 
the plant cell wall, xyloglucan forms non-covalent interactions with cellulose, ‘coating’ 
the microfibrils, and is believed to act as a cross-linker, providing structural support 
during cell expansion. Another possible role xyloglucan provides is the prevention of 
cellulose microfibril aggregation, with xyloglucan acting as a spacer (Whitney et al., 
2000).  
Xylans are a major constituent of the hemicellulose of grass cell walls and are 
extensively substituted.  Up to 90 % of the xylose backbone of glucuronarabinoxylan, 
can be decorated with an array of saccharide residues, predominantly L-arabinose 
and D-(methyl)glucuronic acid but also D/L galactose D-xylose, acetate and ferulate 
groups, presenting a highly complex substrate (Albersheim et al., 1994) . Methyl-
glucuronic acid substitutions are more prevalent in dicots (10 %) than grasses (Pauly 




Mixed linked glucans are prevalent in grass cell walls, consisting of a linear β—linked 
glucan. The proportion of β1,4 to β1,3 linkages is 70:30 respectively.  
Heteromannans, such as β-mannans and glucomannans, represent a lower proportion 
of hemicellulose and act as a potential energy source in angiosperms. β-mannans are 
comprised of β1,4-linked mannosidic residues, whilst glucomannan consists of 
random sequences of glucose and mannose residues β1,4-linked in a linear fashion.  
Galactoglucomannan and galactomannan are polysaccharides in which galactose 
side chains are appended (α1,6)  to the respective β1,4-linked backbones (Vogel, 
2008).  
Three major pectins are present in the plant cell wall; homoglacturonan (HG), 
rhamnogalactturonan I (RG-I) and rhamnogalactturonan II (RG-II), the proportion of 
which is ~60%, ~30% and 10% respectively. RG-II, a sub-domain of the pectic fraction, 
represents a structurally complex carbohydrate and consists of an α1,4-linked 
homogalacturonan backbone decorated with two structurally distinct disaccharides 
and two distinct oligosaccharides (Buffetto et al., 2014). RGII exists as a dimer within 
the plant cell wall, and is cross linked via a borate molecule, forming a 1,2 borate-diol 
diester with the apiosyl residue containing side chain of RG-II (Kobayashi et al., 1996). 
Pectins are proposed to act as spacers within the plant cell wall, preventing the 
aggregation of cellulose microfibrils (Chanliaud and Gidley, 1999) 
Lignin, a component of secondary cell walls, provides strength to the plant cell wall. 
Lignin is highly hydrophobic and is comprised of hundreds of aromatic monomers, 
providing an extremely chemically complex structure. Lignin molecules are composed 
mainly of three monolignols; p-coumaryl, coniferyl and sinapyl alcohols which are 
polymerised via an oxidative process via free radicals (Davin and Lewis, 2000). As 
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such, the variety posed by lignin both chemically and sterochemically, renders the 
polymer extremely recalcitrant to enzymatic targeting. 
1.3.2 The yeast cell wall 
Yeast cells, typified by Saccharomyces cerevisae, are protected from environmental 
stresses via a cell wall. The wall consists of a variety of glucan and chitin 
polysaccharides cross linked covalently with proteins to form a matrix. Chitin 
contributes only 1% by dry weight of the total polysaccharide content of the wall of 
Saccharomyces species (Aguilar-Uscanga and Francois, 2003).  Described below are 
the more prominent polysaccharides, typical of the yeast cell wall, Figure 1.3. 
Significantly, the polysaccharide and mannoproteins components of the yeast cell wall 
have been found to display an array of bioactive properties in both humans and 
animals, predominantly through interaction with mammalian pattern recognition 
receptors. Pattern recognition receptors, such as the Toll-like and mannose receptors 
located on the cell surface of immune cells bind to both β-glucans and mannoproteins 
respectively, recognising these molecules as pathogen associated molecular patterns 
(Latge, 2010). Indeed, the polysaccharides of the yeast cell wall have been attributed 
to the stimulation of immunoregulatory cells (Chen and Seviour, 2007) and anti-










1.3.2.1 Yeast mannan 
 
1.3.2.1.1 Saccharomyces cerevisiae yeast mannan and mutant mannans 
Attached to the yeast cell wall proteins are α-mannans, bound via asparagine 
residues, which protrude extracellularly from the yeast cell. Manno-proteins constitute 
up to 50% of the yeast wall (Klis et al., 1998). The structure and saccharide 
constituents of yeast mannan can vary amongst species.   
Yeast α-mannans (yeast mannan) consist of an inner core region and an outer chain, 
Figure 1.4. The structure of the inner core region of yeast mannan is reminiscent of 
mammalian high mannose N-glycans. The inner core is composed of two β1,4 linked 
N-acetylglucosamine (GlcNAc) residues linked to a mannose residue via a β-1,4 bond.  
Appended to this trisaccharide structure are two branches, the first of which consists 
of two α1,6 linked mannose residues that are capped with α1,3 and α1,2 mannosyl 
residues, respectively. The other branch contains an α1,3-linked mannose.   
(Nakajima and Ballou, 1974). The outer chain of yeast mannan from S. cerevisae, 
consists of an α1,6 linked mannose backbone, decorated with α1,2 linked mannose 
side chains capped with α1,3 linked mannose residues.  Phosphate bridges also exist 
within the polysaccharide and add additional mannose side chains to the 
Figure 1.3. A cartoon representation of the polysaccharide network 
constituting the yeast cell wall. Figure adapted from Brown et al., 2014. 
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polysaccharide. The synthesis of yeast mannan is mediated by glycosyltransferases.  
The core region of yeast mannan is synthesised in the endoplasmic reticulum and the 
outer chain in the Golgi apparatus.  The glycosyltransferases responsible for the 
biosynthesis of the outer chain in S. cerevisae has been characterized through 
deletion studies in yeast cells. Mutants missing various outer chain 
















Figure 1.4. The structure of Saccharomyces cerevisiae Yeast mannan. M represents mannose 
residues and P represents phosphate. All arrows unless stated otherwise, denote an α-bond. The 
number above the arrow shows linkage.  Mutations of glycosyltransferases are coloured red.  All 
residues which follow/are below the blue lines are missing in that respective mutation. Figure adapted 




1.3.2.1.2 Schizosaccharomyces pombe yeast mannan  
Schizosaccharomyces pombe possesses a morphologically unique Golgi apparatus, 
which differs from other eukaryotes (Ziegler et al., 1994; Gremmill and Trimble, 1998). 
Two galactosyl transferases localized to the Golgi append galactose residues to 
mannans which are elongated from the core mannan structure (Ziegler et al., 1994). 
As such, the outer chain of S. pombe consists of an α-1,6 linked mannose backbone, 
with 98% of the backbone 2-O-substituted with α-1,2 linked, pyranose galactose 
residues. Around 10% of these galactose side-chains are capped with an additional 
β-linked galactose residue. Terminal β-linked galactose residues possess a pyruvate 
residue linked in a 4,6-acetal-(ketal-) manner.  
1.3.2.2 β-glucan fractions of the yeast cell wall 
1.3.2.2.1 β1,3-glucans 
Two fractions of β-glucan exist within the yeast cell wall. β1,3-glucans account for over 
half of the cell wall polysaccharides in S. cerevisiae. The β1,3-glucans of the yeast cell 
wall contain moderate β1,6-linked glucosdic decorations, and can extend up to ~1,500 
residues in length. The polysaccharide adopts a single or triple helical confirmation, 
stabilised by inter-chain hydrogen bonding, and present ‘spring’ like structures, 
believed to endow the yeast cell wall with a degree of tensile strength (Kopecka, 2013). 
1.3.2.2.2 β1,6-glucans 
β-1,6-glucans have an important role in cell wall structure by cross-linking other 
constituents of the cell wall, including manno-proteins and chitin (Kapteyn et al., 1999). 
Indeed, mutations resulting in disruptions to β1,6-glucan synthesis have lethal effects 
on yeast cells, owing the β1,6-glucan fraction acting to ‘hold’ the cell wall polymers 
intact (Kopecka, 2013).  The structure of the mature β-1,6-glucan polysaccharide in S. 
cerevisiae has only recently been fully elucidated by Aimanianda et al. (2009). The 
β1,6-glucan polysaccharide consists of a glucose backbone linked via β-1,6 bonds. 
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The backbone is substituted with β1,3 linked glucose units with sporadic capping of 
an additional β1,6 linked glucose appended to the glucose side chains (Figure 1.5).  
The polymer can extend up to 200 glucose residues in length (Aimanianda et al., 
2009), with the degree of branching of the polysaccharide varying between yeast 
species. In S. cerevisae β-1,6 glucans up to 7% of the polymer is branched, while 75% 
branching occurs in  S. pombe (Aimanianda et al., 2009). 
β1,6-glucans purified from S. cerevisae have previously been shown to possess anti-
carcinogenic properties inhibiting metastasis in a number of cancers, including colon 
carcinoma cells. This is believed to occur through the modulation of macrophages and 
natural killer cells (Yoon et al., 2008). β1,6-glucans interact with C11b/CD18 and 
Dectin-1 receptors, presented by neutrophils and macrophages, respectively. β1,6-
glucans, therefore, activate cytokine production and adaptive immunity, which,  
potentially may attenuate the impact of colitis (Jawhara et al., 2012). Indeed, Jawhara 
et al. (2012), demonstrated that yeast β-glucans demonstrated a beneficial effect on 
inflammation and the colonization of C. albicans (a potentially pathogenic yeast), in 





Figure 1.5. The structure of Saccharomyces cerevisiae β-1,6-Glucan. G indicates a glucose 
residue. All Arrows denote β-bonds and the numbers above the arrows represent linkage. Figure 
adapted from Aimanianda et al. (2009) 
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1.3.2.3 High mannose N-glycans 
High mannose mammalian N-glycans (HMNGs) are similar in composition to the core 
structure of yeast mannan.  The trisaccharide motif of GlcNAc-β1,4-GlcNAc-β1,4-
Mannose is preserved. Appended to this trisaccharide are eight mannose residues, 
linked via an assortment of alpha- linkages found in yeast mannan. HMNGs, however, 
are distinct from the yeast mannan core structure due to additional α1,2 linked 
mannose residues capping the termini of the mannose branches and their lack of an 
outer chain. 
HMNGs decorate the surface of intestinal epithelial glycoproteins and are present in 
secreted mucus. Bacteroides species, such as B. theta can scavenge these glycans 
(Martens et al., 2011) 
1.4 The human gut microbiome 
1.4.1 The composition of human gut microbiota and environment 
The human large bowel is inhabited by a vast array of micro-organisms which directly 
influence host health and nutrition. This community of microorganisms is referred to 
as the microbiota and encompasses commensal, symbiotic and pathogenic bacteria 
present within the gut (for review see (Bakhtiar et al., 2013). The microbiota contains 
~1014 bacteria grouped into around 1000 different species. The most prominent 
members of the distal gut belong to the phyla Firmicutes and Bacteroidetes, with 90% 
of the microbiota belonging to these two genera. The composition of the microbiota 
can fluctuate dramatically between individuals; however, a core ensemble of gut 
microbes is possessed by the majority of people (Qin et al., 2010) 
 
The composition of the gut microbiota can fluctuate dramatically due to diet and most 
astonishingly, the distribution of bacteria can alter in a time-scale of hours as a result 
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of selective feeding (Turnbaugh et al., 2009).  A diet high in fibre and containing 
abundant plant polysaccharides results in the proliferation of Bacteroidetes species 
and a decrease in the levels of Firmicutes (De Filippo et al., 2010). Calorie restricted 
mice display increased levels of Bacteroidetes than those whose calorie intake is low 
(Ley et al., 2005).  Likewise, obese ob/ob mice, which are genetically predisposed for 
over-eating, have a much lower abundance of Bacteroidetes species in their 
microbiota and an increased level of Firmicutes species than their wild-type 
counterparts. 
 The relationship between the human host and the microbiota is symbiotic in healthy 
individuals (Hwang et al., 2012).  Commensal bacteria inhabiting the gut prevent the 
colonisation of potentially pathogenic bacteria on the intestinal epithelium and so 
constitutes a barrier to infection (Turner, 2009).  Dendritic cells, generated in the gut-
associated lymphoid tissue, sample commensal bacteria via pattern recognition 
receptors such as Toll-like receptors. This enables the innate and adaptive immune 
system of the gut to distinguish between commensal and pathogenic bacteria, 
maintaining intestinal homeostasis (Quigley, 2010). A change in the composition of 
the microbiota results in dysbiosis and potentially disease. Inflammatory Bowel 
Disease (IBD) is the chronic inflammation of the gastro-intestinal tract and has been 
associated with dysbiosis. Crohn’s disease, a prevalent IBD, has been linked to a 
decrease in the number of Firmicutes species within the microbiota (Sokol et al., 
2008).  The microbiota is crucial for gut homeostasis, the imbalance of which has the 
potential to induce disease states.  
1.4.1.1 Bacteroides  
The Bacteroides genus of the Bacteroidetes phyla are glycan-degrading generalists. 
Bacteroides thetaiotaomicron (B. theta), is a Gram-negative bacterium belonging to 
the phylum Bacteroidetes (Rogowski et al., 2015). B. theta is a prominent member of 
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the human colonic microbiota and is one of the primary bacteria involved in glycan 
degradation in the gut (Sonnenburg et al., 2010). The microbiota presents a highly 
competitive environment. The success and fitness of the Bacteroides can be attributed 
to the capacity of this phylum to degrade the major classes of plant polysaccharides 
and host derived glycans. Transcription and growth studies (Martens et al., 2011) 
demonstrate that B. theta, in addition  to metabolising major plant polysaccharides 
such as starch, fructans and the pectins, is also capable of utilizing host O- and N-
linked mammalian glycans and α-mannans derived from yeast and other microbial 
eukaryotes (Cuskin et al., 2015b).  The closely related species, Bacteroides ovatus 
(B.ovatus), in addition to degrading pectins and fructans, also utilizes the major plant 
hemicelluloses such as xylans, -mannans and xyloglucans (Larsbrink et al., 2014; 
Rogowski et al., 2015). The ability of the Bacteroides genera to degrade such glycans 
is attributed to the many glycanases encoded by the organism’s genome. The CAZy 
database predicts that the B. theta genome encodes 261 glycoside hydrolases. 
Indeed, the strategies by which B. theta degrades glycans, beyond the proto-typical 
starch utilization system, have recently been further elucidated (See 1.6 Characterised 
PULs of Bacteroides). 
1.4.2 Complex glycan utilization and nutrient sharing 
The catabolism of complex dietary carbohydrates in the human alimentary underpins 
the structure of the human gut microbiota. The metagenome of the gut microbiota 
encodes for ~100-fold more genes than that of the human genome, many of which are 
targeted to polysaccharide degradation. As much as 18% of the B. theta genome is 
dedicated to glycan degradation and utilization (Rogers and Bruce, 2012). The human 
gut microbiota is exposed to a plethora of complex glycans which pass through the 
gastrointestinal tract largely undigested. Furthermore, the colonic microbiota is 
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exposed to host derived glycans in the form of secreted mucins and surface glycans 
of epithelial cells that are shed (Rogers and Bruce, 2012).  These dietary and host 
glycans represent a major potential nutrient source for gut bacteria. Indeed, prebiotic 
strategies (See Section 1.4.4), used to manipulate the composition of the human gut 
microbiota via the promotion of prebiotic bacteria, rely upon the use of complex 
carbohydrates only accessible to the targeted bacterial subset.  Such a strategy is 
heavily reliant on the glycan food web of the human gut microbiota (Rogowski et al., 
2015). For example, studies have shown that organisms, such as Ruminococcus gnavus 
modify host sialic acids such that the product is used exclusively by the Ruminococcus 
(Crost et al., 2013).  Apart from these few reports, how complex glycan degradation 
and utilization is orchestrated between the numerous members of the human gut 
microbiota is little understood, as is the potential for nutrient sharing in such a complex, 
highly competitive environment.  
1.4.3 Short chain fatty acids and their influence on host health and nutrition 
Short chain fatty acids (SCFA), the end products of bacterial fermentation of dietary 
glycans, are absorbed through the intestinal gut epithelium and can contribute up to 
10% of our total calorific intake (Ley et al., 2005). The role of the gut microbiota in 
energy harvesting is emphasized by the observation that germ-free rats display a 
lower abundance of SCFAs in the gut and excrete two-fold the amount of calories than 
colonized rats fed on identical, polysaccharide rich diets (Hoverstad and Midtvedt, 
1986). Germ-free Rats must compensate for this lack of energy absorption via 
increased feeding (Tremaroli and Backhed, 2012). This evidence suggests that the 
gut microbiota can be described as a functional metabolic organ and so underpins the 
mutualistic dependence which exists between the human host and gut microbiota. 
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The three main SCFA products of bacterial fermentation are butyrate, acetate and 
propionate and have repeatedly been shown to have a positive impact on gut health, 
some of these roles include acting as epithelial energy sources, vasodilators and 
modulators of the inflammatory response (For review see Tremaroli and Backhed 
(2012).  The ratio and abundance of SCFA produced within the gut is dependent on 
the level of carbohydrates consumed in the diet and the composition of the microbes 
which colonize the gut. For example, the co-colonisation of B. theta and 
Methanobrevibacter smithii is optimal for the fermentation and utilization of dietary 
fructans due to M. smithii using the products of B. theta fructan degradation and 
fermentation. Mice which are co-colonised with M. smithii and B. theta displayed a 
dramatic increase is adiposity, demonstrating an increased efficiency of fermentation 
and SCFA absorption compared to animals colonised only with B. theta (Samuel and 
Gordon, 2006). Butyrate is a major energy source for colonocytes. In germ-free mice 
colonocytes are starved of energy (Donohoe et al., 2011). Butyrate is an inhibitor of 
histone deacetylase, and so plays a significant role in cellular proliferation, 
differentiation and modulation of gene expression within the host colonic epithelium. 
As such, butyrate is believed to regulate up to 2% of transcription within mammalian 
colonocytes (Davie, 2003). Acetate and propionate are utilized in the liver and are 
important substrates in lipogenesis and gluconeogenesis. This is consistent with the 
increased levels of stored triglycerides in the livers of mice which harbour a gut 
microbiota..  
1.4.4 Probiotic and prebiotic strategies 
Dysbiosis of the gut-microbiota results in the induction of disease states, including 
obesity and Inflammatory Bowel Diseases (IBDs) (Quigley, 2010). In addition, due to 
the numerous health benefits conferred by SCFAs, dietary strategies designed to 
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target subsets of bacteria are being devised in the hope of engineering the microbiota 
to maintain human health. This is achieved by introducing or inducing sub-populations 
of bacteria to proliferate within the gut using probiotics or prebiotics.  
Probiotics are orally administered live strains of microorganisms, intended to colonise 
the GI tract to induce health benefits, including aiding in digestion. Clostridium 
butyricum, a butyrate synthesising bacterium present within the intestines of healthy 
adults, is utilized as a probiotic in the treatment of non-antimicrobial induced diarrhoea 
and constipation in humans (Okamoto et al., 2000). One recent study administered 
Clostridium butyricum to rats where it was observed that fatty liver disease progression 
was severely reduced as a result of the bacterium indirectly modulating lipogenesis 
leading to a reduction in triglyceride content and insulin resistance (Endo et al., 2013). 
Prebiotic strategies entail the inclusion of complex glycans resistant to host 
degradation within the diet, which are utilized by a specific subset of bacteria in the 
microbiota. Such strategies are cheaper than probiotics and are utilized readily in the 
animal rearing industries (Goffin et al., 2011). Evidence suggests that the composition 
of the gut microbiota can shift in response to short and long term dietary intervention 
(Turnbaugh et al., 2009).  Reduced inflammation was observed in genetically altered 
mice, predisposed for obesity when administered with prebiotics (Delzenne and Cani, 
2011).  
The findings of Rogowski et al. (2015) described in Section 1.4.2, illustrates the 
importance of understanding the mechanisms by which complex glycans are degraded 
by different members of the microbiota. For instance, the complex 
glucuronoarabinoxylan, utilized ‘selfishly’ by B. ovatus, would result in the proliferation 
of B. ovatus exclusively, a documented producer of propionate. However, if the diet 
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was supplemented with the less complex wheat arabinoxylans or glucuronoxylans, 
both B. ovatus and Bifidobacteria, which uses the oligosaccharides generated by the 
Bacteroides, could potentially thrive. Bifidobacteria mediate the production of the 
beneficial SCFA butyrate in the microbiota (Wachtershauser and Stein, 2000).  
Understanding these interactions with respect to glycan metabolism is critical when 
designing bespoke prebiotics.   
Yeast is a key component of the brewing and baking industries. The inclusion of 
mannan oligosaccharides and yeast cultures in diet has been observed to have a 
positive impact on intestinal health in a number of animal studies.  Weaning pigs 
whose diet was supplemented with yeast cultures demonstrated increased growth, 
improved intestinal health and a better immune function. These improvements were 
comparable to pigs fed antibiotic growth promoters and so has the potential to replace 
antibiotics in animal feed (Shen et al., 2009). Both yeast culture and manno-
oilgosaccharide supplementation in diet have been observed to improve gut 
morphology.  Increased jejunal villus height and an improved villus height to crypt 
depth ratio has been observed. This process is thought to be modulated by intestinal 
microbe colonisation, explaining increased growth rates through better absorption of 
nutrients in the gut (Dimitroglou et al., 2009). 
1.5 Polysaccharide utilization loci 
When B. theta was cultured with polysaccharides, it was observed that transcription 
of specific genetic loci were up-regulated. These gene clusters, defined as 
Polysaccharide Utilization Loci (PULs), encode an array of proteins tailored for the 
sensing, degradation and utilization of the polysaccharide that activates the locus. The 
defining aspect of a PUL is the presence of an extracellularly located homologs of the 
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SusD and SusC proteins (defined henceforth as SusDh andSusCh, respectively) 
present in the starch utilization system. SusDh binding proteins bind environmental 
glycans and facilitate the translocation of captured glycans into the periplasmic space 
through delivery to the energy dependant SusCh  transporter (Sonnenburg et al., 2010; 
Martens et al., 2011). There are 208 homologs of SusC and SusD pairs encoded by 
B. theta, indicating that the genome encodes an extensive array of glycan utilizing 
systems (Xu et al., 2007). Encoded by most PULs are other extracellular binding 
proteins, such as surface glycan binding proteins (SGBPs), which sequester glycans 
from the environment as a prelude to enzymatic digestion and translocation to SusDh 
proteins prior to import through SusCh pores. A myriad of extracellular and periplasmic 
glycanases, encoded by the PUL degrade captured glycans in a sequential manner, 
rendering short chain oligosaccharides and monosaccharides, which can be 
metabolized by the bacterium. Polysaccharide sensing and signal transduction is 
achieved via sensors encoded by the PUL. Hybrid two component systems (HTCS) 
and extra cytoplasmic function (ECF) σ factors which span the internal cytosolic 
membrane  are utilized in the up-regulation of the PUL and are activated by specific 
glycans (Miyazaki et al., 2005). 
The cellular localization of cell envelope associated proteins is inferred by the 
presence of a bacterial signal peptide. Proteins harbouring a type I signal peptide 
recognition motif are secreted to the periplasmic compartment of the cell. Proteins 
which encode a type II signal peptide motif are predicted lipoproteins and are localised 
to the extracellular membrane. Lipo-proteins harbour a canonical N-terminal cysteine 
residue to which an N-acyl-S-diaglyceryl molecule is bound following cleavage of the 
signal peptide, therefore anchoring the protein to the lipid membrane (Bos et al., 2007). 
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As stated above the PUL paradigm was built upon the starch utilization system (sus) 
first characterised in B. theta. The PUL encoding the sus system is composed of eight 
genes susRABCDEFG. SusE and SusF bind and sequester starch from the 
environment, enabling the extracellular α-amylase, SusG, to cleave the captured 
starch, hydrolysing the polysaccharide into long chain oligosaccharides. SusC and 
SusD work in tandem to import the products of SusG degradation into the periplasmic 
space where enzymes, encoded by susA and susB, act upon imported 
oligosaccharides, degrading them into small oligosaccharides and the 
monosaccharide glucose through neopullulanase and α-glucanase activities. SusR is 
a sensor/regulator element which spans the cytosolic membrane and is responsible 
for the further up-regulation of the sus system. A model of starch degradation by the 
sus system is shown in Figure 1.6. 
1.5.1 Extracellular binding proteins 
1.5.1.1 SusD-like  
The extracellularly located SusD, characterized in the starch utilization system of B. 
theta, has previously been shown to bind starch (Shipman et al., 2000). The 3D 
structure of SusD indicates that the 551 amino acid residue protein is composed of 22 
α-helicies, eight of which constitute four highly conserved tetra-trico peptide repeats 
(TPRs)(Koropatkin et al., 2009). These TPR motifs are implicated in the formation of 
protein-protein interactions, and are thought to mediate the SusC/SusD complex 
formed at the extracellular membrane (Cho and Salyers, 2001). 
The 3D structure of the SusD reveals a shallow-surface binding site which can interact 
with three individual glucose moieties of the starch molecule. Binding studies indicate 
that the curved starch analogue β-cyclodextrin binds to SusD with a ~10 fold higher 
affinity than the linear starch derivative, maltoheptaose (Koropatkin et al., 2008). 
Starch forms a cyclic complex in solvent, owing to the α1,4-glycosidic bonds which link 
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the glucose monomers of the polysaccharide, indicating that SusD displays preference 
for starch surrogates which possess a helical conformation. This suggests that starch 
recognition by SusD is structure dependant and is not conferred by the 
stereochemistry of the monomeric constituents of the polysaccharide. Conversely, the 
SusDh protein, BT1043, encoded by the O-glycan PUL of B. theta, binds to the 
reducing end of Di-β-N-acetyl glucosamine through hydrogen bonding. This is 
mediated via polar amino acid residues located in the ligand binding site (Koropatkin 
et al., 2009) and so ligand recognition is conferred by interactions with individual β-N-
acetyl glucosamine units. This indicates there is diversity in ligand recognition 
displayed by SusDh proteins. 
SusDh proteins have been shown to play a substantial role in polysaccharide utilization 
in B. theta (Koropatkin et al., 2008). The deletion of SusD in the sus system abolishes 
the ability of B. theta to utilize starch and its derivatives. Surprisingly, it has been found 
that SusD is vital for the utilization of linear malto-oligosaccharides, even with malto-
oligosaccharides with a D.P <6, for which the protein has undetectable affinity for. This 
suggests that SusD is not only required for starch binding and sequestering, but serves 
other functions vital to polysaccharide utilization. Martens et al. (2009) speculate this 
could be due to SusD being required to stabilise the SusC/SusD complex located to 
the outer-membrane in addition to delivering malto-oligosaccharides to the outer 
membrane SusC transporter. Indeed, SusD-like proteins have been observed that 
seemingly possess no binding function, suggesting that a proportion of SusDh proteins 
may act solely to stabilise the outer-membrane complex (Cuskin et al., 2015b). These 
hypotheses are consistent with the observation that other outer membrane proteins, 
such as SGBPs, are encoded by PULs and are more likely candidates for glycan 
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sequestering and initial binding of environment polysaccharides, reflecting their high 
affinity for these ligands (Bolam and Koropatkin, 2012).  
1.5.1.2 Surface glycan binding proteins 
Unlike SusDh proteins, SGBPs are not vital to polysaccharide utilization (Cho and 
Salyers, 2001). In vitro studies have shown that the deletion of SGBP genes does not 
impact on the capacity of B. theta to grow on the respective polysaccharide (Shipman 
et al., 2000).  Whilst the position of the SGBP ORF is generally conserved within the 
PUL, there is little sequential/structural homology shared between these binding 
proteins.  
1.5.2 SusC-like 
The SusCh transporter belongs to a family of TonB-dependant receptors found in 
gram-negative bacteria. The protein consists of seven domains, forming a porin at the 
extracellular membrane through which molecules can be transported into the cell in 
an energy dependant manner. Energy for transportation is generated through the 
formation of the TonB-ExbBD complex and proton-motif forces. Whilst energy is 
required for the translocation of macro-molecules, smaller molecules are able to 
diffuse freely through the porin and into the periplasmic space (Ferguson and 
Deisenhofer, 2002) 
1.5.3 Carbohydrate sensing and PUL up-regulation 
Carbohydrate sensing and PUL up-regulation is mediated primarily through hybrid 
two-component systems (HTCS) and extracytoplasmic function (ECF) sigma/anti-
sigma factors which span the cytosolic membrane of the bacterial cell. PULs are 
perpetually expressed at low levels. In response to the appropriate molecular cue, 
such as ligand binding to the sensor/regulator protein, specific PULs are up-regulated 
(Sonnenburg et al., 2010)  
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HTCS are composed of the domains found in the typical bacterial two-component 
system, and include, within a single polypetide chain, an N-terminal extracellular 
sensor, cytoplasmic histidine kinase, response regulator, phosphoacceptor domain 
and DNA binding domain (Sonnenburg et al., 2010; Bolam and Koropatkin, 2012). The 
degradation products generated by extracellular and periplasmic enzymes encoded 
by the PUL bind to the sensor domains of the HTCS, which protrude into the 
periplasmic space.  Once activated, it has been proposed that the cytoplasmic DNA-
binding domain may be released, binding DNA and therefore activating transcription 
(Miyazaki et al., 2005). Two classes of HTCS exist, the Reg_prop class and 
Periplasmic Binding Protein (PBP) class, grouped according to the structure of their 
respective periplasmic sensor domains. The Reg_prop class of HTCS bind 
oligosaccharides with a D.P ≥ 2 (Martens et al., 2011). Conversely, the only 
characterized PBP HTCS binds monomeric fructose (Sonnenburg et al., 2010). 
Nevertheless, the mechanism of signal transduction appears to be conserved 
(Sonnenburg et al., 2006; Martens et al., 2011). 
Recently, the structure of the periplasmic domain of a HTCS (BT4663), encoded by 
the heparin PUL of B. theta, reveals that ligand binding induces a conformational 
change in protein structure, which differs from the previously observed piston/rotation 
mechanisms of the sensor histidine kinases of two component systems. Upon ligand 
binding, the C-terminal domain of the protein appears to adopt a scissor blade-like 
closing mechanism. This enables the cytoplasmic histidine kinase domain to catalyse 
reciprocal phosphorylation for signal transduction (Lowe et al., 2012) 
Extracytoplasmic function (ECF) sigma/anti-sigma factors are regulatory elements 
which are encoded by some PULs. When the appropriate signal is received, the ECF 
sigma/anti-sigma release their sigma factor which binds to RNA polymerase and 
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stimulate transcription (Helmann, 2002). These regulators are mainly distributed in 
PULs dedicated to the degradation of O-linked mucins (Bolam and Koropatkin, 2012).   
1.5.4 Enzymes 
PULs encode an array of glycanases, which are tailored for the deconstruction of the 
polysaccharide. A myriad of enzyme are required to hydrolyse complex 
polysaccharides, reflecting the different linkages and sugar monomers that comprise 
such complex glycans. This is exemplified by the complex polysaccharide 
rhamnogalacturonan II (RGII). RGII is composed of 20 different linkages. To fully 
degrade RGII, no less than 20 glycanases would be required. B. theta has the capacity 
to degrade RGII. When B. theta was cultured on RGII, 30 ORFs were up-regulated, 
constituting the RGII PUL of B. theta (Martens et al., 2011).  This evidence suggests 
the number of glycanases encoded by PULs correlates to the complexity of the 












Figure 1.6. The starch utilization system of B. theta. A diagram of the starch utilization system of B. 
theta, the archetypal polysaccharide utilization loci. Environmental starch is sequestered via the 
extracellular binding proteins; SusFED, whereby it is hydrolysed via SusG, an extracellular α-amylase. 
Products of SusG degradation are transported into the periplasmic space through the extracellular 
membrane spanning porin, SusC. Long chain oligosaccharides are further degraded by the 
periplasmically located enzymes, SusAB, via neopullulanase and α-glucanase activity respectively and 
are transported into the cell through an inner membrane sugar permease whereby they are catabolised 
by the cell.  The products of periplasmic degradation also result in the further up-regulation of the PUL, 
mediated via the senor/regulatory element, SusR. Figure adapted from Martens et al. (2009). 
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1.6 Characterised PULs of Bacteroides  
Recent studies of the polysaccharide utilization systems of Bacteroides, highlights the 
complexity of the enzymes that mediate glycan degradation and are described below. 
1.6.1 The xyloglucan PUL of Bacteroides ovatus 
A B. ovatus PUL was up-regulated when the bacterium was cultured on xyloglucan, a 
relatively abundant dietary polysaccharide consisting of a β1,4-glucan backbone 
decorated with α1,6-xylose side chains, in a repeating XXXG or XXGG motif 
depending on the polysaccharide source. Side-chains can be capped with 
monosaccharides of galactose (β1,2-linked) or a β-D-1,2-galactose-L-α1,2-fucose 
disaccharide respectively.  The xyloglucan PUL, referred to as XyGUL, encoded for a 
SusD-like protein, a SusC-like protein, a HTCS as well as eight predicted glycoside 
hydrolases based on their location in CAZy sequence based families. A schematic of 
XyGUL and a model of xyloglucan utilization by B. ovatus is displayed in Figure 1.7 
and Figure 1.8 respectively. The extracellular degradation of xyloglucan is dominated 
by surface endo-xyloglucanase activity, mediated by two enzymes BoGH5A and 
BoGH9A respectively, generating short oligosaccharides from the polysaccharide.  
Genetic knock-outs of the BoGH5A ORF abrogated B. ovatus xyloglucan utilization, 
highlighting the importance of the enzyme in xyloglucan utilization. BoGH9A displayed 
low activity and deleting the gene encoding the endoglucanase did not affect B. ovatus’ 
ability to grow on xyloglucan.  Interestingly, no homologs of BoGH9A were encoded 
by orthologous xyloglucan PULs, perhaps providing an example of functional 













The remaining enzymes, predicted to be localised to the perisplasmic space, 
demonstrated the following exo-acting activities; GH2 β-galactosidase; GH3(A/B) β-
glucosidase; GH31A α-xylosidase and GH43 (A/B) α-L-arabinofuranosidase, 
Figure 1.7. The xyloglucan PUL (XyGUL) of B. ovatus. ORFs encoding enzymes are 
coloured blue. The function of the protein encoding ORFs are labelled accordingly 
according to function.  Figure adapted from Larsbrink et al., 2014. 
Figure 1.8. Proposed model of xyloglucan utilization by B. ovatus. Proteins are 
labelled according to function/GH family. Saccharide residues are represented by 
shapes and colours. Blue circles represent glucose, orange stars represent xylose, 
turquoise pentagons represent arabinofuranose and yellow circles represent galactose 
residues. The enzymes which remove individual monomers are coloured according to 
the saccharide residue they target. Figure adapted from La.rsbrink et al., 2014. 
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respectively, and act sequentially to debranch and depolymerise imported 
oligosaccharides into monomeric saccharides. Interestingly, the two GH3 β-
glucosidases encoded by XyGUL share specificities and act upon β-glucosidic 
linkages in identical contexts. The requirement for two seemingly identical activities in 
the PUL system is not understood, but again, suggests a degree of functional 
redundancy (Larsbrink et al., 2014) 
Interestingly, evidence suggests the XyGUL systems encoded by different  
Bacteroides species, harbour ORFs, which enable the use of xyloglucans derived from 
other plant sources. For example, orthologous XyGULs encode GH29 and GH95 α-
fucosidases, enabling the bacteria to efficiently utilize the xyloglucan of dicots. The B. 
ovatus XyGUL does not, however, encode α-fucosidases.  
The PUL described above provides an example whereby the depolymerisation of the 
targeted glycan, specifically a relatively abundant glycan, is mediated primarily by 
surface, endo-acting enzymes which show tolerance for decorations and release a 
plethora of short oligosaccharides into the extracellular space for import by the 
bacterial cell. Decoration removal is exclusively mediated in the periplasmic space.  
1.6.2 The xylan PULs of Bacteroides ovatus 
A study by Rogowski et al. (2015) demonstrates B. ovatus utilization of complex xylans 
and how different forms of xylan are degraded through the recognition of unique 
specificity determinants by the encoded protein ensemble. The genome of B. ovatus 
contains two PULs, implemented in the deconstruction of complex xylans. A schematic 
of the xylan PULs of B. ovatus is shown in Figure 1.9. Interestingly, the two loci appear 
to be regulated by different signalling molecules. The xylan PULs, designated PUL-
XylS and PUL-XylL, were up-regulated by undecorated xylans (birchwood 
glucuronoxylan (BGX)) or by more complex GAXs and arabinoxylans. Interestingly, 
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PUL-XylS encodes for fewer enzymes, reflecting the lower complexity of the glycans 
targeted by the locus. Both PULs encode a plethora of glycoside hydrolases belonging 
to CAZy families with known activities against xylans. However, PUL-XylL encodes 
glycoside hydrolases belonging to families which were not implicated in xylan 
deconstruction (GH31, GH95, GH97 and GH98), and highlights the potential 
difficulties faced when predicting enzyme specificities based on CAZy family location.  
Three surface enzymes, located in GH10 (BACOVA_04390), GH30 
(BACOVA_03432) and GH98 (BACOVA_03433), were implicated in the cleavage of 
the xylan backbone at the cell surface. Interestingly, the activity of the surface GH10 
enzyme appeared to be tailored to generate xylooligosaccharides with a DP >5.  
Previously characterised GH10 family members appear better suited to targeting 
smaller xylooligosaccharides.  Indeed, the typical GH10 (β/α)8-fold barrel of the 
enzyme appeared to be interrupted by two xylan binding CBMs, and it is speculated 
to form the extended substrate binding cleft of the enzyme (Rogowski et al., 2015).  
Such evidence suggests BACOVA_04390 had evolved to accommodate longer 
oligosaccharides at the cell surface, reducing release of short chain oligosaccharides 
which could potentially be lost to the extracellular space. The surface GH30 enzyme, 
BACOVA_03432 targets glucuronoxylan, conferred by the infrequent (Me)GlcA side 
chains positioned in the -2 subsite of the enzyme, which thus generates long 
oligosaccharides with a DP ~10. Similarly, the surface GH98, BACOVA_03433 
generates oligosaccharides specifically from CX; the first GH98 family member to 
display endo-xylansae activity. The GH98 enzyme required unique specificity 
determinants for activity, requiring xylopyranose and arabinofuranose decorations 
linked O3 and O2 to the xylan backbone. The three surface xylanases of the xylan 
PULs therefore require infrequent specificity determinants for activity, recognising the 
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differing decorations of a multitude of xylans and are seemingly adapted to target 
different substrates.  
The binding specificity of the SusD-like surface binding proteins of PUL-XylS and PUL-
XylL reflect the enzyme and signalling specificities of their respective PULs. 
BACOVA_04390 of PUL-XylS bound to xylooligosaccharides with a a DP >6, 
consistent with the xylooligosaccharide products liberated by GH10 endo-xylanase 
activity. BACOVA_03427, encoded by PUL-XylL, displayed affinity for BGX and CX, 





Figure 1.9. The xylan PULs encoded by B. ovatus. A schematic of the two xylan PULs 
encoded by B. ovatus, PUL-XylL and PUL-XylS respectively. Protein encoding ORFs are 
labelled according to protein function or CAZy sequence based family (if applicable). 
Figure adapted from Rogowski et al., 2015.  
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Three SGPB are also encoded by the xylan PULs of B. ovatus. The SGPB encoded 
by PUL-XylS displayed identical specificity as the SusD-like protein encoded by the 
same PUL, binding to undecorated xylooligosaccharides with a degree of DP >6 with 
affinities higher than the SusDh protein. 
Only one SGBP encoded by PUL-XylL demonstrated binding activity. 
BACOVA_03431, which bound to both BGX and CX. Interestingly, BACOVA_03431 
appears to be related to the GH10 family of xylanases but lacks the conserved catalytic 
nucleophile of the family. Similarly, the -2 subsite appeared to be abrogated. The 
SGBP, BACOVA_03431, appears to be an ‘inactive’ GH10 enzyme and is the first 
example of a catalytically inactive enzyme functioning as an SGBP.  
Similar to the xyloglucan utilization model (Larsbrink et al., 2014), the bulk of xylan 
decoration removal occurs in the periplasm, and is performed by an array of exo-acting 
enzymes. Such enzymes display activities against xylan decorations in different 
contexts. For example, BACOVA_03422, the first GH31 family member to display α-
xylosidase activity, liberates α-D-xylose units from the side chains of corn xylan but 
displays no activity against xyloglucan.  
Deletion studies performed by Rogowski et al. (2015) again reinforce the differing roles 
of PUL-XylS and PUL-XylL in degrading different xylans. Deletion of PUL-XylS 
abrogated B. ovatus growth on simple xylans, but not complex xylans. Conversely, 
deletion of the larger PUL, PUL-XylL, prevented B. ovatus growth on complex xylans 











The aims of this study are as follows; 
1. To further elucidate the specificity the CBM65 family demonstrates for 
xyloglucan over linear glucans through the biochemical and structural 
characterization of the second CBM65 module (CBM6BB), encoded by the 
endoglucanase EcCel5A. 
2. To explore the hierarchal degradation and mechanisms of yeast α-mannan 
utilization by B. theta through the biochemical characterisation of glycoside 
hydrolases which target α-mannosidic linkages. Elucidate the biochemical 
mechanisms by which B. theta targets the α-mannan of different yeast species, 
and to understand how the enzymatic ensemble encoded by the yeast α-
mannan PULs and high mannose N-glycan PUL of B. theta displays specificity 
for similar, but structurally distinct glycans.  
3. Explore β1,6-glucan utilization and degradation by Bacteroides through the 
biochemical and structural  characterisation of the enzymes/proteins encoded 









Chapter 2: Materials and Methods 
 
2.1 Molecular biology 
2.1.1 Bacterial strains and plasmids 
The strains of Escherichia coli and plasmids utilized in this study are listed in the 










Strain Description Usage Reference 
BL21 
(DE3) 




F'ompT,hsdSB (rB-mB), gal.dcm. lacY1, 
(DE3) 
Protein Expression Novagen 
TOP 10 F-mcrA Δ(mrr-hsdRMS-
mcrBC)±80lacZΔM15 ΔlacX74 recA1 
end A1 araD139 Δ(ara, leu)7697 galU 
galK Δλ- rpsL nupG tonA hsdR 
DNA manipulation Invitrogen 
Plasmid Size (kb) Genotype Supplier 
pET21a 5.4 Ampr*, T7 lac laclq Novagen 
pET28a 5.4 Kanr**, T7 lac laclq Novagen 
pET32b 5.9 Ampr*, T7 lac laclq Novagen 
PET43b 5.9 Kanr**, T7 lac laclq Novagen 
Table 2.1. Bacterial Strains used in this study 
Figure 1 
Table 2.2. List of plasmids used in this study 




2.1.2 Growth media  
Growth media used in this study is presented in Table 2.3. Once fully dissolved, all 
growth media utilized were subjected to autoclaving, as detailed in section XX. Unless 
stated otherwise, growth media, like all chemicals and reagents in this study, were 





Medium Reagents Amount per litre Notes
Bacto®tryptone 10 g
Bacto®yeast extract 5 g
NaCl 10 g
LB-agar Agar 2 g Agar added to pre-prepared 
100 mL LB media (2%), 
sterlilised and cooled before 
antibiotic addition
Tryptone Peptone 10 g
Bacto Yeast extract 5 g
Glucose 2 g
Cysteine (free base) 0.5 g
1 M KPO4 pH 7.2 100 mL
Vitamin K solution, 1 mg/mL 1 mL
TYG salts 40 mL
0.8% CaCl2 1 mL
FeSO4 , 0.4 mg/mL 1 mL 
Rasazurin, 0.25 mg/mL 4 mL





Cysteine (free base) 0.5 g
1 M KPO4 pH 7.2 100 mL
Vitamin K solution, 1 mg/mL 1 mL
FeSO4 , 0.4 mg/mL 10 mL
Rasazurin, 0.25 mg/mL 4 mL
Vitamin B12 0.01 mg/mL 0.5 mL
Mineral salts for defined medium50 mL
His-Heam solution (0.2 M 
Histidine, pH 8.0)
See notes
Final pH adjusted to 7.4 
using NaOH.
 Appropriate volumes of 
media were aliquoted into 
individual vessels prior to 
autoclaving. Media was left 
to cool before His-heam 
solution addition (1 µM per 1 
mL)
For growth experiments, 
excluding the appropriate 
controls, concentrated 
monosaccharide/polysaccha
ride solutions were added for 
a final concentration of 5 
mg/mL following sterilization 
and cooling. His-heam 











2.1.3 Selective media  
Selection of bacterial cells harbouring the plasmid of interest was performed by the 
addition of the appropriate antibiotic stock solution (1000-fold dilution) to growth media 




2.1.4 Sterilisation  
Growth media, apparatus and solutions utilized in the growth of bacterial cells were 
sterilized via autoclaving at 121 oC, 32 lb/ inch-1 for 20 min. Heat sensitive reagents 
were sterilised by filtering through 0.22 – 1 µM pore, filter discs (Supor® Acrodiscs 
(Millipore)) using sterile syringes.  
 
2.1.5 Storage of DNA and bacterial cells 
Plasmid DNA was stored at -20 oC in 10 mM Tris/HCl buffer, pH 8.5 (Elution buffer, 
(Qiagen)).  Bacterial colonies grown on agar plates were stored at 4 oC for a maximum 
of one week.  Bacterial cells subject to long term storage were kept at -80 oC in 25% 






Ampicillin 100 mg/mL in H20 100 µg/mL 4 oC < 5 days 
Kanamycin  10 mg/mL in H2-0 10 µg/mL 4 oC < 5 days 
Table 2.4. Antibiotic stocks 
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2.1.6 Plating of bacterial cells 
Prior to spreading, a metal utensil was sterilised via submersion in 100% ethanol and 
passing through a flame and subsequently allowed to cool (~30 sec). Bacterial cells, 
suspended in media (100 µL), were pipetted onto the surface of the media-agar plate 
and spread evenly over the plate surface. Plated cells were incubated for 16 h at 37oC 
2.1.7 Anaerobic growth of B. thetaiotaomicron and B. ovatus 
Bacteroides species were cultured in tryptone, yeast extract, glucose (TYG) media 
when optimal growth was required and to generate a ‘viable’ cell population following 
cryo-storage. Typically, a glass test tube containing 5 mL of TYG media (prepared as 
described in Section 2.1.3) was inoculated with 50 - 100 µL of Bacteroides cells from 
a glycerol stock (25% (v/v)) or directly from a previous culture. The tubes were 
subsequently incubated in an anaerobic cabinet at 37oC until stationary phase was 
reached (2.0 OD600nm). 
For experiments assessing the ability of Bacteroides species to utilize differing carbon 
sources, minimal media was utilized (prepared as described in Section 2.13). Prior to 
experiments, cells were first washed via repeated centrifugation (5,000 x g, 10 min) 
and resuspension steps.  Cells were pelleted, supernatant discarded and cells 
resuspended in minimal media (5 mL) at least three times. Sterile tubes containing 5 
mL minimal media were inoculated with 200 µL of washed cells. The appropriate 
carbon source was added for a final concentration of 5 mg/ml via the addition of a 
concentrated sugar stock, sealed with cotton wool and incubated in an anaerobic 
cabinet (37oC). Cell growth was monitored by measuring the optical density of cells 
within the anaerobic cabinet via the use of a spectrophotometer. 
2.1.8 Centrifugation 
Cultured bacterial cells (100 – 1000 mL) were harvested via low speed centrifugation 
(5,000 x g for 10 min) in 500 mL vessels at 4oC using a JA-10 rotor and a Beckman 
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Coulter, J2-21 centrifuge. Bacterial cultures which were < 10 mL were centrifuged in 
25 mL sterilin tubes at 5,000 x g for 10 min using a Hettich Zentrifugen bench-top 
centrifuge. For Cultures < 1 mL, Eppendorf tubes were used as vessels and pelleted 
using a HEREAEUS PICO17 (Thermo Scientific) bench-top centrifuge. 
2.1.9 Chemically competent E. coli 
The chemically competent E. coli cells utilized in this study were prepared utilizing a 
protocol derived from Cohen et al. (1972) (Cohen et al., 1972). A single E. coli colony 
was used to inoculate 5 mL of LB media and incubated at 37oC for 16 h with 180 RPM 
shaking. The overnight culture (1 mL) was subsequently used to inoculate 100 mL of 
LB media and incubated under the previously described conditions until an OD600nm of 
4.0. The cells were put on ice for 20 min, and pelleted via gentle centrifugation (280 x 
g for 5 min). The resultant supernatant was discarded and pelleted cells were 
resuspended in 3 mL of ice cold 0.1 M CaCl2. The aforementioned process was 
repeated but with cell resuspension in 1 mL of ice cold 0.1 M MgCl2. Cells were 
subsequently kept on ice for 2 h, completing the process. Competent cells were stored 
as 100 µL aliquots with 25 % (v/v) glycerol at -80oC for long term storage.  
2.1.10 Transformation of E. coli 
Plasmid DNA (4 ng) was pipetted directly into competent E. coli cells (Section 2.1.9), 
mixed via gentle tapping and put on ice for 30 min under flame sterile conditions. Cells 
were subsequently heat shocked at 42oC for 1.5 min, before being replaced back into 
ice for a further 2 min. LB media (500 µL) was added to cells before incubation at 
37oC/180 RPM shaking for 1 h.  Following recovery, bacterial cells were subjected to 
gentle centrifugation (1.5 k RPM for 2 min). Upon centrifugation, 500 µL of supernatant 
was discarded, and transformed cells were gently resuspended in the remaining media 
supernatant by pipetting. Resuspended cells were then plated onto the appropriate 
antibiotic containing LB-agar plate as detailed in Section 2.1.3. 
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2.1.11 Replication of DNA 
The E. coli TOP 10 cell strain was utilized to generate plasmid DNA. TOP 10 cells 
were transformed, as described in Section 2.1.10 and plated on selective LB plates as 
described previously. Following incubation and TOP 10 colony formation, a single 
colony was used to inoculate 5 mL of LB-media containing the appropriate antibiotic. 
Cells were allowed to incubate at 37oC for 16 h with 180 RPM shaking. The cultured 
cells were subsequently harvested via centrifugation at 5,000 x g for 10 min. Resultant 
supernatant was gently removed and discarded before plasmid DNA was extracted 
from cells using a Qiagen QIAspin miniprep kit according to manufacturer’s 
instructions.  
2.1.12 Determination of DNA and protein concentration 
The estimated concentration of purified DNA and protein was assessed by absorbance 
at 260nm and 280nm respectively using a spectrophotometer (NanoDrop 2000 UV-
Vis spectrophotometer (Thermo Fisher Scientific Inc, USA) and applying the Beer-
Lambert formula; 
A = εCI 
 
Where by A = absorbance 280nm or 260nm; ε = molar extinction coefficient; I = length 
of light path (cm) and C = molar concentration of sample. The extinction coefficient of 
recombinant proteins was predicted using the following online tool; 
http://web.expasy.org/protparam/.  
2.1.13 Extraction of genomic DNA from Bacteroides cells 
Extraction of genomic DNA from Bacteroides cells was performed using the Sigma 
GenElute™ Genomic DNA kit, according to manufacturer’s guidelines. 
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2.1.14 mRNA extraction and protection from Bacteroides cells 
For experiments where-by the up-regulation of open reading frames in response to 
molecular cues needed to be ascertained in Bacteroides, Bacteroides cells were 
cultured anaerobically in minimal media and the appropriate carbon source as 
described in Section 2.1.7. Once mid-exponential phase (0.6 – 0.8 OD600nm) was 
reached, the RNA of the bacterial cells was protected and extracted using the 
RNAprotect (Qiagen) reagent and the RNeasy Plus minikit (Qiagen), respectively, in 
accordance with manufacturer’s guidelines.  
2.1.15 Reverse transcription of mRNA to cDNA 
The reverse transcription of mRNA to cDNA (extracted according to Section 2.1.14), 
was performed using the QIAGEN QuantiTect Reverse Transcription Kit, in 
accordance with manufacturer’s guidelines.  
2.1.16 Polymerase Chain Reaction 
DNA amplification was performed by PCR, using the Novagen Hot start PCR kit 
(Novagen). A typical PCR reaction is shown in Table 2.5. In this study, standard PCR 
was used primarily to amplify the DNA of protein encoding open reading frames 
(ORFs) via specific primers, complementary to each strand of the DNA molecule and 
designed to the flanks of the DNA region to be amplified (Mullis and Faloona, 1987). 
Primers were designed such that ~20 bases were complementary to the target DNA 
sequence. Where possible, target sequences were extended/reduced to permit for 
optimal G/C content; ensuring a melting temperature (Tm) of ≥ 50oC and a difference 
in Tm between the two primers not exceeding 5 oC. For cloning experiments, 
endonuclease restriction sites were engineered onto the 5’ end of the primers. An 
additional six bases were added onto the primer, preceding the restriction site, to 
facilitate restriction enzyme cleavage and subsequent ligations in similarly cut vectors. 
The online service, Webcutter 2.0 (http://rna.lundberg.gu.se/cutter2/), was used to 
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ensure desired restriction sites were not encoded internally within the DNA sequence 
to be amplified. OligoCalc (http://www.basic.northwestern.edu/biotools/oligocalc.html) 
was used to calculate primer parameters using the following formula; 
 
Tm = 64.9 + 41* (yG + zC -16.4)/ wA +xT +yG +zC) 
Where w, x, y, z are the number of bases A, T, G, C in the sequence, respectively 
 
Primers were synthesised and provided in lyophilized form by Eurofins MWG 
(Germany), and subsequently resuspended in highly distilled H20 (Sigma-Aldrich, UK) 
with a volume appropriate to provide the desired concentration. Amplifications were 
performed using a PHC-3 thermocycler (Biorad). A typical thermo-cyclic reaction is 
shown in Table 2.6.  The success of the amplification and integrity of the amplified 













Highly pure H2O 24 µL 
10 x KOD buffer (10 X 1.2 M Tris-HCL, 100 
mM KCl, 50 mM (NH4)2SO4, 1% Triton X-100, 
0.01% BSA, pH 8.0) 
5 µL 
dNTPs (2 mM) 5 µL 
MgSO4 (25 Mm) 4 µL 
Template DNA (~70 ng/µL) 1 µL 
Novagen KOD DNA polymerase (2.5 
U/µL) 
1 µL 
Forward oligonucleotide primer (5 µM) 5 µL 
Reverse oligonucleotide primer (5 µM) 5 µL 
Total Volume 50 µL 
 
 
Program name Event Temperature Duration Number of 
cycles 
Program 1 Denaturation 95oC 1 min 1 
Program 2 Denaturation 95 oC 1 min 
30 Annealing 50 oC 1 min 
Extension 68 oC 1 min/ 1 kbp 
Program 3 Final extension 68 oC 10 min 1 
Program 4 Storage 10 oC 16 h 1 
 
 
2.1.17 Site-directed mutagenesis 
Site directed mutagenesis (SDM) is a technique utilizing PCR to introduce nucleotide 
changes that encode a single, specific, amino acid change in the target protein. 
Forward and reverse oligonucleotide primers harbouring the mutation (in the centre of 
the primer) were designed to be complementary to the plasmid DNA template and 
codon optimised for E. coli. Primer parameters were calculated as described in Section 
2.1.16. For SDM applications, primers were typically designed to ~30 bp and to 
Table 2.5. Typical PCR reaction 
Table 2.6. Typical PCR thermocycle 
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possess melting temperatures of ≥ 50 oC. The standard SDM-PCR reaction, utilizing 
a Novagen hot-start KOD DNA polymerase, is displayed in Table 2.7. The thermo-
cyclic program is shown in Table 2.8. The success of the amplification and integrity of 
the amplified products was probed as described in Section 2.1.12 
 
5 µL  10 x Reaction buffer (20 mM Tris-HCL, pH 7.5) 
1 µL  dNTP mix (2 mM each) 
1 µL  KOD DNA polymerase (2.5 U/µL ) 
20 ng Plasmid dsDNA template 
125 ng Forward oligonucleotide primer 
125 ng Reverse oligonucleotide primer 





1 cycle at 950C for 2 min 
18 cycles at 950C for 1 min 
  550C for 1 min 
  680C for 2 min/kb of plasmid length (vector + insert) 
 
 
Table 2.7. A typical SDM-PCR reaction mixture 
Table 2.8. Thermocycler program for SDM-PCR reaction 
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After successful PCR amplification, 1 µL (10 units) of Dpn1 restriction enzyme was 
added to the reactions and incubated for 1 h at 37 oC. The enzyme digested parental 
methylated DNA but not the newly amplified, unmethylated DNA (harbouring the 
mutation). The plasmid DNA containing the mutation was then transformed into 
Escherichia coli TOP10 competent cells. SDM-plasmid DNA was subjected to 
sequencing analyses by Eurofins MWG, and read in the forward and reverse direction 
using primers designed to the T7 promoter and T7T terminator regions contained in 
the pET vectors (Novagen). 
2.1.18 Analysis of PCR result by agarose gel electrophoresis of DNA 
Agarose gel electrophoresis was used to probe the success of PCR, allowing for the 
detection and separation of amplified DNA fragments by size. Agarose gels (1 %) were 
created by the addition of 0.5 agarose (low grade (Melford Ltd) or SeaKem® Gold 
Agarose (Lonza) into 50 mL of 1 x 0.9 mM Tris base/ 0.9 mM boric acid/ 0.2 mM EDTA, 
pH 8.0 (TBE) buffer and subjected to heating via microwave. Once sufficiently cooled 
(< 50oC), ethidium bromide (1 µg/mL final concentration) was added, allowing 
visualisation of DNA. Gels were cast in mini-gel trays (Biorad) with an appropriate 
comb to provide wells. Once set, the gel-containing tank was filled with ~50 mL 1 x 
TBE buffer. Samples to be ran were prepared via the addition of 5 µL loading buffer 
(0.25% (w/v) bromophenol blue, 50% (v/v) glycerol, 10 x TBE buffer) to 5 µL of PCR 
reaction/DNA and loaded into wells. Hyperladder™ I markers were ran as DNA 
fragment size standards. Electrophoresis was ran at a constant voltage of 70 V for ~45 
min. Gels were visualised using Bio-Rad Gel Doc 1000 system (Bio-rad)  
2.1.19 Purification of PCR products 
Products of PCR amplification were purified using the Qiagen QIAquick PCR 
purification Kit (Qiagen), according to manufacturer’s instructions. To separate and 
purify amplicons of interest, DNA was extracted from the agarose gel (Seakem® Gold 
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Agarose) and purified using the Qiagen QIAquick Gel Extraction Kit (Qiagen), in 
accordance with manufactures’ guidelines 
2.1.20 Digestion of DNA using restriction enzymes 
Restriction digest of double stranded DNA harbouring endonuclease restriction sites 
was performed according to manufacturer’s guidelines (MBI Fermentas), providing 
optimal conditions for endonuclease activity. DNA subjected to endonuclease activity 
was purified as detailed in Section 2.1.19, preceding subsequent ligation steps.  
2.1.21 Ligation of digested insert and vector DNA 
Before being subjected to ligation, digested insert DNA and vector DNA were first 
purified as described in Section 2.1.19. DNA concentrations were first ascertained as 
detailed in Section 2.1.12, in order to provide a molar ratio of insert to vector of 3:1 in 
ligation reactions. Ligations were performed using the Novagen rapid ligation kit 
(Novagen) in accordance with manufacturer’s instructions. A typical ligation reaction 
is shown in Table 2.8. Reactions were left at room temperature for 30 min and 












Vector ( X ng/µL) Concentration dependant 
Insert DNA (Y ng/µL) Concentration dependant 
5 x Ligase buffer (250 mM Tris/HCL, pH 7.6, 
50 mM MgCl2, 25 µM ATP, 25 mM dithiothretol, 
25% (w/v) polyethylene glycol 8000) 
4 µl 
T4 DNA ligase (4 U/µL) 1 µl 
Ultra-pure H2O Up to total volume 
Total volume 20 µL 
 
 
2.1.22 Automated DNA sequencing 
DNA sequencing was performed using the MWG Biotech (Germany) Value Read 
service, to ensure the successful introduction of the desired mutation into the protein 
encoding DNA sequence (SDM) and/or to assess plasmid DNA integrity. Plasmid DNA 
samples (1.5 µg) were lyophilized using a vacuum pump. Typically, plasmids were 
sequenced from the forward and reverse direction using T7 promoter 
(TAATACGACTCACTATAGGG) and T7 terminator (CTAGTTATTGCTCAGCGGT) 
primers respectfully. If Internal regions of inserted DNA sequences were beyond 
flanking sequencing range, complementary internal primers were designed to probe 
sequence integrity. Bespoke primers for sequencing were also synthesised and 
utilized by MWG Biotech (Germany). Generated sequencing data was analysed using 
a multiple sequence alignment tool such as ClustalW 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
 
Table 2.9. Typical Ligation reaction 
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2.1.23 Quantitative PCR 
Quantitative PCR was performed using a Roche Light Cycler 480 real-time PCR 
system. For each sample of DNA to be quantified, 10 ng of cDNA (Section 2.1.15) was 
used and ran in duplicate. A typical qPCR reaction consisted of 5 µL SYBER green I 
master mix (Roche), 1 µL of forward and reverse primer (5 µM), 2 µL of cDNA template 
and 1 µL ultra-pure H20.  A typical qPCR reaction consisted of three cycles. 1) 
denaturing – 1 cycle, at 95oC for 5 min.; 2) cycling – 45 cycles at 95oC (5 sec), 50 oC 
(5 sec) and 72 oC (10 sec), respectively and 3) melt curve – 1 cycle at 95 oC (5 sec) 
and 65 oC for 1 min. The resultant data was analysed using the LightCycler® 480 
version 1.5.0.39 software (Roche) 
2.1.24 Over-expression recombinant proteins in E. coli 
E.coli BL21 or TUNER cells were transformed as described in Section 2.1.10 with 
the plasmid encoding antibiotic resistance and gene of interest, and plated onto 
Luria-Bertani (LB) media-agar with the appropriate antibiotic (10 µg/mL (kanamycin) 
or 100 µg/mL (ampicillin)). The transformed cells were grown for 16 h at 37 oC, and 
were subsequently used to inoculate 1 L baffled flasks of LB broth media containing 
the selective antibiotic (10 -100 µg/mL final concentration). Bacterial cells were 
cultured at 37oC with 180 RPM shaking to mid-exponential phase (A600 = 0.6). After 
cooling of bacterial cultures to room temperature, recombinant protein expression 
was induced via the addition of 1 mM (E. coli BL21) or 0.2 mM (E. coli TUNER) 
isopropyl β-D-1-thiogalactopyranoside (IPTG).  Induced cells were incubated 
overnight at 16 oC with 150 RPM shaking.  Cells were harvested via centrifugation at 
5000 x g for 10 min. The bacterial pellet was subsequently resuspended in 10 mL 
Talon buffer (20 mM Tris/HCl, 300 mM NaCl, pH 8.0) and sonicated, lysing the cells. 
The sonicated pellet was centrifuged at 15, 000 x g for 30 min, leaving a supernatant 
containing the soluble fraction (cell free extract, (CFE)) and an insoluble fraction (the 
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pellet).  The CFE containing the recombinantly expressed protein was then 
subjected to Immobilized Metal Affinity Chromatography (IMAC).  
2.1.25 Purification of protein 
2.1.25.1 Immobilised metal affinity chromatography (IMAC) 
Immobilized metal affinity chromatography was utilized to purify recombinant protein.  
The column, containing 2 mL bed volume of Cobalt Talon Resin (ClonTech), was 
first equilibrated by passing 20 mL Talon buffer through the column. The cell free 
extract (CFE), containing the His-tagged recombinant protein, was loaded onto the 
column through a 1.2 AcroDisc syringe filter (Pall Corporation), binding the tagged 
protein to the resin.  The column was washed using 20 mL Talon buffer, before the 
protein was eluted in a series of 10 mL elution steps using increasing concentrations 
of Talon buffer containing imidazole (5 mM and 100 mM respectively). Each fraction 
was subsequently analysed using SDS-PAGE for quality control.  Elution fractions of 
sufficient purity were dialysed overnight in 4 L of buffer at an appropriate pH 
(selected to reduce protein precipitation), removing imidazole from the purified 
fraction.  Protein concentration was analysed post-dialysis, as described in Section 
2.1.12. 
2.1.25.2 Ion-exchange and gel filtration chromatography 
Recombinant proteins of insufficient purity were subjected to further purification via 
ion-exchange chromatography and/or gel filtration, as were proteins entering crystal 
trails. An Akta pure system (GE healthcare) was utilized for both ion-exchange and 
gel filtration chromatography. Anion exchange chromatography was performed using 
a CaptoQ (GE healthcare) column. Proteins subjected to anion-exchange were first 
dialysed overnight into 20 mM TRIS/HCL pH 8.0 (Buffer A), concentrated if required 
(See Section 2.1.27) and subsequently loaded onto the pre-equilibrated column using 
a 1 mL loop (maximum of 10 mg total protein). A reservoir of 20 mM Tris/HCl,1 M 
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NaCl, pH 8.0 solution (Buffer B) was utilized to provide an increasing salt gradient over 
time. Fractions (1.5 mL) above an absorbance threshold of 0.02 absorbance units 
(280nm) were collected and subsequently probed by SDS-PAGE analysis.  
Gel filtration was performed using a HiLoad™ 16/60 Superdex™ 200 Prep grade 
column (GE Healthcare). Preceding the injection of protein,  the column was first 
equilibrated by passing two column volumes of buffer A (20 mM Tris, 150 mM NaCl, 
pH 8.0) through the column. The protein sample (concentrated to 1 mL), was 
subsequently loaded into a 1 mL loop and injected onto the column. Buffer A was 
passed through the column at a flow rate of 1 mL min-1. Protein fractions (1.5 mL) 
exceeding the set absorbance threshold were analysed in the same manner as 
described for anion-exchange. 
 Following SDS-PAGE analysis, samples of sufficient purity were pooled and buffer 
exchanged into a buffer of choice through repeated concentration/dilution steps (See 
Section 2.1.27). 
2.1.26 SDS-PAGE analysis 
The relative purity and size of recombinantly expressed proteins was analysed via 
SDS-PAGE. Polyacrylamide gels of 12.5 % (v/v) were utilised in this study. The 
polyacrylamide gels consist of two layers, a stacking layer and a larger resolving later 
respectively. The composition of each respective layer is displayed in Table 2.9. Gels 
were cast in 12 cm x 10 cm glass plates (ATTO Corporation (Genetic Research 
Instruments) and sealed via rubber bands. The resolving layer was first poured into 
the glass cassette, filling two 2/3s of the cassette, and topped off with water. Once the 
resolving layer had polymerised, additional water was discarded before the final 
stacking layer was poured. A comb (providing wells) was placed into the stacking 
layer, and allowed to set. Before gel use, the rubber seal and comb were removed. 
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Protein samples were prepared by the addition of 7 µL SDS loading buffer (Table 2.9) 
to 10 µL of purified protein fractions. Quality control samples generated during a typical 
IMAC purification, such as the insoluble fraction, cell free extract, un-bound flow 
through and the column wash, were prepared by adding 7 µL of SDS loading buffer to 
1 µL of the respective fraction.  Samples were boiled in a heat block for 3 min and 
centrifuged at 13,000 RPM for 5 min before being loaded onto the gel. Protein 
standards (Sigma), providing Mr markers, were ran with protein samples to provide an 
estimation of protein size. 
SDS-PAGE was performed by placing the gel containing plates within the 
electrophoresis  tank, which is filled with running buffer (Table 2.9). Samples were 
loaded onto the gel via pipetting and subjected to electrophoresis at a current of 35 
mA per gel. Protein bands were stained upon the completion of electrophoresis via 
submerging the acrylamide gel in Coomassie Blue stain (0.4% Coomassie Brilliant 
Blue R, 10% (v/v) glacial acetic acid) for ≥ 30 min and visualised using a Bio-Rad Gel 











Resolving Gel (12.5%) For 4 gels 
0.75 M Tris/HCl buffer, pH 8.8, 0.2 % SDS 9.4 mL 
40% Acrylamide 5.8 mL 
H20 3.5 mL 
10% (w/v) Ammonium persulphate 90 µL 
TEMED 30 µL 
Stacking gel  
0.25 M Tris/HCl buffer, pH 8.8, 0.2 % SDS 3.75 mL 
40% Acrylamide 0.75 mL 
H20 3.0 mL 
10% (w/v) Ammonium persulphate 60 µL 
TEMED 20 µL 
Loading buffer  
SDS 10% (w/v) 
0.25 M Tris/HCl buffer, pH 8.8, 0.2% SDS 5 mL 
Glycerol 25% (w/v) 
β-mercaptoethanol 2.5 mL (w/v) 
Bromophenol blue dye 0.1% 
Running Buffer  
32 mM Tris/ 190 mM glycine, pH 8.3 350 mL 
SDS 0.1% 
 
 Table 2.9 SDS-PAGE buffers 
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2.1.27 Concentrating protein and buffer exchange 
Purified protein fractions were concentrated using 20 mL Vivaspin™ centrifugal 
concentrators (Vivasceince) with appropriate Mr cut offs, dependant on protein size 
(30 or 10 kDa respectively). Centrifugation (5,000 x g) was performed using a swing 
out – MSE Mistral 3000i desktop centrifuge (MSE, UK).  For crystal screens where 
buffer exchanging was a necessity, the process was repeated via extensive 
dilution/concentration cycles, where by additional buffer/H2O was added to the protein-
containing compartment and centrifuged until a low volume (< 1 mL). The buffer 
exchange process was repeated at least four times.  
2.1.28 Protein crystallization screens 
The sitting vapour diffusion method was utilized for all crystal screens performed in 
this study. Typically, three commercial screens were utilized unless stated otherwise 
(JCSG+, PACT and STRUCTURE (Qiagen)). Screens were pipetted into the 96- well 
plates by hand.  In general, 80 µL of screen solution was added to the respective main-
well. The protein of interest (mg/mL) was pipetted using a mosquite™ robot (TTP 
Labetch), into the two sub-wells per condition with a 1+1 and 2+1 program, providing 
1 µL of protein plus 1 µL of screen solution and 2 µL of protein samples  plus 1 µL of 
screen solution, respectively. Attempts at the co-crystallisation of protein and ligand 
were performed via the addition of the respective ligand (concentration variable) to the 
protein of interest, before robot distribution.   Plates were visualised using a Leica MZ-








2.2.1 Enzyme assays 
Unless explicitly stated, all enzyme assays in this study were performed at 37oC and 
performed in triplicate in the presence of bovine serum albumin (0.1 mg/mL (w/v)). 
Kinetic graphs were plotted using GraphPad Prism 5.0 Likewise, the kinetic 
parameters generated were analysed and calculated using the aforementioned 
software using the appropriate form of regression 
2.2.1.1 Glucose and Mannose detection using mannose assay kit (Megazyme) 
A megazyme detection kit (D-Mannose, D-Fructose and D-glucose (K-MANGL)) was 
used for assays whereby the release of glucose or mannose by glucosidases or 
mannosidases  was quantified, respectively. For the detection of glucose, glucose 
released by the enzyme of interest is phosphorylated by hexokinase and adenosine-
5’-triphosphate (ATP) to glucose-6-phosphate (G-6-P). G-6-P is subsequently 
oxidised by NADP+, in the presence of G-6-P  dehydrogenase, to gluconate-6-
phosphate thereby simultaneously reducing NADP+ to NADPH. The formation of 
NADPH can be quantified at A340nm . The measurement of mannose by the kit relies 
on two additional enzymes to those described above, in addition to the hexokinase 
and G-6-P hydrogenase. Liberated mannose is converted to mannose-6-phosphate 
by a hexokinase, before being converted to fructose-6-phosphate (F-6-P) by 
phosphomannose isomerase (PMI). The generated F-6-P, is then converted to G-6-P 
by phosphoglucose isomerase. The subsequent steps, leading to the reduction of 
NADP+, are the same as described for glucose detection.  
The reactions were performed with the appropriate buffer for the enzyme of interest. 
The reaction mixture, minus enzyme, was aliquoted into glass cuvettes (500 µL) and 
allowed to equilibrate at 37oC, as was enzyme before being added. Absorbance was 
measured overtime at the aforementioned OD using a Pharmacia Ultrospec 400 
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spectrophotometer. The rate of monosaccharide (glucose/mannose)  release is 
stoichiometric to NADP+ reduction and can be quantified using the rate of NADP+ 
reduction over time and the extinction coefficient of NADPH (6300 M-1 cm-1) 
respectively. 
2.2.1.2 Galactose detection using galactose assay kit (Megazyme) 
A linked enzyme assay kit (Megazyme, (K-ARGA)) was used to quantify galactose 
released by galactosidases, and therefore deduce the kinetic parameters of the 
enzyme of interest. The methodology when performing these assays was as described 
in Section 2.2.1.1.  
The enzymes utilized in this assay result in the reduction of NAD+ to NADH, the 
absorbance of which can be measured at A340nm. Galactose, liberated by the enzyme 
of interest, is converted to β-D-galactose by galactose mutarotase. β-D-galactose is 
subsequently oxidised by NAD+ in the presence of β-galactose dehydrogenase . NAD+ 
is thereby reduced to NADH which is stoichiometric to galactose release. The rate of 
galactose release can therefore be quantified, as detailed in Section 2.2.1.1, using the 
extinction coefficient (6200 M-1 cm-1) 
 
2.2.1.3 Determining enzyme kinetic parameters using pNP-substrates 
The kinetic paramters of exo-acting enzymes against pNP-substrates were deduced 
spectrophotometrically, with the same methodology to Section 2.2.1.1. Enzymatic 
cleavage of the pNP group results in a stoichiometric increase in A400nm when the 
glyosidic linkage is cleaved. The resultant 4-nitrophenolate group has a molar 




2.2.1.4 5-Dinitrosalicyclic acid assay (DNSA) 
Reducing sugar assays measure the reducing ends of sugars. As a polysaccharide is 
cleaved, a new reducing end is exposed. This can be quantified using DNSA reagent. 
In this study, a reducing sugar assay was used to assay the activity of endo-acting 
enzymes against polysaccharides. Reactions included 1 mg/mL BSA. At the 
appropriate time point, 500 µL of DNSA reagent (1% w/v) DNSA, 0.2% (v/v) phenol, 
1% (w/v) NaOH, 0.002% glucose, 0.05% (w/v) NaS03) was added to a 500 µL aliquot 
of the reaction, terminating enzymatic activity.  The mixture was then boiled for 20 min, 
placed on ice for 10 min and left to equilibrate at room temperature. The absorbance 
of the reactions was measured at 575 nm. A standard curve containing 0, 50, 100, 
150, 200, 250, 300, and 400 µg of the appropriate monosaccharide was utilized to 
quantify the formation of reducing ends.  Excluding the addition of monosaccharide, 
standard curve samples were identical to reaction samples, including polysaccharide 
to control for background reducing ends. 
2.2.2 Fluorescent labelling of substrates  
Substrate labelling with 2-aminobenzamide, enabling detection via HPAEC with a 
fluorescent   detection module (Section 2.2.4), was performed using a Sigma 
GlycoProfile 2-AB labelling kit as per manufacturer’s instructions. 
2.2.3 Thin layer chromatography (TLC) 
In this study thin layer chromatography was used to analyse the digestion products of 
an enzymatic degradation of polysaccharides and oligosaccharides and to analyse 
purified oligosaccharides. Briefly, 3 µL of sample and the appropriate standards (1 
mM) is spotted onto a 10 cm tall TLC plate (Silicagel 60, 20 x 20, Merk). The width of 
the plate was sample dependant. Samples were spotted 1 cm from the bottom of the 
plate with 1 cm spacing between each sample and dried. The plate was placed into a 
1 cm deep pool of running buffer (butan-1-ol/acetic acid/water (2:1:1 (v/v))) inside a 
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covered, glass tank. Running buffer was left to migrate within 1 cm of the top of the 
plate, before being dried and replaced into the tank to run again as done previously.  
The plate was subsequently dried thoroughly and submerged in developer (sulphuric 
acid/ethanol/water (3:70:20 (v/v)), 1 % (w/v) orcinol) for 30 s before again being dried 
thoroughly.  The plate was developed through heating at ~80 oC for  5 min. Enzyme 
digestions to be analysed via Thin Layer Chromatography (TLC) typically included  
BSA (1 mg/mL) and were heat deactivated by boiling for 10 min.  Prior to analysis by 
TLC, assays would be centrifuged at 13,000 x g for 10 min.  
2.2.4 High Pressure Liquid Chromatography 
High pressure liquid chromatography (HPLC) was performed in this study for both 
qualitative and quantitative purposes. HPLC was used to elucidate the products of the 
enzymatic degradation of polysaccharides/oligosaccharides and to verify the 
homogeneity of oligosaccharides generated via size exclusion chromatography 
purification (Section 2.1.25.2 Ion-exchange and gel filtration chromatography). 
Substrate depletion assays were analysed using HPLC to ascertain the catalytic 
efficiency of an endo-acting glycoside hydrolases against oligosaccharides. Samples 
were analysed using a pre-equilibrated, analytical CARBOPACTM PA-200 anion 
exchange column and BorateTrap (Dionex) connected to an automated Dionex DX500 
and ICS3000 system (Dionex), which included a gradient pump, detector 
compartment, electrochemical detector and auto-sampler. Mono/oligosaccharides 
were detected using pulsed amperometric detection (PAD) using the following 
settings; E1 = +0.05, E2= +0.6, E3= -0.6. Typically, samples were eluted with 0-5 min 
100 mM NaOH, 5-25 min 100 mM NaOH and a 0-75 mM NaAC linear gradient, with a 
flow rate of 0.5 mL/min and a maximum pressure of 2000 psi. The appropriate 
monosaccharide and oligosaccharides were used as standards at a concentration of 
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0.1 mM unless stated otherwise. For quantitative assays, an internal standard of 
fucose (0.03 mM) was included in reactions. Fluorescent detection of 2-
aminobenzamide labelled substrates was achieved using a fluorometric detector 
module. Data was collected and manipulated using Chromeleon™ Chromatography 
Management System V.6.8 (Dionex) via a Chromeleon™ server (Dionex) and 
GraphPad Prism 5.0. 
2.2.5 Binding Assays 
2.2.5.1 Isothermal titration calorimetry (ITC) 
The thermodynamic parameters of protein-ligand interactions were ascertained via 
isothermal titration calorimetry (ITC), performed using a MicroCal™ VP-isothermal 
titration calorimeter. Heats of dilution were minimised during ITC experiments by 
dialysing the protein of interest into buffer. Said buffer was subsequently used as a 
solvent for ligand. Protein and ligand samples were first centrifuged (13,000 RPM for 
10 min) to pellet any impurities. Protein (typically 50 µM – 100 µM) was equilibrated in 
the cell of the machine (1.8 mL) at a constant temperature (25oC). Ligand was injected 
into the protein containing cell in 28 titrations of 10 µL with 200 s spacing between 
each injection, with stirring. Temperature fluctuations are measured during ligand 
injection. An increase (exothermic) or decrease (endothermic) in temperature per 
injection over a titration, is indicative of a protein-ligand interactions. 
The thermodynamic parameters of ligand binding generated via ITC, including the 
association constant Ka, binding enthalpy ∆H and the stoichiometry of binding (n) were 
interpreted using MicroCal Origin 7.0 software.  The change in Gibbs free energy ∆G0 





-RTInKa = ΔG = ΔH – TΔS 
R is the gas constant (1.99 cal.K-1 .mol-1), T is the temperature in degree absolute 
(298.15k), ΔG is free energy and ΔS is the entropy of binding. 
2.2.5.2 Affinity gel electrophoresis 
Affinity gel electrophoresis was used as a qualitative screen of binding to assess 
protein-polysaccharide interactions. Single layer, non-denaturing, polyacrylamide gels 
were produced and ran utilizing the same apparatus and equipment as described in 
Section 2.1.26. A typical non-denaturing, native gel consisted of  7.5 % (w/v) 
acrylamide and native buffer  (25 mM Tris and 250 mM glycine buffer, pH 8.3). Ligand 
binding was assessed via electrophoresing the protein/s of interest through a non-
ligand containing and a ligand containing gel. Polysaccharides were incorporated into 
gels prior to polymerisation, typically at a concentration of 0.1 % (w/v) unless stated 
otherwise. 
Protein samples were prepared via the addition of protein (5 µg total) to loading buffer 
(7 µL, 5 % (v/v) glycerol and 0.0025 % bromophenol blue)) and gently mixed. Both 
gels (ligand and non-ligand) were ran concurrently in the same tank, filled with native 
buffer and electrophoresed with a current of 10 mA per gel for ~ 2 h. BSA (5 µg total) 
was ran parallel to protein samples as a negative binding control. The resultant gels 
were stained and visualised following the same protocol as Section 2.1.26 
2.2.6 Generation and verification of substrates 
2.2.6.1 Purification of yeast α-mannan and mutant derivatives  
Overnight cultures of yeast (S. cerevisiae or S. pombe) were used to inoculate 1 L 
non-baffled flasks of Yeast extract/peptone/dextrose (YPD) media. Yeast cells were 
cultured at 30 oC with 150 RPM shaking until fully grown. Cells were harvested via 
centrifugation at 6000 RPM for 10 min. The resultant yeast pellet was resuspended in 
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10 mL 20 mM citrate buffer, pH 7.0 per litre of cell culture. The resuspended yeast 
pellets were subsequently pooled and autoclaved at 126 oC for 90 min. Autoclaved 
cells were subjected to centrifugation at 10,000 RPM for 10 min, giving a supernatant 
containing extracted polysaccharides and a pellet. The supernatant (supernatant 1) 
was collected. The remaining pellets were again resuspended in 20 mM citrate buffer, 
pH 7.0 (1.5 x original resuspension volume) and autoclaved again (125oC, 90 min). 
Following being autoclaved, the above centrifugation step was repeated and the 
resulting supernatant (supernatant 2) collected. Supernatants 1 and 2 were 
subsequently pooled and an equal volume of Fehling’s reagent was added to the 
pooled supernatants. The mixture was incubated at 40 oC for 2 h with stirring. 
Following incubating, the solution was divided into sterilins and the resulting precipitate 
harvested by centrifugation (5,000 x g for 10 min), rendering a pellet and supernatant. 
The supernatant was discarded and the white pellets resuspended with 3 M 
Hydrochloric acid, giving a light green solution (~2 mL of 3 M HCl per pellet). HCl (1 
mL at a time) was added to pellets if not fully dissolved. The resultant green 
resuspension was pooled together and slowly added to 100 mL of methanol/acetic 
acid (8:1) with gentle stirring and incubated for 15 min, giving a thick, white precipitate. 
The precipitate was subsequently pelleted via centrifugation (5000 RPM, 10 min) and 
the supernatant discarded. The pellets were further washed  (x3) with 100 mL 
methanol/acetic acid (8:1) by evenly distributing methanol/acetic acid mixture amongst 
pellets, vortexing briefly and centrifuging for 1500 RPM for 5 min.  A final methanol 
wash step (100% methanol) was performed before pellets were left to dry overnight . 
Once dry, each pellet was dissolved in ultra-pure H20 and dialysed into H20. When 
dialysis was complete, the solution was freeze dried, rendering purified α-mannan. 
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2.2.6.2 Purification of oligosaccharides by size exclusion chromatography 
The respective oligosaccharide mixtures was freeze dried and re-suspended in a 
minimal volume of 50 mM acetic acid (<5 mL).  Size exclusion chromatography was 
utilized to separate the mixture according to molecular mass.  Shorter 
oligosaccharides (D.P <6) were separated using P2 Bio-Gel (Bio-Rad), whilst longer 
oligosaccharides (D.P >5) were separated using P4 Bio-Gel. The respective Bio-Gels 
were packed into two Glass Econo-columnsTM (2.5 cm x 80.0 cm), and connected in 
series with flow-adapters (Bio-Rad) before being equilibrated with degassed 50 mM 
acetic acid, pumped through the columns at 0.2 mL min-1 using a peristaltic pump (LKB 
Bromma 2132 microperpex™).  The digestion mixture was loaded directly onto the 
column bed and allowed to settle before the acetic acid reservoir was pumped through 
the columns at 0.2 mL min-1. After the column dead volume (200 mL) had run through 
both columns, 2 mL fractions were collected with 3 µL of every 10th fraction (or more 
frequently for regions of interest) via TLC, and the D.P. of the oligosaccharides were 
estimated by comparing their migration with appropriate oligosaccharide standards. 
Selected pooled fractions were then freeze dried and analysed further through MALDI 
mass spectrometry (Section 2.2.6.3) and High Pressure ion exchange 
Chromatography (HPAEC) (Section 2.2.4). 
 
2.2.6.3 Mass spectroscopy 
Purified manno-oligosaccharides were analysed via MALDI-TOF MS (Matrix-Assisted 
Laser Desorption Ionisation – Time Of Flight Mass Spectrometry) to measure the 
molecular weight of the purified oligosaccharide. The purified oligosaccharide (100 
µM) was dissolved in water and diluted 10 fold with matrix (2,5-dihydroxybenzoic acid 
(DHB) 10 mg/mL (w/v) . The mixture (2 µL) was then spotted onto a MALDI plate and 
dried to co-crystallize the analyte and matrix before being analysed with the help of 
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Dr. Joe Grey and Dr. Adam Jackson. MALDI-TOF mass spectrometry analyses were 
performed with an AB4700 MS instrument (Applied Biosystems) in positive ion, 
reflector mode with 100 shots taken per spectrum. 
2.3 Bioinformatics 
2.3.1 Alignments 
The sequences of protein encoding ORFs analysed in this study were acquired via the 
integrated microbial genomes (IMG) gene search tool (https://img.jgi.doe.gov/cgi-
bin/mer/main.cgi?section=FindGenes&page=geneSearch). Alignments of DNA and 
protein sequences in this study were performed using ClustlW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/)  
2.3.2 Prediction of prokaryotic signal peptides 
The presence/type of signal peptide encoded by gram negative bacterial proteins 










Chapter 3: Understanding How Non-catalytic 
Carbohydrate Binding Modules Can Display 
Specificity for Xyloglucan 
3.1. Introduction 
Plant biomass represents a major nutrient source for the bacterial ecosystems of the 
rumen and large bowl of mammals (Mackie and White, 1990). This abundant carbon 
source is exploited through an array of microbial plant cell wall degrading glycanases 
encoded by such bacterium. The plant cell wall however, is highly recalcitrant to 
enzymatic degradation owing to its heterogeneous and complex structure (See 
Introduction Section 1.3.1. Because of such complexity, many of the plant cell wall 
degrading glycoside hydrolases encoded by ruminant bacteria often encode for non-
catalytic carbohydrate binding modules (CBMs). Primarily, CBMs potentiate catalytic 
activity through targeting or proximity effects (Bolam et al., 1998) . 
CBMs are grouped into amino acid sequence based families in the CAZY database 
(www.cazy.org) (See Introduction, Section 1.2). Recognition of target ligands by CBMs 
can be highly specific or promiscuous (Montanier et al., 2011). Usually, in CBMs which 
display a degree of plasticity, specificity is conferred through the recognition of a 
structure common to the target ligands. For instance, all CBMs which bind β-glucans 
(β1,4-glucans) also bind xyloglucan (β1,4-glucose backbone, α1,6-xylose single 
substitutions). However, as of yet, no evidence exists to suggest that such CBMs 
target the O6 α-xylose decorations of the polysaccharide, but merely accommodate 
them (Najmudin et al., 2006).  Ligand recognition in CBMs is therefore diverse and 
often compliments the activity/biological context of its cognate catalytic domain. 
A previous report identified an endoglucanase (EcCel5A) encoded by Eubacterium 
cellulosolvens. The enzyme two CBM domains that could not be designated into a 
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family based on sequence based similarities (molecular architecture shown in Figure 
3.1). Reported target substrates of the EcCel5A enzyme include lichenin, a β1,3-β1,4 
mixed linked glucan, carboxymethylcellulose and to a lesser extent, oat spelled xylan 
(poly-β1,4-xylose) (Yoda et al., 2005). The two CBMs, CBM65A and CBM65B share 
73 % sequence identity. It was previously reported that the two CBM65 modules of 
EcCel5a displayed binding to acid swollen cellulose and lichenin (β1,3/β1,4 glucan), 
barley β-glucan (β-1,3/β-1,4 glucan) and xyloglucan, indicating an unquantified 








Qualitative binding experiments suggest that the CBM65s of EcCel5a display a 
preference for xyloglucan. This was explored during my Masters of Research degree. 
CBM65A and CBM65B were expressed recombinantly and the specificity and 
mechanism of polysaccharide recognition was investigated through quantitative 
binding assessments and a structure informed strategy to probe the ligand binding site 
of CBM65A. No protein in complex with ligand was obtained during the Masters project 
Figure 3.1. The molecular architecture of EcCel5a. CBM65A comprises residues 27 – 120 
of EcCel5a. CBM65B comprises residues 581 – 713 of EcCel5a. 
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and so the exact mechanism of ligand recognition by the CBM65s was unclear. The 
data generated throughout the Masters project is incorporated into the following results 
chapter to provide a clear narrative.   
3.2 Objectives 
The objectives of this chapter are to explore the binding specificity and ligand 
recognition of the CBM65 family, informed by pre-existing biochemical data generated 
during the Masters of Research degree, and to provide further insight into how 
differential ligand recognition of β-glucans is achieved in this newly characterised CBM 
family.  
3.3 Results 
3.3.1 Biochemical characterisation of CBM65 specificity 
3. 3.1.1 Protein expression and purification 
 In order to investigate the binding specificities of the two CBM65s of EcCel5a, DNA 
encoding CBM65A and CBM65B, residues 27 – 170 and residues 581 – 713 of ful 
length EcCel5A respectively, were synthesised with codon usage optimised for 
expression in Escherichia coli and sub-cloned into a pET28a derivative by NZYTech 
Ltd, Portugal. The CBM encoding plasmids were used to transform E. coli TUNER 
competent cells. Cells were cultured and recombinant protein expression was induced 
according to standard protocol as outlined in Materials and Methods, Section 2.1.24. 
The recombinant protein contained an N-terminal His6-tag and were thus purified by 
immobilised metal affinity chromatography. Purity was assessed by SDS-PAGE. Both 
CBM65A and CBM65B ran with an apparent Mr of 17 kDa and 18 kDa respectively, 
consistent with their predicted size. For crystallography, CBM65A and CBM65B were 
purified further using size exclusion chromatography using a HiLoad 16/60 Super-dex 
75 colomn (GE healthcare). Chromatography was carrired out in 20 mM Tris-HCl 
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buffer, pH 7.5 containing 150 mM NaCl. Following purification, confirmed by SDS-
PAGE, recombinant protein was buffer exchanged into Sigma-ultra pure H2O using a 
10 kDa molecular mass centrifugal concentrator (Amicon). 
3.3.2. Specificity of the CBM65s 
3.3.2.1 Qualitative Evaluation of CBM65 ligand binding. 
The binding specificities of CBM65A and CBM65B were explored during the Master of 
Research degree using affinity gel electrophoresis (AGE) to provide a qualitative 
assessment of ligand binding. The results of AGE are displayed in Figure 3.2. 
Recombinant protein was electrophoresed through a non-denaturing, polyacrylamide 
gel in the presence and absence of ligand (varying concentrations (% w/v)). Protein-
ligand interactions retard recombinant protein migration and are indicative of binding 
when compared to the migration of a non-binding standard of bovine serum albumin 
(BSA).  Recombinant CBM65A and CBM65B bound to a several soluble β-linked 
glucans. Binding was observed to barley β-glucan, a β1,3/β1,4 mixed linked glucan 
and to decorated β1,4-linked glucans, such as xyloglucan (α1,6-xylose sidechain 
substitutions) and hydroxyethylcellulose (HEC). Neither CBM65A nor CBM65B bound 
to other β-linked polysaccharides, including xylans, glucomannans or galactans.  No 
binding was observed to α-linked glucans, indicating that the two CBMs preferentially 
target β1,4 – linked glucans. The inability of the CBMs to bind xylan suggests that the 
O6 moieties of the glucose residues which comprise the backbone of the β1,4 – linked 
glucans are specificity determinants, whilst the ability of the two CBM65s to bind to the 
decorated xyloglucan suggest a degree of side-chain tolerance or indeed specificity in 







3.3.2.2. Quantitative Evaluation of CBM65 ligand binding  
To further probe the binding specificities of the two CBM65 modules and to 
quantitatively assess the thermodynamic parameters of binding, isothermal titration 
calorimetry (ITC) was performed as described in Materials and Methods, Section 
2.2.5.1. The thermodynamic parameters of ligand binding generated via ITC, including 
the association constant Ka, binding enthalpy ∆H and the stoichiometry of binding (n) 
were interpreted using MicroCal Origin 7.0 software.  The change in Gibbs free energy 
∆G0 and change in entropy ∆S0 were derived using the equations,  also described in 
Materials and Methods, Section 2.2.5.1. 
 
Figure 3.2. Affinity gel electrophoresis of CBM65A and CBM65B against soluble 
polysaccharides.  CBM65A and CBM65B were electrophoresed through a non-denaturing, 
polyacrylamide gel in the presence and absence (Control) of ligand. Bovine serum 






















CBM65A β-Glucan 1.5  (±0.0) x 104  -5.7 -11.8 ± 
0.1 
-6.1 1.01 ± 
0.0 
CBM65A Xyloglucan 1.7 (±1.4) x 105 -7 -18.0 ± 
0.3 




1.2 (±0.0) x 104 -5.5 -11.1 ± 
0.2 
-5.6 1.02 ± 
0.0 
CBM65A Cellohexaose 2.1 (±0.3) x 103   -4.3 -11.3 ± 
5.5 





5.62 (±0.1) x 103 -5.1 - 9.6 ± 
0.4 
-4.5 1.03 ± 
0.0 
CBM65B β-Glucan 8.2 (±0.2) X 103 -5.3 -12.1 ± 
0.1 
-6.8 1.0 ± 0.0 
CBM65B Xyloglucan 1.01 (±0.1) X 105 -6.8 -4.2 ± 
0.1 
-7.7 1.0 ± 0.0 
CBM65B Hydroxyethylcellu
lose 
1.42 (±0.4) X 104 -5.6 -7.0 ± 
0.1 
-1.4 1.0 ± 0.0 
CBM65B Cellohexaose 2.31 (±0.2) X 103 -4.6 -2.8 ± 
1.0 




1.7 (±0.0) x 103 -4.4 -10.2 ± 
0.0 
-5.8 1.0 ± 0.0 
Table 3.1. Affinity and thermodynamics of CBM65A and CBM65B binding to soluble polysaccharides and 




The results of ITC of CBM65A and CBM65B, generated during the Masters of 
Research project are shown in Table 3.1. Both CBM65A and CBM65B display identical 
binding specificities, consistent with the AGE data. The CBM65s demonstrated affinity 
for the polysaccharide xyloglucan with a (Ka  ~105 M-1), whilst showing a ~10-fold 
reduction in affinity to the undecorated, mixed linked barley β-glucan and to 
hydroxyethylcellulose. 
Binding of the two CBM65s was quantifiably assessed against oligosaccharides. 
Moderate  binding affinities were observed against cellohexaose, with Ka values of 
~103 M-1 for both CBMs. Unquantifiable  binding to the oligosaccharides cellopentaose 
and  cellotetraose  was observed for the CBM65s with an estimated Ka value of << 
~103 M-1.  No binding to cello-oligosaccharides with a degree of polymerisation (D.P.) 
less than four was observed.  The CBMs displayed preferential binding affinities (Ka 
of ~103 M-1) for xyloglucan heptasaccharide (Glc4Xyl3 or XXXG), an oligosaccharide 
consisting of four β1,4-linked glucose residues with single xylose decorations at the 
O6 position of three glucose residues; the reducing end glucose is unsubstituted. The  
binding affinities and specificities of the two CBM65s, preferentially targeting β1,4-
linked and mixed β1,3-β1,4-linked ligands, is consistent with the documented activities 
of the CBM65s cognate enzyme, EcCel5a.  
 Typical of CBM binding to soluble ligands, the thermodynamic parameters of CBM-
ligand binding suggests that binding was primarily enthalpy driven with a canonical 
entropic penalty on binding affinity, indicated by a decrease in entropy (Boraston et 
al., 2004). The stoichiometry of CBM binding to soluble polysaccharides was 
calculated by altering the concentration of ligand until an n value of 1 was achieved (n 
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= number of binding sites), assuming a single site binding model. To determine the 
number of sugar residues occupied per CBM protomer, the following calculation was 
performed; 
 
Occupancy (No. of sugar residues per protein molecule)= 
 
 
CBM65A and CBM65B on average bound once per ~11 sugar residues in tandem, 
thereby indicating that the CBM65s bind to target ligands internally.  
 
3.3.3 Crystal Structure of the CBM65s 
To investigate ligand recognition and specificity determinants in the binding site of the 
CBM65s, attempts to co-crystallise the CBM65s with cellohexaose or XXXG were 
performed.  Co-crystallisation screens of CBM65A (80 mg/mL) using the hanging drop 
vapour diffusion method (described in xxxxx) with cellohexaose (10 mM) and XXXG 
(10 mM) produced crystals in the conditions 0.2 M ammonium sulphate, 0.1 M sodium 
acetate, pH 4.6, 30 % v/v PEG 2000 MME and 0.2 M lithium sulfate, 0.1 M Tris, pH 
8.5, 25 % w/v PEG 1500 respectively. The crystals of CBM65A in the presence of 
cellohexaose diffracted with a resolution of 1.6 Å and the data set was solved by Dr. 
Arnuad Baslé using molecular replacement of a selenomethionine-SAD derived 
CBM65A structure previously generated Dr. Shabir Najmudin (Lisbon, Portugal). No 
ligand was bound to the protein in crystal.  
 Concentration of polysaccharide used in ITC titration  g L  ÷ Mr of sugar monomer  Da    X 1000 (mM)




CBM65B (80 mg/mL) was co-crystallised with XXXG (100 mM) in 200 mM ammonium 
acetate, 100 mM tri-sodium citrate, pH 5.6, 22 – 30 % (w/v) PEG 4000. The CBM65B-
XXXG crystals are shown in Figure 3.3. Upon harvesting, the crystals were cryo-
protected in reservoir solution and 20 % PEG 400 containing XXXG (100 mM). The 
crystals were subjected to X- ray diffraction at the DIAMOND light source (Harwell, 
UK), beam line IO2 and diffracted at a resolution of 2.4 Å, generating a data set which 
was subsequently processed using the CCP4 suite. The CBM65B-XXXG protein-
ligand complex had a P43212 space group, belonging to the hexagonal system. The 
phase problem was solved utilizing the apo-crystal structure of CBM65B (previously 
solved by Dr. Shabir Najmudin (Lisbon, Portugal), in conjunction with MOLREP. 
Crystal fishing, data collection, structure building and refinement were all performed 
by Dr. Arnaud Baslé, structural biology lab, Newcastle University. Data collection and 





























Figure 3.3. Crystals of CBM65B and XXXG obtained via hanging drop vapour diffusion 
method.  CBM65B (80 mg/mL)/XXXG (100 mM) crystals were obtained in the following 
conditions; 200 mM ammonium acetate, 100 mM tri-sodium citrate, pH 5.6, 22 – 30 % 
(w/v) PEG 4000 . Figure taken from Venditto et al.(Venditto et al., 2013). 
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3.3.3.1. The apo-crystal structure of CBM65 
The solved structure of apo-CBM65A reveals that CBM65A protein adopts a β-
sandwich fold. Interestingly, unlike most CBMs which assume a β-sandwich fold, the 
CBM65s seemingly lack a stabilising calcium ion coordinated by loops connecting the 
β-strands (Simpson et al., 2002). The β-sandwich is comprised of two β-sheets 
connected by loops. β-sheet 1 is formed by five anti-parallel β-strands (termed β1, β9, 
β3, β7, β6) and  is convex in shape. The concave β-sheet 2, which comprises the 
solvent accessible surface of the protein, consists of four anti-parallel β-strands (β2, 
β8, β4, β5 respectively). The loop connecting β4 and β5 in CBM65A is longer than the 
structurally equivalent loop in CBM65B and is seemingly of functional significance 
(See 3.3.4.2 Understanding ligand recognition in the CBM65s). An α-helix (Lys125 to 
Tyr132/ Lys668 to Tyr675) completes the structures of CBM65A and CBM65B 
respectively. A protein schematic of the apo-structures of CBM65A and CBM65B is 
shown in Figure 3.4A 
3.3.3.2 The ligand binding site of CBM65 
The crystal structure of CBM65B in complex with XXXG shows a distinct cleft like 
structure, 20 – 25 Å in length presented by a β-sheet, typical of type-B CBMs which 
bind internally to target ligands (Figure 3.4B). The co-crystallised structure reveals the 
binding site harbours a significant number of tryptophan residues (Figure 3.4C). An 
overlay of the apo-CBM65A structure indicates these residues are strictly conserved 
(Figure 3.4D). Indeed, site directed mutagenesis of these residues to alanine 
diminished ligand recognition (see 3.3.4. Site Directed mutagenesis of CBM65A and 
CBM65B), thereby undoubtedly confirming that location of the ligand binding site 




3.3.3.3 β1,4-backbone recognition of xyloglucan heptasaccharide by CBM65B 
Analysis of the CBM65B-XXXG co-crystallised structure revealed that four tryptophan 
residues (Trp602, Trp607, Trp646, and Trp651) located inside the ligand binding cleft, 
coordinate recognition of the β1,4-linked glucose backbone of XXXG. Recognition of 
the backbone is mediated primarily through apolar contacts. Trp646 makes a parallel 
apolar interaction with the undecorated, reducing end glucose henceforth termed Glc-
1 (residues downstream from this residue are termed Glc-2,3 and 4 respectively,  with 
Glc-4 being the non-reducing end) . Trp651 coordinates both Glc-2 and Glc-3 whilst 
Trp602 interacts with Glc-4 through the formation of parallel hydrophobic contacts. The 
β1,4-backbone of XXXG is further coordinated via perpendicular apolar interactions 
between Glc-3 and Trp607. The orientation of the tryptophan residues within the cleft 
induce a twisting conformation between Glc-2 and Glc-4 of the tetrasaccharide 
backbone. The pyranose ring of Glc-1 is coordinated at an 180o angle relative to 
glucose-2. The only polar contact between CBM65B and the glucose backbone of 
XXXG is mediated via Gln653, which forms a hydrogen bond with the O2 and O3 
moieties of the non-reducing glucose residue (Glc-4).   
3.3.3.4 CBM65B recognition of the α1,6-xylose substitution of xyloglucan 
heptasaccharide.  
Xyl-2 (corresponding to the O6 linked xylose residue to Glc-2, Xyl-3 is O6 linked to 
glucose-3 etc.) is coordinated by Trp607, Trp646, Trp651, and Tyr685. Xyl-3 forms 
hydrophobic interactions with Trp651.  Polar interactions are mediated between O2 and 
the endocyclic oxygen of the Xyl-2 residue, coordinated by the nitrogen moiety of 
Trp607 and the Nζ group of the Lys689 residue. (Figure 3.4) The observed ligand 
recognition between CBM65B and XXXG and can be extended to CBM65A with a high 





3.3.4. Site Directed mutagenesis of CBM65A and CBM65B 
3.3.4.1 CBM65 Mutant generation, expression and purification  
Mutant variants of CBM65A (Master of Research degree) and CBM65B (D649A), were 
generated via single site directed mutagenesis as described in Materials and Methods, 
Section 2.1.17. The primers used to generate CBM65B variant, D649A are shown in 
Table 3.2. PCR amplifications, harbouring the single amino acid substitution were 
treated with Dpn1 in order to digest methylated-DNA, leaving the cDNA intact. 
Successfully amplified products were sent for sequencing (MWG, Germany) to check 
the integrity of the cDNA sequence, confirming the single base substitution to alanine 
was successful.   CBM65 mutant variants were expressed and purified with identical 




CBM65B variant Sequence (5´→3´) Direction 
D649A GCACGTTGGGATAAAGCCATTTGGGCGCAG Forward 
CTGCGCCCAAATGGCTTTATCCCAACGTGC Reverse 
 
3.3.4.2. Understanding Ligand Recognition in the CBM65s 
The apo-CBM65A crystal structure and the co-crystallised CBM65B-XXXG structure 
were used to inform which amino acid residues located in the ligand binding cleft of 




the CBM65s may mediate ligand recognition and specificity. The predicated aromatic 
ligand binding residues were conserved between CBM65A and CBM65B. Thus, 
mutations which were predominantly performed on CBM65A during the Masters of 
Research project to explore ligand recognition can also be applied to CBM65B. A 
number of single site substitutions of amino acid residues (Trp55. Trp60, Trp99 and 
Trp108) were previously generated by Ms S. Ana Luis (Lisbon, Portugal) in the ligand 
binding cleft of CBM65A 
AGE (polysaccharides) and ITC (polysaccharides and oligosaccharides) were 
performed to assess the binding capacity of CBM65A and CBM65B mutant variants 
to an array of ligands (Table 3.3). Substituting Trp55. Trp60, Trp99 to alanine in CBM65A, 
equivalent to Trp602, Trp607 and Trp646 in CBM65B, disrupted binding to barley β-glucan 
and cellohexaose but not to xyloglucan. Only mutating Trp108 to alanine (Trp651 in 
CBM65B) abrogated all ligand recognition. These data confirm the importance of these 
four aromatic amino acid residues to the recognition of the β1,3/β1,4 backbone of β-
glucan and cellohexaose and by extension, cellulose. The observation that xyloglucan 
recognition is maintained in all mutants except CBM65A W108A suggests that 
xyloglucan recognition is primarily preserved through other specificity determinants 





















The recognition of XXXG by the two CBM65s is generally conserved, as described in 
Sections 3.3.3.3 and 3.3.3.4 respectively. The connecting loop between β4 and β5 of 
CBM65A (harbouring residues Trp99 to Gln106), is longer than the equivalent region in 
CBM65A 
variant 










T58A β-Glucan 8.3 (±1.0) x 103 -5.3 -12.9  ± 
0.2 
-7.6 1.0 ± 
0.1 
Q106A β-Glucan 1.1 (±0.03) x 104  -5.5 -8.0  ± 0.2 -2.5 1.0 ± 
0.0 
Q110A β-Glucan 3.9 (±0.4) x 103 -4.9 -10.0 ± 
0.2 
-5.1 1.0 ± 
0.1 
K146A β-Glucan 5.3 (±0.2) x 103  -5.1 -9.9  ± 
0.5 
-4.8 1.0 ± 
0.0 
Y70A β-Glucan 1.1 (±0.08) x 104  -5.3 -11.7 ± 
0.8 
-6.4 1.0 ± 
0.0 
Y114A β-Glucan 1.1  (±0.02) x 104  -5.5 -12.8 ± 
0.3 
-7.3 1.0 ± 
0.0 
Y142A β-Glucan 8.9 (±0.04) x 103  -5.4 -13.0  ± 
0.6 









T58A Cellohexaose 2.5 (±0.4) x 103  -4.6 -11.4 ± 
5.5 
-6.8 1.01 ± 
0.4 
Q106A Cellohexaose No binding 
Q110A Cellohexaose Weak binding (unquantifiable) 
K146A Cellohexaose ~9.0(±1.2) x 102   Binding too weak to quantify 
Y70A Cellohexaose 2.9 (±0.3) x 103  -4.7 -11.8  ± 
3.8 
-7.1 1.0 ± 
0.2 
Y142A Cellohexaose 1.6 (±0.007) x 103   -4.3 -14.7 ± 
3.0 
-10.4 1.01 ± 
0.1 
Q106A Xyloglucan 3.5 (±0.5) x 104 -7.5 -26.7 ± 
0.7 
-19.2 1.0 ± 
0.0 
Q110A Xyloglucan 1.3 (±0.2) x 105 -6.9 -16.6 ± 
0.3 
-9.7 1.0 ± 
0.0 
W55A Xyloglucan 6.6 (±0.3) x 104 -6.5 -22.4 ± 
0.2 
-15.9 1.0 ± 
0.0 
W60A Xyloglucan 3.1 (±0.06) x 103 -4.7 -22.8 
±0.3 
-18.1 1.0 ± 
0.0 
W99A Xyloglucan 5.0 (±0.9) x 103 -5.0 -22.7 ± 
0.3 
-17.7 1.0 ± 
0.0 
W108A Xyloglucan No binding 
CBM65B 
variant 










D649A Cellohexaose 1.5 (±0.05) x 103 -4.3 -8.1 ± 0.2 -3.8 1.0 ± 
0.2 
Table 3.3. Affinity and thermodynamics of CBM65A and CBM65B variant binding to soluble 
polysaccharides and oligosaccharides   
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CBM65B. Inspection of an overlay of the two CBM65 protein structures indicates that 
Gln106 makes polar interactions with the O2 and O3 moieties of Glc-2 of the 
tetrasaccharide β1,4 backbone of XXXG. However, the equivalent residue Asp649, of 
CBM65B, is beyond hydrogen bond forming range and is unlikely to make polar 
contact with ligand, suggesting differential modes of cellulose recognition between the 
highly conserved CBM65s. Mutants, substituting Gln106 (CBM65A) and Asp649 
(CBM65B) for alanine displayed identical binding affinities to WT proteins for β-glucan 
and xyloglucan. The CBM65B mutant, D649A, did not abrogate cellohexaose 
recognition. However, the CBM65A mutant, Q106A, displayed no affinity for 


















Figure 3.4. Structure of the CBM65s. A. CBM65A and CBM65B, continuously colour 
ramped, are shown in a schematic form. The loop containing residues Gln106 and Asp649 of 
CBM65A and CBM65B respectively, are highlighted by an arrow. Gln106 is seemingly 
crucial for cellohexaose recognition in CBM65A; Asp649 (CBM65B) is not key in cellulose 
recognition. B. CBM65B is depicted as a schematic (colour ramped as A), with ligand 
electron density (2F0 – Fc) at 1.5 σ shown. XXXG is represented in stick format. Sugar 
residues are coloured according to element. Carbon moieties of glucose residues are 
coloured yellow, whilst the carbon moieties of the xylose decorations are yellow. C. Surface 
representation of the solvent accessible surface of CBM65B with XXXG in complex 
(coloured as in B). The aromatic residues key to ligand recognition are highlighted green. 
D. Overlay of the ligand binding sites of CBM65A and CBM65B showing conserved 
residues involved in ligand binding. The carbons of CBM65A amino acid residues are 
highlighted and labelled in cyan. The carbons of CBM65B amino acid residues are labelled 
and highlighted in green. Hydrogen bonds are represented by dashed lines. The diagrams 
were drawn in PyMOL. Figure taken from Luis et al., 2012. 
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3.4 Discussion  
This chapter reports the apo structure of CBM65A and CBM65B in complex with 
XXXG. The biochemical and structural data described demonstrates how the 
differential recognition of structures within the same ligand is mediated in the CBM65 
family.  Recognition of β-glucans, as shown by the CBM65B-XXXG complex, is 
primarily mediated through hydrophobic interactions between the tryptophan 
residues housed in the ligand binding cleft and the glucopyranose rings of the ligand 
backbone. These extensive hydrophobic interactions contribute significantly to 
binding affinity.   
The CBM65s displayed a significant preference for polysaccharides (xyloglucan and 
barley β-glucan) and decorated oligosaccharides (XXXG). The association constants 
generated by ITC indicate that both the CBM65s bind to cellotetraose with a lower 
affinity than cellohexaose The β1,4-backbone of cellotetraose however, fully 
occupies the ligand binding site. It is plausible that the increased interactions 
between the ligand binding site of the CBMs and the two additional glucose moieties 
of cellohexaose are responsible for the increase in observed affinity. However, the 
amino acids which mediate these extra ligand contacts are unknown. Potential 
candidates include Tyr70 and Tyr617 of CBM65A and CBM65B respectively, located at 
the entrance of the ligand binding cleft, and a glutamine (Gln67 in CBM65A and 
Gln659 in CBM65B). However, mutant variants of CBM65A where the aforementioned 
residues were substituted for alanine demonstrate similar affinities for the 
hexasaccharide to that of the WT protein, excluding their possible involvement in 
cellulose recognition. An alternative explanation for the seemingly low affinity 
displayed for cellotetraose could be due to mutarotation of the reducing end glucose, 
which would adopt multiple conformations and result in a loss of entropy. Ligands 
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with a D.P > 4 would instead be in a fixed conformation and thereby restrict 
mutarotation, reducing the associated entropic penalty.  However, the fact that mixed 
linked glucans or β1,4-gluco polysaccharides bind with higher affinity than 
cellohexaose suggests that the conformational fixing of the reducing end glucose is 
not the sole reason for the observed decrease in affinity for cellotetraose. It has been 
observed that ligands which extend out of the ligand binding cleft of the CBM can 
bind with greater affinity than a ligand which occupies the binding site fully (Boraston 
et al, 2011) due to intra-chain hydrogen bonding formed between the glycan chains 
and may explain the displayed increased affinity the CBM65s share for longer, linear 
β-glucans. Thermodynamic parameters generated in this study must be viewed with 
a degree of caution. The c – value, product of protein concentration and the binding 
constant (Ka), provides an indication of reliability of the thermodynamic data 
generated by ITC.  A c - value of < 1 is potentially indicative of unreliable data 
(Turnbull and Daranas, 2003). Many of the protein-ligand interactions investigated in 
this study have c - values < 1. However, for low affinity systems, such as protein-
carbohydrate interactions it is not possible to achieve c – values in optimal ranges 
due to limited solubility of ligands. Nevertheless, reliable Ka and ΔH values can be 
generated in low-affinity systems through measures deployed in this study as 
described by Turnbull and Daranas (Turnbull and Daranas, 2003). 
Mutating Gln106 in CBM65A completely abrogated cellohexaose binding. However 
the affinity of the mutant CBM Q106A for xyloglucan and the mixed linked, β-glucan 
was retained. This observation implies that CBM65A displays plasticity in ligand 
recognition, recognizing both linear β1,4 glucans and  β1,3-1,4 mixed linked glucans 
independently and that Gln106 is only necessary for cellulose recognition. 
Interestingly, CBM65B lacks a functional equivalent to Gln106. Mutating the perceived 
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functional equivalent in CBM65B, Asp649, the only residue observed to form polar 
contacts with the glucose backbone of XXXG, did not impact upon cellohexaose 
recognition.  Additionally, if the mechanism of CBM65B recognition of linear β1,4 
glucans can be disrupted independently of β1,3-1,4 mixed linked glucan recognition 
is not known.  
 The data presented in the chapter shows how the CBM65s preferentially target 
xyloglucan. The increased affinity demonstrated by the CBM65s for decorated 
ligands can be attributed to both the apolar and polar interactions between the ligand 
binding site residues of CBM65B and the O6-linked xylose residues of XXXG (and 
by inference CBM65A). These interactions significantly increasing the affinity of the 
protein modules for the decorated ligands. Ligand binding is primarily achieved by 
hydrophobic contacts of the sugar rings with aromatic amino acids (McCartney et al., 
2006). Indeed, hydrophobic stacking of aromatic residues against the 
pyranose/furanose rings of sugar residues are common features of β-glucan binding 
CBMs, which is usually coordinated by three aromatic residues housed within the 
ligand binding cleft (Simpson et al., 2000). However, five aromatic residues are 
located within the binding site of the CBM65s which make apolar interactions with 
the glucose backbone or xylose decorations of XXXG. 
The importance of the aromatic residues of the ligand binding cleft to ligand binding 
is emphasised by the observation that mutating Trp108 in CBM65A, equivalent to 
Trp651 in CBM65B destroys ligand recognition, including the recognition of 
xyloglucan. This is consistent with the observation that the CBM65B-XXXG complex 
reveals that significant coordination of the bound ligand is mediated by Trp651. The 
aromatic residues interacts with the Glc-2 and Glc-3 residues and the Xyl-2 and Xyl-
3 decorations of XXXG. Trp60 and Trp99 alanine substitutions in CBM65A (Trp607 and 
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Trp646 in CBM65B) also result in reductions in binding affinity, highlighting the 
importance of these of aromatic residues in recognising the glucan backbone and 
xylose decorations of XXXG. Conversely, mutating Trp55 (Trp602 in CBM65B) to 
alanine did not diminish CBM65A affinity for xyloglucan, most likely due to the lack of 
interactions with xylose-4 of XXXG. These data help to provide a model for the 
recognition of decorated polysaccharides.  
 3.5 Future Work 
CBM65A and CBM65B, new members of the CBM family 65 share limited sequence 
similarities to two endoglucanases encoded by Cellulosilyticum ruminicola and 
Clostridium lentocellum. The endoglucanase of C. ruminicola, displays two tandem 
repeat sequences with homology to EcCel5a. Significantly, three of the four 
tryptophan residues which are critical for β-glucan recognition in CBM65A and 
CBM65B are conserved in the related protein modules the C. ruminicola 
endoglucanase (Figure 3.5). One can hypothesise that these conserved residues 
likely play a similar role and are key in mediating β-glucan recognition. A better 
understanding of how this new family of CBMs recognise the decorations of 
substituted polysaccharides in lieu of conserved structural elements may enable the 
engineering of CBMs with multiple specificities in tandem with higher affinities which 



















Figure 3.5. Amino acid sequence alignments of CBM family 65 proteins. The amino 
acid sequences labelled EcCBM65A(/B) are from the Eubacterium cellulovorans (Ec) 
GH5 endoglucanase. The protein sequences labelled CrCBM65A(/B) are from the 
Cellulosilyticum ruminicola (Cr) GH5 endoglucanase.  Key residues necessary for ligand 
recognition are coloured green. Fully conserved residues are denoted by an *. Figure 
adapted from Luis et la., 2012. 
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Chapter 4: α-mannan degradation and utilization by 
Bacteroides thetaiotaomicron. 
4.1. Introduction 
The human gut microbial community, termed the microbiota, plays a pivotal role in 
human health and nutrition (Arpaia et al., 2013). Key glycan degraders such as 
Bacteroides thetaiomicron (B. theta), are prevalent in the microbiota of ‘healthy’ 
humans. Complex glycan utilization is achieved through a protein/enzyme ensemble 
up-regulated to orchestrate the deconstruction of a specific glycan. These glycan 
degrading systems are encoded by polysaccharide utilization loci (PULs). Each PUL 
encodes a system that degrades a specific glycan (Bolam and Koropatkin, 2012) 
Yeast α-mannan is an  important component of the cell wall of yeasts such as 
Saccharomyces cerevisiae (S. cerevisiae) A ubiquitous feature of the glycan is an 
α1,6-mannose backbone that comprises the outer chain of the polysaccharide. The 
mannose containing backbone is decorated with a range of side chains that can vary 
significantly amongst yeast species. The α1,6-mannan backbone of S. cerevisiae is 
decorated with α1,2-linked mannose side chains and is capped with α1,3-linked 
mannose residues. Phosphate bridges provide additional complexity to this substrate, 
linking an α1,3-mannobiose moiety to mannose residues appended directly to the 
α1,6-mannan backbone of the glycan. The side chains decorating the α-mannan 
backbone of Schizosaccharomyces pombe (S. pombe) are less extensive, and 
consists of single α1,2-linked galactose residues and single α1,2-linked mannose 
residues appended directly to the backbone (Ziegler et al., 1994). 
The core region of S. cerevisiae α-mannan, from which the outer chain extends, is 
nearly identical in composition and structure to that of mammalian high mannose N-
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glycans (HMNG), which decorate mammalian cells. HMNG, consist of two β1,4-linked 
N-acetyl glucosamine residues, to which a β1,4-linked mannose residue is appended. 
Extending from the central mannose residue are two branches which consists of 
mannose residues linked by various α-linkages. The structures of yeast α-mannans 
and HMNG are shown in Figure 4.1. 
 
 
The genome of B. theta encodes 36 glycoside hydrolases predicted to target α-
mannosidic linkages due to sequence similarities to previously characterised 
glycoside hydrolase families (GHs)  known to possess α-mannosidase (GH38, GH47, 
GH92 and GH125) or α-mannanase (GH76) activities (Xu et al., 2007).  Three PULs, 
designated PUL-Man1, PUL-Man2 and PUL-Man3 (Figure 4.2) (Cuskin et al., 2015b) 
were shown to be upregulated in B. theta when the bacterium was cultured with S. 
cerevisiae α-mannan as a sole carbon source. Intriguingly, PUL-Man1 and Pul-Man2 
display a significant degree of synteny in the ‘core’ region of these loci PUL, encoding 
Figure 4.1. Structure of yeast α-mannans and mammalian high mannose N-glycans. 
A cartoon representation of the structure of the yeast α-mannan of Saccharomyces 
cerevisiae (S. cerevisiae) and Schizosaccharomyces pombe (S. pombe) α-mannan and 
mammalian high mannose N-glycans (HMNG). The saccharide and linkage composition of 
each polysaccharide is denoted by a key. Asn, to which HMNGs are covalently bound, 
represents asparagine. (Figure adapted from Cuskin et al., 2015). 
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proteins with seemingly identical predicted activities. Thus, both PUL-Man1 and PUL-
Man2 encode two predicted GH76 endo-α1,6-mannanases, a GH125 α1,6-
mannosidase and GH92 α-mannosidase, a phosphatase, as well as the importation 
machinery of the PUL (SusD-like and SusC-like). The syntenic region of the two PULs 
also contain proteins of unknown function that flank the SusC/D pairs.  Interestingly, 
the open reading frames (ORFs) encoded by the peripheries of PUL-Man1 and PUL-
Man2 have seemingly divergent activities. Man-PUL1 encodes for a predicted GH97 
α-galactosidase and so plays a potential role in S. pombe α-mannan degradation. 
Likewise, PUL-Man2 encodes for a GH38 α-mannosidase, BT3774, an enzyme which 
was shown by Dr Cuskin to display broad specificity. Indeed Cuskin showed that 
BT3774 plays a pivotal role in the periplasmic side chain removal of S. cerevisiae yeast 
α-mannan; it is the only enzyme capable of efficiently removing the sterically restricted 
α1,2-linked mannose residues appended directly to the backbone of yeast α-mannan 
(Cuskin et al., 2015b).  PUL-Man3 shares no discernible similarities in PUL 
organisation to PUL-Man1 and Pul-Man2, but encodes for a GH99 endo-α1,2-
mannosidase, which has known involvement in S. cerevisiae yeast α-mannan side-
chain removal (Hakki et al., 2015) 
 Surprisingly, despite the significant similarities in the structure and composition 
shared between the core region of yeast α-mannan and HMNGs, HMNGs up-regulate 
a single PUL, (PUL-HMNG), which is distinct from the mannan loci. PUL-HMNG 
mediates HMNG deconstruction (Cuskin et al., 2015b) and encodes four enzymes, 
three GH92 α-mannosidase and a GH18 endo-β-N-acetylglucosaminidase, and two 




 Transcriptomic data showed that yeast α-mannans are not surrogates for HMNG 
(Cuskin et al., 2015b), but are nutrient sources for B. theta.  Given the limited number 
of different α-mannosyl linkages in α-mannans and HMNGs, the biological rationale 
for such an extensive array of B. theta enzymes that target these bonds is unclear. It 
is possible that the branched structure of glycans containing these α-mannosyl 
linkages predicates a complex hierarchical degradative process, in which the various 
α-mannosidases display specificity for structures downstream of the target bond. This 
may explain the requirement for such a large number of enzymes and PULs which 
target similar but distinct substrates. It is likely that the HMNG-specific PUL encodes 





















Figure 4.2. The polysaccharide utilization loci encoded by Bacteroides thetaiotaomicron 
which are up-regulated by, and target, α-mannan. A schematic representation of the 
polysaccharide utilization loci encoded by the genome of B. theta which target (A) yeast α-
mannans (PUL-Man1, PUL-Man2 and PUL-Man3) and (B) high mannose N-glycans (PUL-
HMNG). The genes encoding known or predicted function are colour coded and are annotated 
according to CAZy family where applicable. Areas of PUL-Man1 and PUL-Man2 which display a 
high degree of synteny are highlighted with a grey background.  SGPB represents surface glycan 






In this chapter B. theta is used as a model for dissecting the mechanism by which a 
key member of the microbiota metabolizes complex carbohydrates containing α-
mannosyl linkages, achieved primarily through the characterization of enzymes 
encoded by PUL-Man1/2/3 and PUL-HMNG, providing a biochemical rationale for the 
distinct yeast α-mannan and HMNG utilization apparatus. The biochemical data 
generated in this chapter, in conjunction with growth studies and pre-exisitng 
genetic/in vivo data provides a model for the utilization of glycans that contain α-
mannosidic linkages.  
4.3 Results 
4.3.1. Elucidating the α-mannosidases encoded by Bacteroides 
thetaiotaomicron capable of de-branching yeast α-mannan 
The enzymatic degradation of α-mannan is greatly restricted through steric constraints 
imposed through mannose side-chains appended to the α1,6-mannan backbone. 
Previous work performed by Dr. Fiona Cuskin found that the four GH76 endo-α1,6-
mannanases encoded by PUL-Man1 and PUL-Man2 were unable to cleave the 
mannan backbone until undecorated regions are exposed. As stated above Dr Cuskin 
showed that the GH38 α-mannosidase BT3774, encoded by PUL-Man2, removes the 
most challenging, sterically restricted, mannosidic bond in which the mannose at the 
base of the mannan side chains is linked α1,2 to the mannan backbone. However, the 
three mannan PULs do not encode a candidate surface α-mannosidase. Such an 
enzyme must exist otherwise the surface endo-α1,6-mannanases would not be able 
to cleave the mannan backbone. The surface deconstruction of yeast α-mannan is 
therefore poorly understood. The capacity of 11 B. theta  α-mannosidases (Zhu et al., 
2010), predicted to be localised to the cell surface and belonging to GHs (ten GH92s 
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members and one GH38 member) with known α-mannosidase activity, to remove 
mannose side-chains was assessed. The localisation of the α-mannosidases explored 
in this section were predicted due to the presence of a type II single peptide, assessed 
via LipoP (http://www.cbs.dtu.dk/services/LipoP/). However, some α-mannosidases 
were assayed, despite being predicted to harbour a type I signal peptide, owing to the 
presence of a canonical cysteine residue encoded early in the N-terminal protein 
sequence (< 20 residues from start codon); a potential indicator of a signal II peptide. 
An example signal peptide analysis is shown in Figure 4.3. The remaining analysis are 





















Figure 4.3. LipoP signal peptide prediction of BT2199. The left hand panel shows 
the full, wild-type amino acid sequence of BT2199, a GH92 α-mannosidase. The right 
hand panel shows a LipoP signal peptide analysis of the BT2199 protein sequence. 
BT2199 is predicted to have a signal II (SpII) peptide, indicating the protein is localised 
to the cell surface. The point of signal peptide cleavage is predicted to be between 
residues 18 and 19, the position of which is denoted by red and green colouring of the 
amino acid residues at the site of cleavage, S18 and C19, respectively. 
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4.3.1.1 Expression and Purification 
The constructs (generated previously by Dr Zhu;(Zhu et al., 2010)) encoding the 
enzymes described above  ere expressed in E. coli TUNER cells and purified by IMAC 
as described in 2.1.25.1 , generating pure recombinant protein, confirmed via SDS-
PAGE. An example of an SDS-PAGE analysis of a typical IMAC purification is shown 



















4.3.1.2 The α-mannosidases which may potentiate side-chain removal. 
The capacity of each α-mannosidase to de-branch yeast α-mannan was performed in 
the presence of characterised enzymes believed to facilitate side chain removal and 
included the GH99 endo-α1,2-mannosidase, BT3862 (Hakki et al., 2015) and the 
sugar-6-monophosphatase, BT2630. Also incorporated into assays was the GH76 
endo-α1,6-mannanase, BT2631 (see below) which can act upon the α1,6-mannan 
backbone exposed following side-chain removal, generating α1,6-linked 
Figure 4.4. Example SDS-PAGE analysis of an IMAC purification. All SDS-PAGE 
gels were 12.5 % (w/v). L = low size marker H= high size marker (kDa); P = 
insoluble fraction; CHE = cell free extract; FT = flow through; W = wash ( 1x 
TALON buffer); E1 = elution 1 (5 mM imidazole,1 x TALON buffer); E2 = elution 
2 (100 mM imidazole, 1 x TALON buffer). A. BT3994 ran with an apparent Mr of 




mannooligosaccharides visualised by TLC analysis. Seven out of the ten α-
mannosidases were active against intact yeast α-mannan, liberating mannose (Figure 
4.5). Of the exo-acting α-mannosidases tested only BT2199 and BT3990, not encoded 
by PUL-Man1-3 of B. theta, were capable of removing the side chains of yeast 
mannan, enabling the GH76 endo-mannanase to attack the α1,6-mannose backbone 
and evidenced by the production of oligosaccharides (Figures 4.6). BT3990 is 
encoded by HMNG-PUL whilst BT2199 appears to be encoded by a PUL seemingly 
distinct from the yeast α-mannan degrading apparatus of B. theta. Subsequent cell 
localization studies by Lowe and Cuskin showed that BT3990 was located in the 
periplasm. Thus, BT2199 is the candidate surface enzyme which generates limited 
undecorated regions of the yeast mannan backbone, which could thus be cleaved by 






Figure 4.5. Thin Layer Chromatography (TLC) of predicted extracellular α-
mannosidases activity against intact S. cerevisiae α-mannan. TLC analysis of S. 
cerevisiae yeast α-mannan (1 mg/ml (w/v)) incubated individually with 50 µM of each 
respective GH92 α-mannosidase, and the GH38 α-mannosidase, BT4072. Assays were 
performed in 20 mM Tris/HCl, 300 mM NaCl, pH 8.0 at 37 
o
C for 1 h. Digests included 1 µM 
GH99 endo-α1,2-mannanase, 1 µM sugar-6-monophosphatase (BT2630) to determine the 
activity of the GH92/GH38 against yeast α-mannan sans GH76 endo-α1,6-mannanase 
activity. Samples were run against α-mannooligosaccharide standards, D.P 1 to 4, denoted by 
S.  Lane 1 - No enzyme, yeast α-mannan; Lane 2 - BT1769 (GH92);Lane 3 – BT1878 (GH92);  
Lane 4 – BT2199 (GH92); Lane 5 - BT3130 (GH92); Lane 6 - BT3773 (GH92); Lane 7 - 
BT3858 (GH92); Lane 8 - BT3990 (GH92); Lane 9 - BT3991 (GH92); Lane 10 - BT3994 
(GH92); Lane 11 -BT4073 (GH92); Lane 12 - BT3862 (GH99); Lane 13 -BT2630 







4.3.1.3 Comparing extracellular side-chain removal with periplasmic side-chain 
removal of yeast α-mannan. 
The GH92 α-mannosidase, BT2199, was deemed to be the most likely putative 
candidate enzyme to facilitate the extracellular de-branching of yeast α-mannan, 
owing to the enzyme’s predicted localisation to the cell surface. Due to the 
periplasmically located GH38 α-mannosidase BT3774’s key role in side-chain removal 
and deconstruction of yeast α-mannan, assays were performed to determine the 
relative differences in the rate of surface and periplasmic side-chain depolymerisation, 
providing potential biological context.  
The ability of the α-mannosidases to de-branch yeast α-mannan at various 
concentrations was assessed (Figure 4.7). The GH76 endo-α1,6-mannanase, BT3792 
was present in the assays to determine debranching activity of the α-mannosidases. 
The relative rate of debranching was deduced via TLC analysis. Both enzymes were 
able to facilitate GH76 endo-mannanase attack, observed by the presence of α1,6-
Figure 4.6. The capacity of endo-mannanases to act on mannan treated with α- 
mannosidases analysed by TLC. The experiment was carried out as described in Figure 4.3 
except that the reactions were supplemented with 1 µM GH99 endo-α1,2-mannanase, 1 µM 
sugar-6-monophosphatase (BT2630) and 1 µM GH76 endo-α1,6-mannanase(BT2631) to 
determine de-branching activity of the GH92/GH38. The lanes are labelled as in Figure 4.3.  
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manno-oligosaccharides and confirming the ability of these enzymes to de-branch 
yeast α-mannan. The GH38, BT3374, was significantly more active, enabling 
backbone access at concentrations as low as 0.2 µM. BT2199 was only able to 
adequately facilitate endo-mannanase activity at concentrations of 5 µM, a ~25-fold 
lower activity than BT3774 in its ability to expose the backbone of yeast mannan 
(Figure 4.8). The GH99 endo-α1,2-mannosidase (BT3862), and the sugar-6-
phosphtase (BT2630), were not incorporated in these assays, demonstrating that the 
respective activity of these enzymes is not required for side chain removal. Surface 
side chain removal appears to be significantly limited relative to periplasmic 
depolymerisation and is consistent with the low quantities of mannose released into 
the culture supernatant when B. theta is cultured with yeast mannan as a sole carbon 











Figure 4.7. Thin Layer Chromatography comparing BT2199, GH92 α-mannosidase  activity 
with the dominant periplasmic debranching enzyme, BT3774 GH38 α-mannosidase, 
against yeast α-mannan. TLC analysis comparing the putative extracellularly located GH92 
(BT2199) with the periplasmically located GH38 (BT3774). The relative activity of the enzymes 
against S. cerevisiae yeast α-mannan at various concentrations was assayed by incubating 
enzyme with the polysaccharide (1 mg/ml (w/v)). The concentration of the enzyme being assayed 
is displayed below the respective lane. Assays were performed in 20 mM Tris/HCl, 300 mM NaCl, 
pH 8.0 at 37 oC for 1 h. Samples were run against α-mannooligosaccharide standards, D.P 1 to 


















Figure 4.8. Thin Layer Chromatography comparing BT2199, GH92 α-mannosidase yeast α- 
mannan debranching activity with the dominant periplasmic debranching enzyme, BT3774 
GH38 α-mannosidase. A. TLC analysis comparing the putative extracellularly located GH92 
(BT2199) with the periplasmically located GH38 (BT3774). The ability of the enzymes to debranch 
S. cerevisiae yeast mannan at various concentrations when incubated with the polysaccharide (1 
mg/ml (w/v)) was assayed in the presence of the extracellular GH76 endo-α1,6-mannanase, 
BT3792 (1 µM). The concentration of the enzyme being assayed is displayed below the respective 
lane. Assays were performed in 20 mM Tris/HCl, 300 mM NaCl, pH 8.0 at 37 oC for 1 h. Samples 
were run against α-mannooligosaccharide standards, D.P 1 to 4, denoted by S. The GH76 endo-
α1,6-mannanase, BT3792 (1 µM) was incubated with the mutant mannan, mnn2 (1 mg/mL (w/v)) 
lacks mannose side-chains) as a positive control of GH76 activity. 
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4.3.2. Characterisation of the enzymes which degrade the α1,6-
mannan backbone of yeast α-mannan 
 
4.3.2.1.1The cellular location of the four GH76 endo-α1,6-mannanases 
(mannanases) encoded by the yeast mannan PULs of B. theta  
The mannan PULs (PUL-Man) of B. theta encode four GH76 enzymes; two derived 
from both PUL-Man1 (BT2623 and BT2631) and PUL-Man2 (BT3782 and BT3792.  
Sequence analysis of the four enzymes by LipoP predicts that BT2623 and BT3782 
have a type I signal peptide and so are located to the periplasmic space, with BT2623 
and BT2631 predicted to contain a type II signal peptide, suggesting that these 
membrane-bound enzymes are on the surface of the bacterium.  Localisation 
experiments utilizing fluorescently labelled antibodies performed by Drs Cuskin and  
Lowe, confirmed that BT3792 was indeed present on the cell surface and therefore 
corroborates these predictions (Cuskin et al.2015).  
4.3.2.1.2. Expression and purification 
The four GH76 enzymes were previously cloned into pET-based expression vectors, 
which supplied a His6 tag, by Dr Cuskin. The four proteins were purified here using 
IMAC and their purity analysed by SDS-PAGE, Figure 4.9. BT2623, BT3782 and 
BT3792 were cloned by Dr. Fiona Cuskin and BT2631 was cloned by Dr. Joanna 
Norman. The four GH76 mannanases, like all B. theta proteins investigated in this 
study, were cloned without signal peptides. The genes encoding BT3782 and BT3791 
were cloned into pET28a with N-terminal truncations of 154 and 74 amino acid 
residues, respectively, and harboured an N-terminal His6-tag. To aid in solubility, DNA 
encoding mature BT2623 and BT2631 were cloned into pET32b and pET43b, which 
supplies a thioredoxin and NUS tag, respectively, and a C-terminal His6-tag to the 
recombinant proteins. BT3792, BT2623 and BT2631 were expressed in E. coli BL21 
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cells and were produced is soluble form, as seen upon SDS-PAGE analysis. BT3782 
was expressed in E. coli TUNER cells to maximise soluble protein production.  
 
Figure 4.9. SDS- PAGE analysis of the protein purification of the four GH76s 
encoded by yeast mannan PULs one and two.  SDS-PAGE data of BT2623 (A), 
BT2631 (B), BT3782 (C) and BT3792 (D) following IMAC. All SDS-PAGE gels were 
12 % (w/v). L= low molecular weight marker; P = insoluble fraction; CFE = cell free 
extract; FT= flow through; W = wash; E1 = elution 1, 5 mM imidazole; E2 = elution 
2, 100 mM imidazole. A. BT2623 ran with an apparent Mr of 66 kDa. B. BT2631 
ran with an apparent Mr of 116 kDa. C. BT3782 ran with an apparent Mr of 40 kDa. 
D. BT3792 ran with an apparent Mr of 48 kDa. These values are consistent with 





4.3.2.1.3. The four GH76 are endo-α1,6-mannanases with activity against mnn2 
mutant yeast mannan 
As demonstrated previously by Dr Cuskin, the four recombinant GH76 endo-
mannanases encoded by PUL-Man1 and PUL-Man2 were active against the 
undecorated α1,6-mannan backbone derived from the mnn2 mutant of S. cerevisiae.  
In this PhD project TLC analysis revealed that the surface located mannanases, 
BT2623 and BT3792, produced larger oligosaccharide products (D.P ≥ 4) than their 
periplasmic counterparts, BT2631 and BT3782 (D.P ≤3) Kinetic data showed that the 
periplasmic GH76 enzymes were ~3 to 10 times more active than their surface 
counterparts (Table 4.1) 
 
KM 
 (mg ml-1) 
kcat  
 (s-1) 
kcat/Km   
(s-1 mg-1 ml) 
BT2623  1.892 ± 0.399 297 ± 19.07 157 
BT2631 nd nd 743 ± 8.048 
BT3782 0.4315 ± 0.333 705 ± 219 1633 
BT3792  2.425 ± 1.136 1263 ± 262 521 
 
 
4.3.2.1.4. Activity of the GH76 mannanases versus α1,6-
mannooligosaccharides 
In order to elucidate the activity of the GH76 enzymes against oligosaccharides, high 
D.P (>4) and low D.P (<4) α1,6-mannooligosaccharides were generated by treatment 
of mnn2 yeast mannan with BT3792 and BT2631, respectively. Enzyme (10 uM) was 
incubated with the polysaccharide (10 mg/mL (w/v) for 2 h at 37 oC , in the presence 
of 20 mM Na-HEPES, pH 7.5. Enzymatic digests were subsequently pooled, 
lyophilized and subjected to size exclusion chromatography using P2-gel columns 
Table 4.1. Kinetic parameters of GH76 endo-α1,6-mannanase 
activity against the mnn2. Generated by Dr. Cuskin. 
109 
 
(BioRad) as described in Materials and Methods, Section 2.2.6.2, rendering pure 
oligosaccharides of single species. The integrity of purified oligosaccharides was 
confirmed by HPAEC-PAD and MALDI-TOF mass spectrometry (Figure 4.10). Full 
methodology of the preparation of the oligosaccharides is detailed in Materials and 






Figure 4.10. Mass Spectrometry result of purified α1,6-
mannooligosaccharides. Details of MALDI-TOF spectrometry (mass spec) 
used to verify purified α1,6-mannooligosaccharides are described in Materials 
and Methods, Section 2.2.6.3. (A) mass spec result of α1,6-mannopentose (M5) 
and (B) α1,6-mannooctose (M8). A mass/charge ratio (m/z) of 851 was given for 
M5, corresponding to the mass of M5 (828) plus a sodium adduct (23). The m/z 




The catalytic activity of the four GH76 enzymes against α1,6-mannooligosaccharides 
was assessed by incubating each enzyme with an α-1,6-mannooligosaccharide with 
a D.P. of 2-8 (defined as M2-M8, respectively). Enzyme concentration was adjusted 
to provide ≥ 80 % degradation within the maximum time point and aliquots of the 
reaction were taken and the enzyme inactivated by boiling. Substrate depletion was 
observed by HPAEC-PAD (Figure 4.11) and plotted using GraphPad Prism 5.0. The 
gradient (velocity (min)) was ascertained via linear regression analysis. The equation 
utilized is shown below; 
 
Velocity (min) = In[St0] / In[Stx]* 
Kcat/Km (M-1 min-1) = Velocity (min) / Enzyme concentration (M) 
*In represents natural log. peak area of oligosaccharide when time = 0 min. tx is peak area of oligosaccharide at time point 
 
The data are displayed in Table 4.2 The four GH76 enzymes displayed comparable 
rates against longer oligosaccharides (D.P 6-8), degrading α-1,6-mannooctose (D.P 
8), with an efficiency of ~1 x 106 M-1 min-1. The activities of the surface endo-
mannanases, BT2623 and BT3792, demonstrated a significant decline in activity 
against oligosaccharides with a D.P < 6, with a kcat/Km ~1 x 103 M-1 min-1 against 
mannotetraose (D.P 4), and  no activity observed against mannotriose over 24 h. 
Conversely, the periplasmic GH76 enzymes, BT2623 and BT3782, maintained 
catalytic efficiency against manno-oligosaccharides with a D.P as low as 4, with only 
a 2-fold decrease in activity observed between mannotetraose and mannotriose. 
These data demonstrate that the substrate binding cleft of the periplasmic enzymes 



















BT2623(s) BT2631(p) BT3792(s) BT3782(p) 
1.0 x 103 ± 1.0 102 5.6 x 103 ± 2.0 x 102
4
2.2 x 102 ± 0.1 x 102 1.3 x 105 ± 2.0 x 102 1.8 x 103 ± 0.3 x 102 5.8 x 105 ± 3.0 x 104
Oligosaccharide d.p.
kcat/K m  (M
-1 min-1)
3 No Activity No Activity
6
1.8 x 104 ± 1.3 x 103 1.2 x 106 ± 5.2 x 104 1.1 x 105 ± 5.9 x 103 6.1 x 106 ± 1.6 x 105
5
7.2 x 102 ± 0.1 x 102 1.3 x 106 ± 6.6 x 104 2.4 x 103 ± 0.5 x 102 3.9 x 106 ± 1.8 x 105
8
1.5 x 105 ± 5.6 x 103 1.9 x 106  ± 1.3 x 105 1.5 x 106 ± 1.3 x 105 1.0 x 107 ± 5.6 x105
7 5.0 x 10
4 ± 3.7 x 103 1.7 x 106 ± 1.8 x 105 1.3 x 106 ± 9.7 x 104 4.5 x 106 ± 2.3 x 105
Table 4.2. Kinetic data of the four GH76 α-1,6-mannanases VS α-1,6-manno-oligosaccharides (d.P 3-8). 
Figure 4.11. GH76 α-mannanases substrate depletion data generation. In Panel a and b, BT3782 (0.05 
µM) and BT3792 (30 µm) respectively, were incubated with α1,6-mannotetraose at a concentration <<Km.. 
Assays were performed in 50 mM Na-phosphate buffer, pH 7.5 in the presence of 0.01 mg/mL (w/v) BSA 
and incubated at 37oC for 1h. Reaction aliquots were taken at the respective time-point and heat 
deactivated. Substrate depletion was measured using HPAEC and the rate (b) was plotted using GraphPad 
Prism 5.0, enabling kcat/KM to be determined. α1,6-mannooligosaccharides were identified by their degree 




4.3.2.1.5. Sequence and structural analysis of the GH76s encoded by 
Bacteroides thetaiotaomicron 
Alignment of the amino acid sequences of the four GH76s revealed a conserved motif 
(YDD) (Figure 4.12). Comparison of the 3D crystal structure of a Listeria innocua 
GH76, Lin0763, with that of the GH76 enzyme, BT3792 (crystal structure solved by 
Dr. Mike D. Suits, Victoria University, Canada), revealed that the two aspartate (Asp) 
residues, Asp258 and Asp259 of the YDD motif are also structurally conserved (Figure 
4.13). These conserved Asp residues are housed within a curved, cleft-like structure, 
possibly indicating the substrate binding cleft of the enzyme (See Discussion section). 
These data suggest that Asp258 and Asp259 are candidate catalytic residues of the 























Figure 4.12. Sequence alignment of the four GH76 α1,6-mannanases encoded 
PUL-Man1 and PUL-Man2 of B. theta. Alignment of the amino acid sequences of the 
four GH76 enzymes; BT2623, BT2631, BT3782 and BT3792 respectively.  The highly 
conserved YDD motif, comprising of the tentative catalytic residues of the enzymes, is 
highlighted in green. * represent conserved residues, : indicates conservation between 
groups of strongly similar properties and . indicates conservation between groups of 























Figure 4.13. Structural alignment of the 3D structures of BT3792 and 
Lin0763. A structural alignment of the Bacteroides thetaiomicron GH76 (BT3792) 
with the Listeria innocua GH76 (Lin 0763), showing conserved aspartate residues. 
The structure of BT3792 is coloured green and the structure of Lin0763 is coloured 
blue. BT3792 aspartate residues are highlighted magenta whilst the Lin0763 
aspartate residues are highlighted yellow.  
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4.3.2.1.6. Site directed mutagenesis of the catalytic residues of the GH76, 
BT3792. 
To determine if the conserved aspartate residues of the GH76 enzyme BT3792 were 
the catalytic residues of the GH76 family of glycoside hydrolases, site directed 
mutagenesis was utilized. DNA encoding the single amino acid substitution was 
generated via PCR amplification using the primers displayed in Table 4.3 and 
analysed by electrophoresis, ensuring amplification of the DNA was successful (Figure 
4.14). Parental DNA was degraded with Dpn1 a restriction enzyme that attacks only 
methylated DNA, and the introduction of the mutation into the cloned amplified DNA 
was confirmed by sequencing (MWG Eurofins),  confirming that the candidate catalytic 
residues, Asp258 and Asp259, had been individually substituted with alanine in the 



































Figure 4.14. Quality control of the Site-Directed Mutagenesis of BT3792. An 
agarose gel of the site-directed mutagenesis PCR amplification of BT3792. Lane 1 = 
PCR product containing D258A mutation; Lane 2 = PCR product of D259A mutation. 
Invitrogen Hyper Ladder 1 (HL1) was run as a molecular weight marker. Agarose 
gels were 1% and electrophoresed for 1 h. Molecular weight markers indicate an 




4.3.2.1.6.1. Mutant expression and purification 
D258A and D259A, were expressed as described in Section 3.1.2 with near-identical 
yields as the wild-type enzyme. An example SDS-PAGE of the purification of D258A 












Figure 4.15. SDS- PAGE analysis of the protein purification of mutant 
variants of BT3792.  SDS-PAGE data of BT3792 mutant variants D258A and 
D259A following IMAC. All SDS-PAGE gels were 12 % (w/v). L= low molecular 
weight marker; P = insoluble fraction; CFE = cell free extract; FT= flow through; W 
= wash; E1 = elution 1, 5 mM imidazole; E2 = elution 2, 100 mM imidazole. Both 
proteins ran with an apparent Mr of 45 kDa, consistent with their expected size.  
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4.3.2.1.6.2. Assaying the ability of BT3792 derivatives to degrade mnn2 mutant 
yeast mannan. 
The catalytic activity of the BT3792 mutants, D258A and D259A, was assessed using 
a reducing sugar assay against the mutant yeast mannan, mnn2. The reducing sugar 
assay assesses the ability of the enzyme to hydrolyse glycosidic bonds, and ergo, 
reveal new reducing ends, which can be quantified using a standard curve of 
mannose. Mutant activity was assayed concurrently with wild-type BT3792. The assay 
was conducted in 50 mM Na-HEPES buffer, pH 7.5. Reactions were incubated at 370C 
for 30 min at a final substrate concentration of 5 mg/mL (w/v).  Both of the mutant 
enzymes displayed no measurable activity against mnn2 yeast mannan at an enzyme 
concentration of 25 µM, whilst wild-type enzyme displayed activity at concentrations 
of 0.1 µM (a 250 fold difference). These findings suggest that Asp258 and Asp259 are 
the catalytic residues of the enzyme.   
4.3.2.2. Investigating the activity of the GH125 enzymes, BT2632 and BT3781, 
encoded by the yeast α-mannan PULs of Bacteroides thetaiotaomicron. 
4.3.2.2.1. Expression and purification 
Both members of GH125 encoded by PUL-Man1 and PUL-Man2 were cloned by Mr. 
Carl Morland into pET28a. Recombinant forms of mature BT2632 and BT3781, 
consisting of amino acid residues 22 – 460 and 24 – 460 respectively, were expressed 
in E. coli BL21 cells, purified by IMAC and analysed via SDS-PAGE. Both GH125 








4.3.2.2.2. The GH125s are α1,6-mannosidases  
The GH125 enzymes encoded by PUL-Man1 and PUL-Man2 (BT2632 and BT3781 
respectively), share 92% sequence homology and are predicted α1,6-mannosidases. 
Sequence analysis suggests both of the GH125 harbour a type I signal peptide, and 
so are predicted to be located to the periplasmic space. As such, the two enzymes 
were assayed against wild type and mnn2 mutant S. cerevisiae mannan. TLC and 
HPAEC-PAD analysis revealed that both enzymes were unable to degrade wild type 
yeast mannan (data not shown) but released mannose from the undecorated α1,6 
backbone of mnn2 mannan, confirming that the two GH125 enzymes are exo-α1,6-
mannosidases (Figure 4.17). 
 
Figure 4.16. SDS-PAGE analysis of the protein purification of the GH125s, 
BT2632 and BT3781. The two proteins were purified by IMAC. All SDS-PAGE gels 
were 12 % (w/v). L= low molecular weight marker; P = insoluble fraction; CFE = 
cell free extract; FT= flow through; W = wash; E1 = elution 1, 5 mM imidazole; E2 
= elution 2, 100 mM imidazole. Both proteins migrated according to their predicted 










4.3.2.2.3. GH125 α1,6-mannosidase activity against α1,6-
mannooligosaccharides. 
Kinetic data of the two GH125 enzymes were generated versus α-1,6 linked 
mannobiose (D.P 2), mannotriose (D.P 3) and mannotetraose (D.P 4), using a 
mannose detection assay kit (Megazyme) as described in Materials and Methods, 
Section 2.2.1.1. Reactions were carried out in 50 mM Na-HEPES buffer, pH 7.5 at 
37oC. 
The kinetic data generated is displayed in Table 4.4 and Figure 4.18. Both of the 
GH125 enzymes (BT2623 and BT3781) displayed similar affinities (KM) for each 
substrate, demonstrating a small preference for mannobiose over mannotriose and 
mannotetraose, indicating that both enzymes contain two subsites, -1 and +1.  
Figure 4.17. The activity of the GH125 α-mannosidases, encoded by PUL-Man1 and PUL-
Man2 of Bacteroides thetaiotaomicron. BT2632 and BT3781 (0.1 µM) were incubated with 1 
mg/ml (w/v) debranched mannan (mnn2) for 1 h in 50 mM Na-HEPES buffer, pH 7.5 at 37 oC. 
Panel A displays TLC analysis of the reactions, while the corresponding samples were analysed 
by HPAEC in Panel B. α1,6-mannooligosaccharides were identified by their degree of 








GH125 Substrate KM (mM) kcat (min-1) Kcat/KM (mM-1 min-1) 
BT2632 α1,6-mannobiose 0.43  
± 0.04 
1777 ± 44 4133 
α1,6-mannotriose 0.53  
± 0.07 
2613 ± 132 4930 
α1,6-mannotetraose 0.67  
± 0.07 
1260 ± 60 1881 
BT3781 α1,6-mannobiose 0.34  
± 0.03 
1051 ± 22 3091 
α1,6-mannotriose 0.59  
± 0.05 
2313 ± 90 3920 
α1,6-mannotetraose 0.42  
± 0.06 
1239 ± 59 2960 
 
 
Figure 4.18.  Graphs of the kinetic data generated for the two GH125s VS α1,6-manno-
oligosaccharides (D.P 2-4). Kinetic data of BT2632 (A) and BT3781 (B) versus 
mannooligosaccharides. Initial rates were derived using the mannose-detection kit (Megazyme). 
Rate of absorption (A min-1) was converted to rate of mannose released (µM min-1) using the 
extinction co-efficient of NADPH and plotted in GraphPad Prism 5.0 using Michaelis-Menten 
kinetics. 
Table 4.4. Kinetic data of the two GH125 α-1,6-mannasidases VS α-1,6-manno-oligosaccharides (D.P 2-3). 
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4.3.2.3. Assaying the activity of the GH97 BT2620, an α-galactosidase encoded 
by PUL-MAN1 of B. theta 
BT2620 is a member of GH97 a family that contains α-galactosidases and α-
glucosidases (Cantarel et al., 2009). Mannan from the yeast S. pombe contains α-
galactose side chains side chains and thus the polysaccharide is potential substrate 
for BT2620. To test this hypothesis the ORF encoding mature BT2620 was cloned into 
the E. coli expression vector pET28a. The protein was expressed in E. coli and 
subsequently purified by IMAC as described for the other B. theta enzymes described 
in this chapter, the methodology of which is detailed in Materials and Methods, Section 
2.1.25. 
4.3.2.3.2 Characterization of GH97 BT2620, an α-galactosidase  
The data displayed in Figure 4.19 showed that when incubation of BT2620 with S. 
pombe α-mannan liberated galactose, demonstrating that the enzyme cleaved the 
α1,2-linked galactosyl units appended to the α1,6-mannan backbone.  Thus, BT2620 
is an α-galactosidase. No galactose was liberated from S. cerevisiae α-mannan by 
BT2620. The specificity of BT2620 was explored against several substrates containing 
α-linked galactose moieties using TLC. BT2620 displayed extremely low catalytic 
activity against raffinose (O-α-D-galactopyranosyl-(1,6)-α-D-glucopyranosyl-β-D-
fructofuranoside) and melibiose (6-O-α-D-galactopyranosyl-D-glucose). No activity 
was observed against stachyose (α-D-galactopyranosyl-(1,6)-α-D-galactopyranosyl-
(1,6)-α-D-glucopyranosyl-β-D-Fructofuranoside)  or carob galactomannan, a 
polysaccharide consisting of a β1,4-linked mannose backbone with α1,6-galactose 
side-chains. Kinetic parameters were unattainable due to the extremely low catalytic 












BT2620, displayed activity against pNP-α-D-galactose but not pNP-β-D-galactose or 
pNP- α-D-glucose. The enzyme was extremely slow with a catalytic efficiency (kcat/KM) 
of 56 min-1 M-1 (Figure 4.20). Individual kinetic parameters could not be determined as 






Figure 4.19. Thin Layer Chromatography assessing GH97 α-galactosidase activity. TLC analysis of GH97 
BT2620 (1 µM), encoded by PUL-Man1, incubated with various polysaccharides/oligosaccharides 
containing α-linked galactose moieties. Assays were performed in 50 mM Na-HEPES, pH 7.0 at 37 oC for 
1 h. Polysaccharide concentrations were 1 mg/mL (w/v) and oligosaccharide concentrations were 1 mM 
respectively. Samples were run against multiple standards, denoted by S. NOE denotes no enzyme 
control. Numbered lanes show GH97 BT2620 incubations with;  1 – S. pombe yeast α-mannan; 2 – Carob 









4.3.2.3.3 De-branching activity of BT2620 against S. pombe α-mannan 
The ability of BT2620, to de-branch S. pombe α-mannan and enable GH76 endo α-
mannanase accesses to the α1,6-mannan backbone was assessed by incubating 
BT2620 (1 µM) in the presence of the periplasmic (BT3782) or surface (BT3792) GH76 
endo-mannanases. TLC analysis of the reactions showed that in in the absence of α-
galactosidase activity, the GH76 endo-mannanases were not able to attack the 
decorated α1,6-mannan backbone, as no  mannooligosaccharides were generated. 
Conversely, in assays incorporating the α-galactosidase BT2620, the GH76 
mannanases were able to attack the mannan backbone releasing 




Figure 4.20.  Graph of GH97 α-galactosidase BT2620 vs pNP-α-D-galactose to 
generate catalytic efficiency constant. Rates were generated spectophotometrically (A 
min-1) at OD400nm. The rate of pNP group cleavage and release, stoichiometric to glucose 
release (mM min-1), was calculated using the extinction coefficient of pNP at pH 7.0. 
Activity against pNP-α-D-galactose was generated by incubating enzyme (0.25 µM) at 37 
oC in the presence of Na- HEPES, pH 7.0. Rates were analysed using linear regression 












4.3.3. Can the degradation products liberated by B. theta cultured 
on α-mannan support the growth of other non-mannan utilising 
Bacteroides? 
To assess if the surface break down products of yeast α-mannan degradation 
generated by B. theta can sustain the growth of other non-mannan utilizing 
Bacteroides species, co-culturing experiments (in collaboration with Dr. Fiona Cuskin 
and Dr. Elisabeth Lowe) were performed with two additional Bacterodies species; 
Bacteroides cellulosilyticus WH2 (B. cellulo) and Bacteroides xylanisolvens NLAE-zI-
Figure 4.21. TLC of S. pombe mannan treated with BT2620 and other mannan 
degrading enzymes. TLC demonstrating that BT2620, a GH97 α-galactosidase, is 
capable of facilitating GH76 endo-α1,6-mannanase attack on the S. pombe α1,6-
mannan backbone. Lanes  1, 2 and 3 show debranched mannan, mnn2 (1 mg/mL (w/v)) 
incubated without enzyme, with the periplasmic (BT3782) and extracellular (BT3792) 
GH76 endo-mannanase, respectively. Lanes 4 to 7 show individual incubations of S. 
pombe α-mannan (1 mg/mL (w/v)) with 4 – no enzyme; 5 – 1µM BT2620; 6 – 1µM 
BT3782; 7 – 1µM BT3792). Lanes  8 and 9 show incubations of S. pombe α-mannan 
(1 mg/mL (w/v)) with the BT2620 (1 µM) in tandem with 8 –  BT3782 (1 µM) and 9 –  
BT3792 (1 µm). Lane 10  - galactose standard (Gal); Lane 11 – α1,6-
mannooligosaccharides standards, D.P 1 – 4 (M1, M2, M3 and M4). Reactions were 
performed in 50 mM Na-HEPES, pH 7.0 and proceeded for 1 h at 37oC 
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p352 (B. xylani). B. cellulo is unable to degrade and utilize α-mannan, but is able to 
grow on mannose. B. xylani contains a PUL syntenic with B. theta PUL-Man1. B. xylani 
exhibits very limited growth on S. cerevisiae mannan (Figure 4.22) but, in addition to 
growing on mannose, can depolymerise and utilize unbranched α-mannan, consisting 
solely of the α1,6-mannan backbone (Cuskin et al., 2015b). B. theta, prepared as 
described in Materials and Methods 2.1.7, was co-cultured with either B. xylani or B. 
cellulo independently, in the presence of either mannose (5 mg/mL (w/v)) or yeast α-
mannan (5 mg/mL (w/v)) as the sole carbon source. All experiments were performed 
in triplicate. Samples of bacterial growth (1 mL) were taken at the point of inoculation, 
early exponential phase, late exponential phase and stationary phase (Assessed by 
OD at 600nm). Cultures were plated onto rich media to determine the number of 
colonies at each phase of growth. The proportions of the Bacteroides species relative 
to each other were determined using quantitative PCR from genomic DNA, using 
unique markers for each strain (performed by Dr. Elisabeth Lowe). Both B. cellulo and 
B. xylani were also grown individually on S. cerevisae α-mannan. The results of the 
co-culturing experiment are depicted in Figure 4.22.  
When B. theta was co-cultured with either B. cellulo or B. xylani in the presence of 
mannose, the relative proportion of the two co-cultured Bacteroides species remained 
constant from the point of inoculation to stationary phase, suggesting that the three 
Bacteroides species are capable of importing and catabolising mannose equally. 
When co-cultured on S. cerevisiae α-mannan, however, B. theta out-competed both 
B. cellulo and B. xylani; the relative proportion of the respective co-cultured organisms 
changed from ~1:1 at inoculation to almost 100% B. theta at stationary phase. These 
data suggest that the limited mannose released by B. theta during extracellular 
















Figure 4.22. Assessing if yeast α-mannan degradation products, generated by B. 
theta can support the growth of other Bacteroides species. B. theta (Bt) was co-
cultured  anaerobically with B. cellulo WHZ (a,b) or B. xylani (Bx) NLAE-zl-p352 (c,d), in 
the presence of mannose (b,d) or S. cerevisiae α-mannan (a,c) as the sole carbon source 
(5 mg/mL (w/v)).  The upper graph of each panel depict the colony forming units mL-1 (c.f.u. 
mL-1) of each strain, relative to the c.f.u mL-1 at inoculation. Total c.f.u. mL-1 was determined 
by colony counts. The relative proportion of each Bacterodies species was determined by 
qPCR (Dr. Elisabeth Lowe) of marker genes from genomic DNA (lower graph of each 
panel). Error bars represents the standard deviation of three biological replicates (Cuskin 
et al., 2015). 
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4.3.4. Further elucidating the enzymatic deconstruction of high 
mannose N-glycan by α-mannosidases encoded by the high 
mannose N-glycan polysaccharide utilization locus of Bacteroides 
thetaiotaomicron.  
PUL-HMNG, encoded by B. theta, is activated solely by HMNG and not yeast α-
mannan, despite the similarities in core structure and composition of the respective 
glycans (Cuskin et al., 2015b). PUL-HMNG encodes three GH92 α-mannosidases that 
hydrolyse α1,2- (BT3990) α1,3- (BT3991) and α1,6- (BT3994) mannosidic linkages 
(Zhu et al., 2010).  As reported by Zhu et al. (2010) using qualitative assays, BT3994 
is able to hydrolyse the terminal α1,6-mannosidic linkage in HMNG treated with 
BT3990, which generates  Man5GlcNAc2, or both BT3990 and BT3991 that produces 
Man3GlcNAc2 (Figure 4.23). BT3994, however, was shown not to be active against an 
α1,6-linked disaccharide of mannose. This observation suggests a specificity 
determinant is required for BT3994 activity, which is present in both Man5GlcNAc2 and 
Man3GlcNAc2, but absent in α1,6-mannobiose. It can be hypothesized that either 
BT3994 requires an essential mannose residue at the +2 subsite or that BT3994 
displays specificity for a GlcNAc moeity at the +3 subsite of the enzyme for catalysis 
to occur. This hypothesis was probed in the following experiments.  
4.3.4.1 A non-reducing end N-acetyl glucosamine is a specificity determinant, 
essential for GH92 BT3994 α-mannosidase activity. 
To provide quantitative detailed information on the specificity of BT3994, a GH92 α1,6-
mannosidase (Zhu et al., 2010), the activity of the enzyme was determined using 
fluorescent labelled substrate.  A Man9GlcNAc2 oligosaccharide was labelled with 2-
aminobenzamide (AB) as described in Chapter 2 Section 2.2.2. Such labelling 
compromises the integrity of the modified reducing end GlcNAc. Man5GlcNAc2-AB and 
Man3GlcNAc2-AB oligosaccharides were generated from Man9GlcNAc2-AB  
(Structures shown in Figure 4.23) using BT3990 and both BT3991 and BT3990, 
129 
 
respectively. This was verified by HPAEC-PAD using a fluorescence detection system. 
Likewise, α1,6-mannotetraose and α1,6-mannotriose were 2-AB labelled (Figure 4.24) 






Figure 4.23. Structure of Man9GlcNAc2 and oligosaccharides generated to probe GH92 BT3994 α-
mannosidase specificity.  The structure of Man9GlcNAc2 is shown. Man5GlcNAc2 is generated by 
incubation of Man9GlcNAc2 with the GH92 α1,2-mannosidase, BT3990. Man3GlcNAc2 can be 
subsequently generated via treatment with the GH92 α1,3-mannosidase , BT3991. The specificity of 
the α1,6-mannosidase, BT3994 was tested against 2-Aminobenzine labelled Man5GlcNAc2 and 
Man3GlcNAc2 and analysed by a fluorescence detection system using HPAEC-PAD. The sugar/linkage 





The GH92 α1,6-mannosidase,  BT3994, was active against both 2-aminobenzamide 
labelled Man5GlcNAc2-AB and Man3GlcNAc2-AB. Efficiency constants (kcat/KM) of 
BT3994 against these substrates were generated by substrate depletion using the 
same methodology as described in Section 4.3.2.1.4.and analysed by HPAEC-PAD 
using fluorescence detection. The data are reported in Table 4.5 and example 
analyses are shown in Figure 4.25. Interestingly, the GH92 α1,6-mannosidase was 
not active against α1,6-mannotetraose-AB (effectively mannotriose) at enzyme 
concentrations as high as 10 µM, strongly suggesting that BT3994 requires GlcNAc at 
the reducing end +3 subsite for catalytic activity. Likewise, the lack of activity BT3994 
displays against α1,6-mannotriaose-AB (effectively mannobiose), confirms the 
observations of Zhu et al., (2010) 
Figure 4.24. HPAEC-PAD flurescence detection of 2-aminobenzne labelled α1,6-
mannotetraose and α1,6-mannotriose.  An example of the detection of 2-aminobenzene  
(AB) labelled α1,6-mannotetraose (Man4-AB) and α1,6-mannotriaose (Man3-AB) using a 
florescence detection system (HPAEC-PAD). The respective labelled α1,6-oligosaccharide 
















Figure 4.25. HPAEC-PAD fluorescent detection to monitor substrate depletion and activity 
of the GH92 α1,6-mannosidase, BT3994. Representative example of the substrate depletion 
data provided by GH92 α1,6-mannosidase BT3994 incubation with Man5GlcNac2-AB and α1,6-
mannotetraose-AB (Man4-AB), analysed by fluorescent detection (HPAEC-PAD).  kcat/KM 
values were generated by determining the rate of substrate depletion using GraphPad Prism 
5.0, if applicable. Assays were performed in 20 mM Na-citrate buffer, pH 7.5. 
Table 4.5. Catalytic efficiency of BT3994 against α1,6-mannooligosaccharides and exposed 
α1,6-linked mannose residues of HMNG. *Substrate is α1,6-Mannotriaose-AB and represents 




The biochemical data generated in this chapter attempts to elucidate the hierarchal 
degradation of yeast α-mannan orchestrated by PUL-Man1-3 of B. theta. As such a 
model of yeast α-mannan degradation by B. theta is displayed in Figure 4.29.  
GH76 endo-α1,6-mannanase attack on the α1,6-mannan backbone is restricted due 
to steric constraints imposed by the mannan side chains of yeast α-mannan. Thus, 
limited side-chain removal must occur extracellularly to facilitate surface GH76 α-
mannanases cleaving mannosidic linkages in the backbone.  Attempts to elucidate the 
α-mannosidases localised to the cell surface which could fulfil this function revealed 
two such candidates; BT3990 and BT2199, which were able to de-branch yeast α-
mannan sufficiently to enable the GH76 α-mannanases to attack the backbone. 
Subsequently, localisation experiments performed by Dr Fiona Cuskin and Dr 
Elisabeth Lowe showed that BT3990 is a periplasmic enzyme. Excluding the potential 
role of the enzyme in extracellular side-chain deconstruction (Cuskin et al., 2015b). 
Instead, the α-mannosidase BT2199 is the most likely candidate enzyme.  The 
BT2199 ORF appears to be encoded by a PUL, owing to the presence of a SusC/D-
pair. This PUL and bt2199 specifically were not upregulated by yeast α-mannan. 
However, only the fold up-regulation of bt2199 in response to α-mannan was explored, 
and so the basal expression levels of BT2199 are unknown. Conversely, the key 
periplasmic debranching enzyme, BT3774, is up-regulated 50~fold compared to 
glucose grown cells, when B. theta cells were confronted with α-mannan (Cuskin et 
al., 2015b).  Uniquely, B. theta has seemingly evolved a strategy to utilize yeast α-
mannan through deploying surface exo-acting enzymes which are not encoded, or up-
regulated by, the cognate PUL or polysaccharide degradation products respectively 
(Cuskin et al., 2015b). Instead, side-chain removal is mediated by a constitutively 
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expressed α-mannosidase, which will thus infrequently expose the mannan backbone. 
Indeed the limited removal of the mannan side chains at the surface of B. theta is also 
reflected by the very low activity of BT2199 compared to the functionally equivalent 
GH38 α-mannosidase BT3774 (Cuskin et al., 2015b). B. theta has seemingly evolved 
a strategy which minimises nutrient loss at the cell surface, illustrated by the lack of 
oligosaccharides observed when B. theta is cultured with yeast α-mannan as a sole 
carbon source (Cuskin et al., 2015b). The inability of B. theta support the growth of B. 
xylani or B. cellulo when co-cultured on yeast mannan supports the view that the 
breakdown of the glycan at the surface of B. theta is minimal. Whilst BT2199 is the 
candidate enzyme which mediates extracellular side chain removal, additional 
experiments must be performed to validate this claim. This hypothesis could be 
verified by knocking out bt2199 and exploring whether the mutant is able to grow on 
yeast mannan.  
 
The GH76 glycoside hydrolases encoded by PUL-Man1 and PUL-Man2 are endo-
α1,6-mannanases. Site-directed mutagenesis of the two highly conserved aspartate 
residues, housed in a curved, cleft-like structure of the enzyme, abolished catalytic 
activity. Asp258 and Asp259 are therefore the candidate catalytic residues of the 
enzyme. Indeed, the topography of the active site is complementary to the 
conformation adopted by α-mannans as illustrated by Thompson et al. (2015). Indeed 
an overlay of the structure of BT3792 with a close GH76 homolog (Bacillus ciculans 
(Bc) endo-α1,6-mannanase; PDB code 5AGD) in complex with mannopentaose 
revealed that the ligand is located in a curved cleft containing the two catalytic 
residues, confirming the location of the substrate binding region and the active site 
Figure 4.26. The distance separating the two catalytic aspartate residues of the 
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enzyme of ~5 Ǻ is typical of  glycoside hydrolases that utilize a retaining, double 
displacement mechanism of catalysis (Rye and Withers, 2000), suggesting that the 
GH76 enzyme BT3792 and, by inference, all members of the family, are retaining 
enzymes. This hypothesis was confirmed by NMR performed by Dr. Alan Cartmell, 
revealing that the α-mannooligosaccharide products generated by the GH76 enzyme 
BT3792 demonstrated an overall net retention in anomeric configuration (Cuskin et 
al., 2015b). In the structural overlay described above, Figure 4.27 Asp258 is below the 
plane of the mannose bound in the active site (-1 subsite) and O1 of the carboxylate 
is 2.6 Å from the anomeric carbon demonstrating its role as the catalytic nucleophile. 
O1 of Asp259 is within hydrogen bonding distance (2.9 Å) indicating that this 









Figure 4.26. Crystal structure of the GH76 endo-α,16-mannanase, BT3792, in 
complex with α1,6-mannopentose. α1,6-mannopentaose is displayed in the ligand 
binding cleft of BT3792, and is coloured yellow. Oxygen moieties are coloured pink 
respectively. The surface of the enzyme is displayed and coloured grey. The conserved 




Endo-α1,6-mannanase activity is key to the sequential degradation of yeast α-
mannan, illustrated by the observed differences in activity displayed between the 
surface and periplasmic GH76 enzymes. The two extracellular GH76 endo-α1,6-
mannanases (BT2623 and BT3792) generate longer oligosaccharides from the 
mannan backbone than the corresponding periplasmic enzymes (BT2631 and 
BT3782), and are catalytically slower against the polysaccharide. Kinetic data of the 
GH76 enzymes versus α1,6-mannooligosaccharides suggest that the periplasmic 
endo-mannanases are more adapted for the degradation of small chain 
mannooligosaccharides than the corresponding extracellular enzymes. These findings 
offer a potential model by which the backbone of yeast mannan is processed by B. 
theta.   The surface GH76 enzymes are catalytically slower and make infrequent cuts 
along the exposed backbone of yeast mannan, generating large oligosaccharides 
which can be imported into the periplasm of the cell. Once within the cell, periplasm 
the GH76 enzymes rapidly degrade the imported mannooligosaccharides. The longer 
oligosaccharides generated by the surface mannanases ensures minimal extracellular 
metabolism and prevents loss of substrate to the human gut microbiota. Indeed, 
limiting the extracellular cleavage of long chain oligosaccharides would help 
synchronise the rate of import with cleavage; maximising substrate acquisition through 














The observed lower rates of surface GH76 endo-mannanase activity is consistent with 
limited biochemical data of surface Bacteroides enzymes (arabinanases and 
xylanases), which also display low catalytic activity (Cartmell et al., 2011). The 
periplasmic GH76 endo-mannanases, by generating numerous short chain α1,6-
oligosaccharides, maximise the substrate available to the periplasmic located GH125 
α1,6-mannosidases.  
The two GH125 α-mannosidases, BT2632 and BT3781, encoded by PUL-Man1 and 
PUL-Man2 respectively, are exo-α1,6-mannosidases which are capable of degrading  
α1,6-mannooligosaccharides and demonstrate the highest affinity for mannobiose.  
The preference for the disaccharide suggests that two sugar binding sub-sites are 
utilized by the enzymes, with Man-α1,6-Man motif occupying the -1 and +1 subsites. 
The crystal structure of the apo form of BT3781 and the Clostridium perfringens 
GH125 exo-α1,6-mannosidase, CpGH125, were previously determined, the latter in 
complex with α1,6-mannobiose (Gregg et al. (2011). In the crystal-structure of 
CpGH125 the non-reducing end of mannobiose occupied the -1 subsite and the 
Figure 4.27. Overlay of the catalytic residues of the GH76 endo-α16-
mannnases, BT3792 and BcGH76, in complex with 
mannopentaose. The catalytic residues of BT3792 are depicted in blue. 
The homologous residues, located within the BcGH76 (PDB code: 
5AGD) active site are coloured green respectively. The bound ligand, 
α1,6-mannopentaose is coloured yellow, with pink oxygen moieties. The 
sub-sites of the enzyme in which each respective pyranose ring of 
mannopentoase interacts is labelled accordingly. 
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reducing end mannose was bound at the +1 subsite. The CpGH125 catalytic site has 
the potential to accommodate longer oligosaccharides, with the reducing end sugar 
protruding into solvent. The structure of the catalytic site of CpGH125 indicates an 
inability for the enzyme to accommodate α1,2-linked side chains as O2 of the mannose 
at the +1 and/or -1 subsites are pointing at the enzyme surface. Indeed an overlay of 
the apo crystal structure of BT3781 and CpGH125 show that the active site (-1 subsite) 
and the +1 subsite are completely conserved in the two enzymes side chains and is 
consistent with the inability of the B. theta enzyme to act on α1,6-mannan backbones 
that contain side chains appended to O2, Figure 4.28. The structural conservation 
between the two enzymes also indicates that BT3781 only contains two subsites 
explaining why the enzyme displays maximum activity against mannobiose.  The 
observation that the GH125 B. theta enzyme could not act upon the highly decorated 
yeast mannan, indicate that side chain removal of oligosaccharides imported into the 































Figure 4.28. The structures of GH125 a1,6-mannosidases that play a key role in yeast 
mannan degradation. Panel A shows an overlay of BT3781 (green; PDB code 2P0V) with 
the substrate and catalytic residues of the Clostridium perfringens GH125 a-mannosidase 
CpGH125 (cyan; PDB code 3QT9), in which the ligand 6-S-alpha-D-mannopyranosyl-6-thio-
a-D-mannopyranose (Man-S-Man) is shown in yellow. Panel B shows the solvent exposed 
surface of BT3781 in the vicinity of the active site in which the catalytic residues (Glu174 and 
Glu439) are depicted in magenta. The position of Man-S-Man is based on the overlay shown 
in Panel A. The figure was prepared using PyMOL. 
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B. theta has seemingly adapted a ‘selfish’ mechanism of yeast α-mannan utilization, 
supported by biochemical characterisation of the enzymes encoded by PUL-Man1/2/3 
and the inability of B. theta mannan degradation products to sustain the growth of 
other Bacteroides species. These data are entirely consistent with the observation that 
wild type B. theta is out-competed by a B. theta PUL-Man1/2/3 deletion strain in 
animals fed a diet not containing α-mannan, highlighting the significant energy 
cost/investment targeting yeast α-mannan entails, most likely owing the significant 
number of enzymes, transporters and binding proteins that must be expressed to fully 
degrade the polysaccharide (Cuskin et al., 2015b). These results reinforce the 
hypothesis that yeast α-mannan is a consistent nutrient source for the human gut 
microbiota. Indeed the selfish utilization strategy of high complexity/low abundance 
glycans extends to other PUL systems, such as the Bacteroides ovatus utilization of 
complex xylans (Rogowski et al., 2015).  
PUL-Man1 encodes a GH97 α-galactosidase, BT2620, which removes the α-
galactose decorations appended to the backbone of S. pombe α-mannan to facilitate 
endo-mannanase attack. This indicates that B. theta has evolved the ability to target 
the α-mannan of different yeast species. The importance of BT2620 in B. theta S. 
pombe α-mannan utilization is emphasized by observed growth defect of the ΔPUL-
Man1 B. theta mutant cultured on S. pombe mannan (Cuskin et al., 2015b). 
Interestingly, PUL-Man2 encodes a GH130 glycoside hydrolases capable of targeting 
the β1,2-mannosidic linkages which cap the mannose side-chains of Candida albicans 
α-mannan, a pathogenic yeast and commensal member of the gut microbiota (Cuskin 
et al., 2015a). This reinforces the variety of fungal mannans targeted by B. theta. 
The GH92 α1,6-mannosidase, BT3994, encoded by PUL-HMNG, targets the α1,6-
mannosidic linkages of Man5GlcNAc2-AB and Man3GlcNAc2-AB. The AB labelled 
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substrates utilized to assay BT3994 specificity in this chapter destroyed the terminal 
reducing end GlcNAc and thus the substrate targeted by these enzymes were 
Man5GlcNAc and Man3 -
mannotriose GlcNAc positioned in the +3 subsites is an absolute specificity 
determinant. Although BT3994 can hydrolyse substrates extended past the +3 subsite 
it is likely that Man5GlcNAc and Man3GlcNAc are the biologically substrates, as the 
GH18 endo-β-N-acetylglucosaminidase encoded by PUL-HMNG is localised to the 
cell surface. This enzymes releases HMNG by hydrolysis of the β1,4-linkage of the 
terminal GlcNAc-GlcNAc moiety of Man9GlcNAc2, before importation into the cell. The 
periplasmic localised enzymes of the HMNG-PUL would therefore only be presented 
with Man9GlcNAc. These data show that BT3994, is specific for HMNG, and supports 
the evidence that the HMNG-PUL apparatus is distinct from the α-mannan degradation 
apparatus, encoding an enzyme profile tailored to HMNG degradation, but not yeast 
α-mannan, deconstruction. Indeed, the inability of a mutant strain of B. theta lacking 
bt3993 (extracellular sigma-factor regulator of PUL-HMNG) to grow on Man9GlcNac2 
demonstrates that the HMNG-PUL targets HMNG exclusively (Cuskin et al., 2015b).  
 
While α-mannan represents a nutrient to the human microbiota, the polysaccharide 
may also have clinical implications. Patients with Crohn’s disease often have 
circulating anti-S. cerevisiae antibodies (ASCA). The epitope for this antibody is a 
mannan with α terminal Man-α1,3-Man disaccharide (Peeters et al., 2001);(Quinton et 
al., 1998), suggesting a relationship between the polysaccharide and Crohn’s disease. 
This view is supported by the observation that the ASCA epitope, expressed by a 
number of microorganisms inhibits the killing of Escherichia coli by macrophages and 
monocytes, suggesting that the suppression of mucosal phagocyte function by 
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microbial α-mannan may contribute to Crohn’s disease pathogenesis (Mpofu et al., 
2007). Intriguingly mannan induces the presentation of the endo-α1,2-mannosidase 
BT3862 and the α1,3-mannosidase on the surface of B. thetaiotaomicron that, 
collectively, would degrade the ASCA epitope and thus prevent the inhibition of 
mucosal phagocytes by α-mannans. Thus, in addition to utilizing yeast mannan as a 
nutrient, the capacity of B. thetaiotaomicron to express a repertoire of α-mannosidases 
that target α-mannans may also protect the large bowel from Crohn’s disease and 













Figure 4.29. Model of Yeast α-mannan degradation by Bacteroides thetaiotaomicron. 
In this model limited degradation of the mannan occurs at the surface and the bulk of 
glycan degradation occurs in the periplasm. Yeast α-mannan is partially de-branched at 
the cell surface by constitutively expressed α-mannosidases (most likely the GH92 α-
mannosidase, BT2199 and potentially with GH99 endo-α1,2-mannosidase assistance), 
providing access for the extracellular  GH76s endo-α1,6-mannanases (BT2623 and 
BT3792) to the α1,6-mannan backbone. High molecular weight oligosaccharide products 
are transported through the SusC homolog into the periplasm. Following concerted side-
chain removal via GH38 α-mannosidase (BT3774), GH92 α-mannosidase 
(BT2629/BT3784) and phosphatase  (BT2630 and BT3783) activity, periplasmic GH76 
enzymes (BT2632 and BT3782), hydrolyse the linear α-1,6-mannooligosaccharides into 
small chain products (D.P ≤3). The α1,6-mannooligosaccharides upregulated the mannan 
PULs prior to their hydrolysis into mannose by the GH125 α1,6-mannosidases BT2632 
and BT3781, which can then be imported and fermented by the bacterium. 
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4.5. Further work 
Further work must be performed in order to elucidate if BT2199 is the only extracellular 
candidate α-mannosidase capable of debranching yeast α-mannan. This could be 
investigated via knocking out the ORF encoding BT2199 and assessing the ability of 
the mutant to grown on yeast α-mannan and the linear mannan backbone.  
Furthermore, to further assess if the break down products of B. theta growth with yeast 
α-mannan can support the growth of other Bacteroides, a more compelling experiment 
would be to co-culture wild type B. theta with a Pul-Man1/2/3 deletion strain of B. theta, 
reducing any possible inter-species differences in mannan catabolism. Similarly, a 
deletion strain of the surface GH76 endo-mannanases encoded by PUL-Man1 and 
PUL-Man2 could be co-cultured with wild type B. theta to assess if the release of high 
molecular weight oligosaccharides during α-mannan depolymerisation are able to 









Chapter 5: Bacteroides thetaiotaomicron and 
Bacteroides ovatus can utilize the β1,6-glucan  
fraction of the yeast cell wall as an energy source 
5.1 Introduction 
The Bacteroides genus, exemplified by the gram negative Bacteroides 
thetaiotaomicron (B. theta), represents a significant proportion of the human gut 
microbiota. Around 40% of the B. theta genome encodes carbohydrate active 
enzymes (CAZymes)  enabling this bacterium to utilize a myriad of complex dietary 
and host-derived glycans (Rogowski et al., 2015). Such CAZymes, many of which 
belong to sequence based glycoside hydrolase families (GHs), are often encoded in 
distinct genetic loci that target and are up-regulated by specific glycans. These 
polysaccharide utilization loci (PULs) encode periplasmic and cell envelope 
associated proteins that mediate the acquisition, degradation, and utilization of specific 
polysaccharides.  All PULs encode homologues to the SusC/SusD pair present in the 
starch utilization locus. These proteins, which are localised to the extracellular 
membrane, mediate glycan import into the periplasm. Hypothetical PULs are identified 
by the presence of homologues of SusC and SusD (defined as SusCh and SusDh, 
respectively), which are upregulated by the depolymerised products of their cognate 
polysaccharide. The portfolio of PULs is not conserved amongst the Bacteroidetes 
genera, and thus the glycan degrading capacity varies in the organisms that belong to 
this phylum (Larsbrink, 2014). 
 It was previously reported that when B. theta was cultured with yeast extract, peptone, 
dextran (YPD) media, the expression of a PUL (defined henceforth as PULbtPUS) 
containing bt3310 and bt3311 that encode a SusCh and SusDh, respectively, were 
upregulated (Sonnenburg et al., 2010). Bioinformatic analysis of PULbtPUS identified a 
number of potential protein encoding genes including a homologue to the regulator of 
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the starch PUL, defined here as SusRh (BT3309), a GH30 glycoside hydrolase 
(BT3312), a surface glycan binding protein or SGBP (BT3313) and a GH3 glycoside 
hydrolase (BT3314). It is possible that the proteins encoded by PULbtPUS orchestrate 
the deconstruction of a polysaccharide present in the YPD medium. A schematic of 













Figure 5.1. Schematic of PULbtPUS. Hypothetical protein encoding open reading 
frames (ORFs) are shown as arrows (to scale), the direction of which indicates the 
orientation of the ORF. Predicted activity is annotated above the ORF, whilst the 
locus tag of the ORF is annotated below. Sus--like indicates the predicted role of 
the encoded protein based on sequence similarities with the homologous protein in 
the prototypic starch utilization system (Sus). GH (glycoside hydrolase) followed by 
a number indicates the amino-acid sequence based family the protein is 




Yeast cell wall polysaccharides present in the yeast extract of YPD media are potential 
target substrates for PULbtPUS. The yeast cell wall, consisting of a number of complex 
polysaccharides, includes chitins, α-mannans and β-glucans that differ in linkage (See 
Chapter 1, Section 1.3.2). B. theta can utilize yeast α-mannan as an energy source 
(Cuskin et al., 2015b), suggesting yeast cell wall polysaccharides are viable targets 
for the human gut microbiota. Indeed, the acquisition and evolution of the PULs which 
target yeast mannan coincides with the human domestication of yeast (Cuskin et al., 
2015b).  The predominant glycan in the yeast wall, comprising ~80%, is β1,3-glucan 
decorated with β1,6-linked glucose side chains. These β-glucans comprise up to 1500 
glucose residues and plays a structural role in the yeast cell wall. The helical 
conformation adopted by the β1,3-glucans provides tensile strength to the cell wall, 
protecting the yeast cell against turgor induced by osmatic stress. The minor β1,6- 
glucans, constituting 10 – 15% of the Saccharomyces cerevisiae (S. cerevisiae) cell 
wall,  consist of a β1,6-glucan backbone substituted with β1,3-glucose decorations, 
and are estimated to extend to ~200 glucose residues in length. The proportion of 
β1,3-glucose side chains is species specific, being 7 % in S. cerevisiae but can be as 
much as up to 75 % in Schizosaccharomyces pombe (Aimanianda et al., 2009). The 
β1,6-glucan fraction of the cell wall is covalently linked to the β1,3-glucan fraction and 
cross-links the yeast cell wall (Aimanianda et al., 2009). The importance of the β1,6-
glucan fraction to cell wall structure and yeast survival, is demonstrated by the lack of 
viability shown by yeast mutants which lack the transferases responsible for the 
assembly of the β1,6-glucan fraction in vivo (Kurita et al., 2011). A representation of 







Previously characterised GH30 glycoside hydrolases which belong to the sub-family 
3 are at present exclusively endo-β1,6-glucanases. Reported activity of GH3 glycoside 
hydrolases includes β-glucosidase activity, suggesting that these enzymes target β-
linked glucans and that PULbtPUS may orchestrate β-glucan deconstruction, specifically 
β1,6-glucans.  
5.2 Objectives 
The objectives of this chapter is to elucidate the degradation of β1,6-glucans by 
Bacteroides through the biochemical characterisation of the proteins encoded by the 
PULs believed to target this substrate. 
5.3 Bacteroides thetaiotaomicron and Bacteroides ovatus are capable of 
utilizing β1,6-glucans as a carbon source. 
5.3.1. Culturing B. theta and B. ovatus with β-glucans. 
To establish the yeast -glucan(s) utilized by B. theta and B. ovatus, the two 
Bacteroides  were cultured anaerobically in the presence of the linear β1,3-linked 
glucan, laminarin and pustulan, a linear β1,6-glucan polysaccharide. Growth curves 
are displayed in Figure 5.3.  Both Bacteroides species were able to utilize pustulan as 
an energy source, growing to an optical density of 2.0 (OD600nm).  No growth was 
observed when B. theta and B. ovatus were incubated in minimal media containing 
Figure 5.2. Structure of  the  β1,6-glucan fraction of the Saccharomyces cerevisiae 
cell wall. G indicates glucose residues. All arrows represent β-bonds, with numbers besides the 
arrows denoting linkage. Figure adapted from Aimanianda et al. (2009) 
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5.3.2. Transcription of PULbtPUS and PULboPUS is upregulated by β1,6-glucans.  
Given that B. theta can grow on yeast β1,6-glucans and the genes encoded by 
PULbtPUS  are predicted to encode PULPUS, it is likely that transcription of the locus is 
activated by pustulan. As described below, B. ovatus contains a PUL (PULboPUS) that 
is synthenic with PULboPUS and thus is predicted to also orchestrates the degradation 
of pustulan. To test the hypothesis that PULbtPUS and PULboPUS were upregulated by 
pustulan, confirming their role in the degradation of the β1,6-glucan, quantitative 
polymerase chain reactions (qPCRs) were performed on the transcripts derived from 
the genes encoded by the two loci. To ensure that no observed activation of the PULs 
Figure 5.3. Growth curves of anaerobic B. theta and B. ovatus cultured on glucose 
and β-glucans. Minimal media (2 mL) containing glucose ( 5 mg/mL), the linear β1,3-
glucan laminarin (5 mg/mL) or the linear β1,6-glucan, pustulan (5 mg/mL), was inoculated 
with  B. theta (BT) or B. ovatus (BO)). Inoculated bacteria were incubated anaerobically in 
a 24-well plate. Bacterial growth was continuously monitored (represented by OD600nm), 
until stationary phase was reached.  Bacterial growths were performed in triplicate, the 
average optical density is plotted on GraphPad Prism 5.0.  
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was due to unspecified components in TYG medium, Bacteroides cells (stored in 
glycerol (25 % v/v)/ TYG) were sub cultured twice over night into minimal media 
containing glucose (5 mg/mL), before being washed and inoculated into minimal media 
(3 mL) containing glucose (5 mg/mL) and pustulan (5 mg/mL), respectively. Cells were 
grown anaerobically until early-exponential phase (0.6 OD600nm) and RNA was 
extracted and reverse transcribed to cDNA as described in Materials and Methods, 
Sections 2.1.14 and 2.1.15, respectively. The primers, complementary to regions of 
the ORFs and designed to produce amplicons between 100 – 150 base pairs are 
displayed in Table 5.1. qPCR revealed that, compared to glucose grown cells, 
pustulan mediated a ~100-fold upregulation of bt3310 – bt3313 in B. theta and ~200- 
fold up-regulation of bacova_00942 – 00945 in B.ovatus, Figure 5.4. No upregulation 
of bt3309 and bacova_00941, the SusRh regulators, was observed as seen in previous 
gene upregulation studies of PULs (Sonnenburg et al., 2010). Interestingly, the ORFs 
encoding for BT3314 and BACOVA_00946, the hypothetical GH3 β-glucosidases, 
were only upregulated ~10- and ~25-fold in B. theta and B. ovatus respectively 
(relative to glucose grown cells) (Figure 5.4). The exact signalling molecule that induce 

























































Table 5.1. Nucleotide sequences of primer utilized in quantitative PCR experiment to assess 




5.3.3. PULbtPUS is wide-spread amongst the Bacteroides genus. 
Analysis of the genomes of Bacteroides revealed that PULbtPUS is conserved amongst 
all other B. theta strains currently sequenced from clinical settings, and numerous 
other Bacteroides species including B. ovatus strain ATCC-8483, where the locus is 
defined as PULboPUS. Thus, PULbtPUS and PULboPUS are syntenic, while the 
corresponding encoded proteins display a high degree of sequence identity and are 
thus highly likely to display the same function (Figure 5.5). 
 
Figure 5.4. Quantitative PCR of the transcripts derived from PULbtPUS and PULboPUS when B. theta and 
B. ovatus were cultured on pustulan and glucose. Anaerobic cultures in minimal media  (3 mL) 
containing the respective carbon source (5 mg/mL) were grown until 0.6 OD600nm before mRNA was 
harvested. Growths were performed in triplicate. The fold up-regulation compared to glucose grown 











Figure 5.5. Schematic representation of the synteny and homology shared between 
PULbtPUS and PULboPUS. The two PULs are labelled by Bacteroides species. The locus tag 
of the predicted protein encoding ORFs are displayed beneath their respective 
representation (bt for B. theta and bacova for B. ovatus). The amino-acid sequence identity 
shared between the encoded hypothetical proteins with the same predicted function 




5.4. Characterisation of the proteins encoded by PULbtPUS  
The mechanism of β1,6-glucan utilization by Bacteroides was initially explored in B. 
theta and accomplished through characterising the proteins encoded by PULbtPUS. 
5.4.1. Characterisation of the extracellular binding proteins, SusDh and SGBP 
encoded by PULbtPUS 
 
5.4.1.1. Expression and purification 
DNA encoding SusDh and extracellular SGBP, BT3311 and BT3313 respectively, were 
cloned via a high-throughput cloning service (NZYtech, Portugal). The proteins (like 
all B. theta proteins investigated in this study), were cloned without signal peptides. 
The genes were cloned into a pET28a derivative and supplied an N-terminal His6-tag 
to BT3311 and BT3313. The two proteins, which were expressed in E. coli TUNER 
cells were produced in soluble form and purified by IMAC, Figure 5.6. The observed 






































Figure 5.6. SDS-PAGE of recombinant expression and purification of BT3311 and BT3313. SDS-
PAGE of typical BT3311 and BT3313 purification following IMAC. All SDS-PAGE gels were 12 % 
(w/v). Marker Mr is displayed in kDa. L = low size marker; P = insoluble fraction; CHE = cell free 
extract; FT = flow through; W = wash ( 1x TALON buffer); E1 = elution 1 (5 mM imidazole,1 x 
TALON buffer); E2 = elution 2 (100 mM imidazole, 1 x TALON buffer).  BT3311 ran with an 
apparent Mr of 58 kDa. BT3313 ran with an apparent Mr of 70 kDa. Both values are consistent 
with the predicted sizes of the recombinant proteins, at 55.5 kDa and 72 kDa respectively. 
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5.4.1.2 The Extracellular binding proteins demonstrate preferential binding to 
Pustulan, a linear β1,6-glucan polysaccharide. 
The activity of the potential carbohydrate surface binding proteins to soluble 
polysaccharides was first assessed via affinity gel electrophoresis as a qualitative 
screening method, which is described in Materials and Methods, Section 2.2.5.2. The 
non-binding negative control protein was bovine serum albumin (BSA). Both BT3311 
and BT3313 displayed binding to pustulan (Figure 5.7). No binding to the linear β1,3 













Figure 5.7. Affinity gel electrophoresis of BT3311 and BT3313 against soluble β-glucans. 
Recombinant BT3311 (SusDh) and BT3313 (SGBP) were electrophoresed through a non-
denaturing, polyacrylamide gel in the presence and absence of ligand (0.1 % (w/v). Bovine serum 
albumin (BSA) was used as a non-binding control.  
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To provide a quantitative assessment of glucan recognition, isothermal titration 
calorimetry (ITC) was utilized to determine the thermodynamic parameters of ligand 
binding. Using ITC the association constant (Ka) change in enthalpy and stoichiometry 
of binding (n) were determined using MicroCal Origin 7.0 software, as described in 
Materials and Methods, Section 2.2.5.1  The data-set is reported in Table 5.2 and 
example titrations are shown in Figure 5.8.  The SusDh (BT3311) and SGBP (BT3313) 
displayed Ka values of 4.0 x 104 M-1 and 5.1 x 105 M-1, respectively, for pustulan. 
 
Protein Ligand Ka (M-1) n 
BT3311 
Pustulan 4.0 (±0.25) x 104 1.1 ± 0.0 
β1,6-glucoheptaose 1.8 (±0.03) x 104 1.0 ± 0.0 




β1,6-glucobiose No Binding 
BT3313 
Pustulan 5.1 (±0.4) x 105 1.0 ± 0.0 
β1,6-glucoheptaose 6.0 (±0.04) x 104 1.0 ± 0.0 












Table 5.2. Association constant values (Ka) generated by isothermal titration calorimetry for 














Figure 5.8. Example ITC data of BT3311 and BT3313 binding to pustulan. Panel A 
and B show an ITC trace of BT3311 and BT3313, respectively, binding to pustulan. 
Panel C demonstrates a control titration of ligand into buffer.  Ligand (5 mg/mL) in the 
syringe was titrated into the protein containing cell (50 µM) or buffer for control titration. 
The top half of each ITC trace shows the raw heats generated per titration; the bottom 
half shows the integrated peak areas, fitted using a single-site binding model by 
MicroCal Origion software. All ITC was performed in 50 mM Na-HEPES buffer, 150 
mM NaCl, pH 7.5  
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To deduce the ability of the surface binding proteins to bind to β1,6-gluco-
oligosaccharides with differing degrees of polymerisation (D.Ps), the pustulan 
polysaccharide (1 g) was subjected to acid hydrolysis (20 mM HCl for 2 h) giving β1,6-
oligosaccharides of varying D.Ps. Following neutralisation, the oligosaccharide 
mixture was subjected to size exclusion chromatography (see Section 2.2.6.2. for 
methodology), rendering purified oligosaccharides of single species ranging from 
glucobiose to glucooctaose (Shown in Figure 5.9). The size of the oligosaccharides 
was based on the assumption that successive eluted glycans differed by a D.P. of 1.   
 
 
Figure 5.9. HPAEC-PAD analysis of purified β1,6-oligosaccharides. Oligosaccharide 
fractions rendered by P2-column size exclusion chromatography were first analysed for 
purity and degree of polymerisation (D.P) by HPAEC-PAD. Samples were diluted in water 
(100-fold dilution) for analysis. A glucose (0.05 mM) standard was ran concurrently to 
provide information on D.P of purified oligosaccharides relative to glucose. Fractions are 
labelled according to D.P (2-10). Once confirmed to be homogenous in composition, 
purified oligosaccharide fractions were pooled and subjected to lyophilisation. 
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Both proteins displayed maximum binding to oligosaccharides with a D.P. of 6 or 7. 
No measurable binding was detected for ligands with a D.P. ≤5. BT3313 displayed an 
affinity for glucohexaose and glucoheptaose around 3.5-fold greater than BT3311, 
Table 5.2.    
5.4.2. Characterisation of the enzymes encoded by the β1,6-glucan 
PUL of Bacteroides thetaiotaomicron 
 
5.4.2.1. Expression and Purification 
The ORFs encoding mature BT3312 and BT3314 (lacking signal peptides) were 
cloned into a pET28a expression vector derivative as described in Materials and 
Methods, Section 2.1.21. The His-tagged proteins were purified by IMAC to 
electrophoretic homogeneity. The size of the purified proteins, as judged by SDS-
PAGE, Figure 5.10 were consistent with their predicted molecular weight based on 
primary sequence.  BT3312, a candidate for crystal trails, was subjected to further 




























5.4.2.2. Sequence analysis and prediction of the cellular location of, BT3312, a 
hypothetical GH30 endo-β1,6-glucanase. 
BT3312  is a member of sub-family 3 of GH30. All previously characterized members 
of this sub-family have been shown to display β1,6-glucanase activity. LipoP 
(http://www.cbs.dtu.dk/services/LipoP/) analysis of BT3312 predicts that the protein is 
localised to the outer membrane of the cell due to the presence of a type II signal 
peptide (Figure 5.11).  
Figure 5.10. SDS-PAGE of recombinant expression and purification of BT3312 and BT3314. SDS-
PAGE of typical BT3312 and BT3314  purification following IMAC. All SDS-PAGE gels were 12 % 
(w/v). Marker Mr is displayed in kDa. L = low size marker; P = insoluble fraction; CHE = cell free 
extract; FT = flow through; W = wash ( 1x TALON buffer); E1 = elution 1 (5 mM imidazole,1 x 
TALON buffer); E2 = elution 2 (100 mM imidazole, 1 x TALON buffer). BT3312 ran with an 
apparent Mr of 55 kDa. BT3314 ran with an apparent Mr of 80 kDa. Both values are consistent 




5.4.2.3. The GH30, BT3312, is an endo-β1,6-glucanase with activity against pustulan, a 
linear β1,6 glucan polysaccharide. 
In order to investigate the specificity and activity of BT3312, the capacity of the enzyme 
to hydrolyse various glyosidic linkages was assessed. Qualitative assessments of 
activity were analysed by TLC. Michaelis-Menten kinetics was generated via reducing 
sugar assays (polysaccharide substrates) or by substrate depletion using HPLC 
(oligosaccharide substrates) as described in 2.2.1.4.1 and 2.2.4, respectively. Assays 
incorporating BT3312 were conducted at 37 oC in 20 mM sodium-phosphate buffer, 
pH 7.5. Rates were plotted using GraphPad Prism 5.0 and analysed via non-linear or 
linear regression where appropriate.  
 
BT3312 was found to be catalytically active against the linear β1,6-linked glucan 
pustulan, rendering glucose and glucobiose as limit products of digestion (Figure 
5.12), thereby confirming that BT3312 is a β1,6-glucanase. During the initial stages of 
the reaction a series of oligosaccharides were generated demonstrating that the 
Figure 5.11. LipoP analysis of the predicted GH30 β1,6-glucananse. LipoP analysis 
(http://www.cbs.dtu.dk/services/LipoP/) indicates the likelihood of a SpII signal peptide 
(lipoprotein signal peptide) and a predicted cleavage site at amino acid residue 20 of the 
protein sequence. These data indicate BT3312 is localised to the outer membrane of the cell.  
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enzyme has an endo mode of action (Figure 5.13).  No activity against the other 




















Figure 5.13. TLC analysis of GH30 endo-β1,6-glucananse ,BT3312, activity against 
pustulan. TLC showing BT3312 (0.1 µM or 0.01 µM) activity against pustulan (1 mg/mL) 
over a time course totalling 1 h. Samples of the reactions were taken at the respective time 
points and deactivated by boiling for 10 min. NOE = No enzyme control. G = glucose (1 mM) 
which was ran as a standard.  
Figure 3.12. Thin layer chromatography (TLC) of 
limit products generated by BT3312 against 
pustulan.  TLC showing a 16 h digest of BT3312 (1 
µM) with pustulan (1 mg/mL), ran against a glucose 
and β1,4-glucooligosaccharide standard (G -> G4). 
NOE = no enzyme control.   
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The full Michaelis-Menten kinetic parameters of BT3312 against pustulan are reported 
in Table 5.3 and Figure 5.14 and were determined via a reducing sugar assay as 
described in Materials and Methods, Section 2.2.1.4.1. Briefly, as the glycoside 
hydrolase cleaves sugar chains internally, new reducing ends are formed, inducing a 
colour change in the assay reagents which can be measured spectrophotometrically 
at OD540nm. A standard curve of glucose was utilized to quantify the formation of new 
reducing ends. Enzyme (50 nM) was incubated with a range of pustulan 
concentrations (0.5 – 8 mg/mL) with aliquots taken of the reaction over a series of time 
points. Reactions were deactivated by the addition DNSA reagent. The initial linear 
rate was plotted against substrate concentration.  BT3312 had a kcat of 13824 min-1 












Figure 5.14. Activity of BT3312 against pustulan. Rates were generated via a DNSA reducing 
sugar assay using a fixed enzyme concentration (0.05 µM) against a range of substrate 





Enzyme Substrate Km (mg/mL) Vmax (µM min-1) Kcat (min-1) Kcat/Km (mg-1 mL min-1) 
BT3312 Pustulan 5.6 69.1 1382 247 
 
5.4.2.4. BT3312 activity vs pustulan-derived oligosaccharides. 
To ascertain the activity of BT3312 against the oligosaccharide β1,6-glucooctose, 
BT3312 (0.01 µM) was incubated with β1,6-glucooctaose (0.03 mM) to ≤ 30 % of the 
starting quantity of substrate (represented by peak area) at T0 (0 min) after a 25 min 
time course. Aliquots of the reactions were taken at 5 min time points (T1 – 6) and 
analysed using HPAEC-PAD to deduce peak area. BSA (0.1 mg/mL) and an internal 
standard of fucose (0.01 mM) were incorporated into all assays. Substrate depletion 
was plotted using Graphpad Prism 5.0 and the gradient (velocity (min)) was 
ascertained via linear regression analysis. The Kcat/Km (M-1 min-1) of β1,6-glucooctose 
hydrolysis by BT3312 was subsequently deduced as performed in Chapter 4, Section 
4.3.2.1.4.. BT3312 demonstrated a kcat/Km value of 6.4 x 106 M-1 min-1 against β1,6-
glucooctaose. The graph used to generate the catalytic efficiency of the enzyme is 



























5.4.2.5. Crystallisation of BT3312. 
Purified protein (20 mg/mL) was distributed into 96 well plates by a Mosquito microliter 
pipetting robot (TTP labtech) with a total of two drops per well; the ratio of protein 
mixture to reservoir, being 1:1 and 2:1 respectively.  Eight commercially available 96-
well screens were used. Crystals of BT3312 were obtained in the commercial 96-well 
screen PACT, the conditions being 0.2 M Sodium Bromide, 0.1 Bis Tris Propane, pH 
6.5, 20 % w/v PEG 3350. The structure of the GH30 enzyme was solved by molecular 
replacement by Arnaud Baslé using the GH30 human glucosylceramidase (displays 
Enzyme Oligosaccharide Kcat/Km (M-1 min-1) 
BT3312 β1,6-glucooctaose 6.39 (± 0.2) x 106  
Figure 5.15. Graph showing substrate depletion of β1,6-glucooctaose by BT3312. BT3312 (10 nM) 
was used to treat β1,6-glucooctaose (0.03 mM). Aliquots were taken at 5 min intervals over a 25 min 
time-course. Reactions were deactivated by boiling for 10 min. The area of the glucooctasoe peak was 
determined at the respective time point and standardised to an internal standard of fucose.  In(S0/St) 
values were plotted using GraphPad Prism 5.0, where S0  = peak area of glucooctaose at T0 (0 min) and 
St =peak area of glucooctaose at time point (X min). Linear regression was used to ascertain the gradient 
(rate) which was subsequently divided by enzyme concentration to derive the Kcat/Km efficiency constant.  




26% identity over 86% of sequence with BT3312) as the search model. Subsequent 
to the PhD project crystals (grown by Dr Elisabeth Lowe) were transferred to a 10 μl 
drop consisting of 7 μl reservoir solution, 2 μl 20% PEG 400 and 1 μl glucose-β1,6-
deoxynijiromycin (kindly provided by Dr Spencer Williams, University of Melbourne) 
and allowed to soak for 5 min prior to freezing. Data was collected at Diamond Light 
Source, on beamline IO3 and the inhibitor-bound structure was solved by Dr Arnaud 
Baslé, as described before. Data collection and refinement statistics are displayed in 
Appendix A.  
5.4.2.6. Analysis of the apo-structure of BT3312, a GH30 encoded by B. theta  
BT3312 comprises two domains. The catalytic domain displays a (β/α)8 barrel fold or 
TIM barrel, extending from residues Asp82 to Lys427, and a  β-sandwich domain 
comprising sequences from both the N- and C-termini. The TIM barrel contains a 
central eight stranded β-barrel (strands 1 and 5 were not represented in the β-strand 
schematic using the pymol programme). Extending from each β-strand is an α-helix. 
In general extended loops link the α-helices with the β-barrel, although a small β-sheet 
comprising three anti-parallel strands is in the loop connecting β-strand-8 and α-helix-
8. The β-sandwich domain contains seven antiparallel β-strands in one sheet, two 
contributed by the N-terminal region of the enzyme. The other β-sheet comprises three 
antiparallel strands with one derived from the N-terminus. As BT3312 is located in 
GH30, the enzyme is a member of clan GH-A in which the fold and catalytic apparatus 
and mechanism are conserved. According to these criteria BT3312 is predicted to 
display a double displacement acid-base assisted mechanism in which anomeric 
configuration is retained after bond cleavage. Similarly the catalytic acid/base and 
catalytic nucleophile are predicted to be in β-strands 4 and 7 of the barrel, respectively, 
and highly conserved within the clan. Thus, the candidate catalytic residues are 
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Glu236 (acid-base) and Glu337 (nucleophile). The catalytic roles of Glu236 confirmed 
by the observation that the mutant E236A rendered the enzyme completely inactive.   
 
Consistent with other clan GH-A glycoside hydrolases the substrate binding is 
predicted to be positioned on top of the β-barrel. Indeed, inspection of this region of 
the enzyme reveals a deep U-shaped pocket that houses the catalytic residues, Figure 
5.16. The active site pocket of BT3312 is very different to the topology of the substrate 
binding regions of other GH-A endo-acting enzymes, which display a linear or curved 
cleft that is open at both ends. The architecture of the substrate binding region of 
BT3312 is adapted to the structure of β1,6 glucan. NMR analysis of this short glucan 
revealed a hooked, u-shaped configuration (Lowman et al., 2011) that is entirely 







Figure 5.16. The pocket topology of the GH30, BT3312 active site. The surface 
of the enzyme is shown. The catalytic residues of the enzyme, residing in the 
pocket-like active site of the enzyme are coloured light blue, The bound inhibitor, 
glucose-β1,6-deoxynijiromycin, is coloured yellow. 
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5.4.2.7. Analysis of the BT3312-inhibitor complex.  
The apo structure of BT3312 bound to the transition state mimic glucose-β1,6-
deoxynijiromycin revealed details of the active site and the distal substrate binding 
subsites. The deoxynijiromycin bound in the active site (-1 subsite) adopts an 4E (E 
refers to envelope) conformation, Figure 5.17. While this may comprise the transition 
state geometry, most β-gluco-configured substrates adopt a 3H4 conformation at the 
transition state. Given that 4E and 3H4 (H refers to a half-chair geometry) are adjacent 
to each other in the reaction coordinate pathways, and nitrogen in the deoxynijiromycin 
ring may skew the conformation adopted by the molecule in active site, it is likely that 











The polar interactions between the active site of BT3312 and deoxynijiromycin are 
displayed in Figure 5.18. The carboxylate of Glu337 and N2 of Asn235 made polar 
contacts with O2. O3 interacted with N1 of Trp177, N2 of Asn242 and the 
carboxylate of Asp129. The O2 of Asp129 and N1 of Trp375 made hydrogen bonds 
with O4. The polar interactions were completed by the endocyclic nitrogen donating a 
hydrogen bond to O2 of Glu337. Binding of deoxynijiromycin in the active site was 
Figure 5.17. The ‘envelope’ conformation adopted by the transition state 
mimic, glucose-β1,6-deoxynijiromycni, when in complex with BT3312. 
The deoxynijiromycin bound in the active site (-1 subsite) adopts an 4E (E 
refers to envelope) conformation. The endocyclic nitrogen of the molecule is 




also mediated through apolar contacts between the sugar ring and Trp375, which 
provides the hydrophobic platform in the -1 subsite. The catalytic nucleophile is ~3 Å 
from the anomeric carbon of deoxynijiromycin and is thus in an optimum position to 
mount a nucleophilic attack on the chiral centre. Glu236 is in an optimal position to 
donate a proton to the glycosidic oxygen appended to C1, and thus is able to function 














The -2 subsite makes only apolar interactions with the glucose at the non-reducing 
end of glucose-β1,6-deoxynijiromycin. Trp343 stacks against the pyranose rings while 
the disulphide formed by Cys391 and Cys394 also makes apolar contacts with the -2 
glucose. Given that O6 of the non-reducing glucose is pointing into solvent it is unlikely 
that there are additional negative subsites in BT3312. It is difficult to establish the 
number of positive subsites without bound ligand in this region of the enzyme. Based 
Figure 5.18. The polar interactions which coordinate the inhibitor complex in the 
BT3312 active site. Amino acids which interact with the deoxynijiromycin inhibitor are 
coloured green and labelled accordingly. The inhibitor is labelled as in Figure 5.20. The 
catalytic subsite in which the respective cyclic ring of the inhibitor binds is also labelled 
accordingly. Hydrogen bonds are denoted by dotted lines. 
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on the height of the wall of the substrate binding cleft, however, there are likely to be 
~2 positive sites in which Glu236, His279, Asn280 and Asp284 contribute to substrate 
binding.  
           
BT3312 is the first structure of GH30 subfamily 3. Comparison of the structure of 
BT3312 with GH30 enzymes with different specificities sheds light on the structural 
basis for substrate specificity, which is dominated by the topology of the substrate 
binding regions of the respective proteins. Thus, when BT3312 is compared with the 
glucuronoxylanase from Dickeya chrysanthemi D1 (PDB code 2y24), The B. theta 
enzyme contains a large loop extending from residues 379-396 that sterically occludes 
the -2 and -3 subsites in the glucuronoxylanase, Figure 5.19A,B. This loop is stabilised 
by a disulfide bond between Cys391 and Cys394, and three short beta strands behind 
the loop (coloured orange in Figure 5.19). BT3312 contains a second extended loop 
comprising Gln234 to Trp250 that prevents access to the positive subsites in the 
glucuronoxylanase, Figure 5.20A,B. Indeed the lack of residues that target O6 of 
substrate bound at -1 or -2 reinforces the view that it is the topology of the proximal 
substrate region of BT3312 that confers specificity for β1,6-glucan over β1,4-xylan. 
The xylose polymer, which lacks O6 moieties, adopts a linear three-fold screw axis 
conformation that is distinct from the highly curved, U-shaped structure exhibited by 
the β1,6-glucan. It should be emphasised that β1,3-glucans are highly curved and 
adopt a conformation that is similar to β1,6-glucans ref. The active site of BT3312, 
however, is not able to accommodate a β1,3-linked glucose as O6 would clash with 












Figure 5.19A. Overlay of BT3312 with a glucuronoxylanase from Dickeya 
chrysanthemi. Both enzymes are depicted in schematic form. BT3312, the 
GH30 encoded by B. theta is shown in green. The Dickeya chrysanthemi 
glucuronoxylanase (PDP code: 2y24) is coloured cyan. Co-complexed inhibitor 
is shown in yellow.  The extended loop of BT3312 which sterically occludes the 
-2 and -3 subsites in the glucuronoxylanase, is shown in orange 
Figure 5.19B. Overlay of BT3312 with a glucuronoxylanase from 
Dickeya chrysanthemi  - Surface. Depicted as described for Figure 










Figure 5.20A.  Overlay of BT3312 with a glucuronoxylanase from Dickeya 
chrysanthemi showing the extended loop of BT3312. Proteins and bound 
inhibitor are represented as described in Figures 5.22. A second extended loop of 
BT3312 (shown in red), is depicted and is predicted to prevent access to the positive 
subsites in the glucuronoxylanase 
Figure 5.20B.  Overlay of BT3312 with a glucuronoxylanase from Dickeya 
chrysanthemi showing the extended loop of BT3312 - Surface. Proteins and 
bound inhibitor are as represented as in Figures 5.23A with a surface 
representation. The second extended loop of BT3312 (shown in red), is predicted 




The active site (-1) subsite of the GH30 subfamily 3 enzyme BT3312 was compared 
with the homo-sapiens β-glucosidase (PDB code 2V3D)  and the D. chrysanthemi  
glucuronoxylanase (PDB code 2Y24), representatives of subfamilies 1 and 8, 
respectively, Figure 5.21. In addition to the catalytic nucleophile and acid-base 
residues many of the other substrate binding residues were conserved in the three 
enzymes. Indeed the only two residues were not conserved. Asn142 in BT3312 was 
replaced in the other two enzymes by an aromatic residue that makes apolar contacts 
with the substrate. The loop containing Asp129 adopts a different position in the 
glucuronoxylanase (to accommodate the linear extended substrate), and thus there is 
no residue equivalent to the aspartate in this enzyme. The additional distal subsites in 
the glucuronoxylanase likely compensate for this loss of binding energy in the active 






Figure 5.21. An overlay of the active site residues of GH30 BT3312, a 
homo-sapiens β-glucosidase and the D. chrysanthemi  
glucuronoxylanase. BT3312 amino acid residues are shown in green, the 
D. chrysanthemi glucuronoxylase (PDB code: 2y24) are depicted in blue and 
the amino acid residues of the homo-sapiens β-glucosidase are shown in 
yellow, respectively. Amino acid residues are labelled according and are 
believed to form interactons with the bound glucose-β1,6-deoxynijiromycin 
inhibitor (coloured pink). 
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5.4.2.8. Cellular location of, BT3314, a predicted GH3 exo-glucanase. 
LipoP analysis suggests that the GH3 BT3314 is predicted to have a signal I peptide, 
indicating that the protein is most likely localised to the periplasmic space. 
 
5.4.2.9. Determining the activity BT3314, a GH3 enzyme encoded by PULbtPUS 
The ability of BT3314 to hydrolyse various glyosidic linkages was assessed by 
incubating recombinant enzyme (10 µM and 0.01 µM) at 37 oC for 1 h against β1,4 – 
linked galactobiose, mannobiose and xylobiose as well as β-linked gluco-
dissacharides (β1,4/ β1,3/ β1,6). TLC analysis revealed that BT3314 was only able to 
hydrolyse β-D-gluco-disaccharides, demonstrating a preference for the β1,6-linkage. 
BT3314 was also active against p-nitrophenyl-β-D-glucopyranoside (PNP-β-D-
glucose), confirming that BT3314 was a β-glucosidase as predicted, and hydrolysing 
gluco-configured sugars from the non-reducing end with an exo-mode of action.  
 
The observed preference for β-linkage was further explored quantitatively using a 
linked-assay kit that detected the production of glucose. Briefly, released glucose is 
phosphorylated and is oxidised by glucose-6-phosphate dehydrogenase, which 
converts NADP+ to NADPH, which can be detected at A340nm.  The assay is fully 
described in Methods and Methodology, Section 2.2.1.1.  The activity of BT3314 
against pNP-β-D-glucose was similarly assessed spectrophotometrically owing to the 
stoichiometric increase in A400nm when the glyosidic linkage is cleaved. The assay is 
described in Methods and Methodology, Section 2.2.1.3. Kinetic parameters of 
BT3314 vs substrates were conducted in 50 mM Na-HEPES buffer, pH 7.0. Rates 
were plotted using GraphPad Prism 5.0 and analysed via linear regression or non-
linear regression (against pNP-β-D-glucose). The full-data set is shown in Table 5.5 




The β-glucosidase BT3314 showed a distinct preference for the β1,6-linked 
disaccharide, demonstrating a kcat/Km value of 5.6 µM-1 min-1 compared to 0.18 µM-1 
min-1 for laminaribiose (β1,3) and 0.05 µM-1 min-1 for cellobiose (β1,4). The Km values 
for these substrates were too high to determine. Full Michaelis-Menten kinetics were 
obtained for BT3314 against pNP-β-D-glucose. BT3314 had an extremely low catalytic 
efficiency against this substrate, with a kcat/Km of 0.02 µM-1 min-1, highlighting the 
potential significance of the +1 sub-site of the enzyme in substrate binding. The GH3 
enzyme displayed a Km value of 2.4 mM and a kcat (number of substrate molecules, 




Enzyme Substrate Km (µM) Kcat (min-1) Kcat/Km (µM-1min-1) 
BT3314 
pNP-β-D-Glu 2403 40.82 0.02 
β-D-Glc-[1->3]-D-Glc ND ND 0.18 
β-D-Glc-[1->4]-D-Glc ND ND 0.05 
β-D-Glc-[1->6]-D-Glc ND ND 5.6 
 




Figure 5.22. Example graphs of kinetic data generated for BT3314, VS pNP-β-D-glucose and β1,3-
laminabiose.  Kinetic data of BT3314 versus pNP-β-D-glucose (A) and β1,3-laminabiose (B). Against 
pNP-β-D-glucose, initial rates were derived spectrophotometrically, where-by rate of absorption (A 
min-1) at OD400nm was converted to rate of glucose released, inferred through pNP group cleavage and 
release (min-1) using the extinction coefficient of pNP at pH 7.0. Rates were analysed in GraphPad 
Prism 5.0  using Michaelis-Menten kinetics. Similarly, against β-linked disaccharides, rates of 
absorption at 340 nm were ascertained and converted to rate of glucose release (min-1) using the 
extinction coefficient of NADPH and plotted in GraphPad Prism 5.0 before being analysed using linear 
regression.  
 
5.5. The Bacteroides ovatus GH3 β-glucosidase, BACOVA_00946, 
displays significantly greater activity than the homologous Bacteroides 
thetaiotaomicron enzyme.  
 
5.5.1. Cloning and Expressions 
DNA encoding for the GH3 β-glucosidase, BACOVA_00946, minus signal peptide, 
was generated by PCR using primers which encoded for Nhe1 and Xho1 restriction 
sites at the 5’ and 3’ ends respectively. Digested DNA was subsequently ligated into 
a pET28a expression vector in a manner which ensured the inclusion of an N-terminal 
poly-His6 tag was appended to the GH3 β-glucosidase. The validity of the cloned DNA 



















1 µM GH3 BT3314 VS pNP-β-D-glucose 25 µM GH3 BT3314 VS β-D-Glc-[1->3]-D-Glu 
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commentary to the T7 promoter and T7 terminator encoded by the expression plasmid. 
BACOVA_00946 was expressed in E. coli TUNER cells according to standard protocol 
and purified by IMAC. SDS-PAGE analysis showed that the enzyme was had been 











5.5.2.2 Evaluation of BACOVA_00946, a GH3 β-glucosidase vs β-linked gluco-
disaccharides 
The GH3 encoded by B. ovatus, BACOVA_00946, displayed identical specificities as 
the characterised GH3 of B. theta, BT3314, confirming that BACOVA_00946 is a β-
glucosidase. The kinetic parameters of BACOVA_00946 against β-linked gluco-
disaccharides and pNP-β-D-glucose was ascertained using the same methodology as 
the B. theta enzyme and are reported in Table 5.6 respectively. Example graphs are 
displayed in Figure 5.24. 
Figure 5.23. SDS-PAGE of recombinant expression and purification of BACOVA_00946. SDS-
PAGE of a typical BACOVA_00946 purification following IMAC. All SDS-PAGE gels were 12 % 
(w/v). Marker Mr is displayed in kDa. L = low size marker; P = insoluble fraction; CHE = cell free 
extract; FT = flow through; W = wash ( 1x TALON buffer); E1 = elution 1 (5 mM imidazole,1 x 
TALON buffer); E2 = elution 2 (100 mM imidazole, 1 x TALON buffer). Bacova_00946 ran with an 
apparent Mr of 80 kDa, consistent with the recombinant protein’s predicted sizes of 53 kDa  
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BACOVA_00964 displayed the same trend in linkage preference as the B. theta 
enzyme, demonstrating the highest catalytic efficiency for the β1,6-linkage with a 
kcat/Km value of 38.8 µM-1 min-1. The enzyme had a ~10-fold lower catalytic efficiency 
against the β1,3-linked disaccharide (3.7 min-1 µM-1) and displayed a Kcat/Km of 0.65 
µM-1 min-1 for the β1,4-linkage, a ~60-fold reduction in activity compared to the 
enzyme’s efficiency when cleaving the β1,6-linkage. The B. ovatus GH3 is significantly 
more active against all tested linkages than the equivalent enzyme in B. theta. 
BACOVA_00964 was ~7-fold more efficient at cleaving the β1,6-linked disaccharide, 
~20-fold more efficient against the β1,3-linkage and ~10 fold more efficient when 
hydrolysing the β1,4-linkage. BACOCA_00964 demonstrated extremely low catalytic 
activity against pNP-β-D-glucose, although the enzyme was 10-fold more efficient that 













Enzyme Substrate Km (µM) Kcat (min-1) Kcat/Km (µM-1min-1) 
Bacova_00946 
pNP-β-D-Glu 1052 195.8 0.19 
β-D-Glc-[1->3]-D-Glc ND ND 3.73 
β-D-Glc-[1->4]-D-Glc ND ND 0.65 






5.5.2.3. Amino Acid sequence comparison between the GH3 β-glucosidases, 
BT3314 and BACOVA_00946  
To explore the possible biochemical rationale between the observed differences in 
catalytic activity demonstrated between the GH3 β-glucosidases of B. theta (BT3314) 
and B. ovatus (BACOVA_00946), an alignment of the amino acid sequences of the 
two proteins was performed, and is displayed in Figure 5.25. The two GH3 β-
Table 5.6. Kinetic parameters of BACOVA_00964, against β-linked gluco-disaccharides. ND = No data.  
0.1 µM GH3 Bacova_00964 VS pNP-β-D-glucose 1 µm GH3 Bacova_00964 VS β-D-Glc-[1->3]-D-Glu 
Figure 5.24. Example graphs of kinetic data generated for BACOVA_00964, VS pNP-β-D-glucose and 




glucosidases share a 91 % sequence similarity. Interestingly, the only major 
differences in amino acid residues is a 12 amino acid insertion in the B. theta protein, 
encompassing residues Ser239 – Tyr250. Sequence alignments of previously 
characterised GH3 family β-glucosidases show that this insertion is, at least in 
sequence, in close proximity to the catalytic nucleophile of the enzyme, Asp265 and 
Asp279 in the B. theta and B. ovatus enzymes, respectively. Whilst highly speculative, 
it is possible that this amino acid insertion near the catalytic nucleophile of the enzyme 
is responsible for the observed difference in catalytic activity. Interestingly, alignments 
of the GH3 amino acid sequences encoded by the β1,6-glucan locus of all sequenced 
B. theta clinical isolates reveals that the insertion of 12 amino acids is 100 % 
conserved, whilst significantly, all alignments of the GH3 from the β-1,6-glucan PUL 
of other sequenced Bacteroides species are more similar to the B. ovatus GH3 



























Figure 5.25. Full amino acid sequence alignment of the GH3 β-glucosidases BT3314 
and BACOVA_00946. Catalytic residues of the enzyme, based on homology, are 
highlighted in green. N= catalytic nucleophile. The 12 amino acid insertion (residues Ser239 
– Tyr250)  in the Bacteroides theta enzyme, hypothesized to be responsible for retardation in 
catalytic activity, is highlighted by a blue box.   
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5.6. Culture supernatant analysis.  
Thin layer chromatography (TLC) of early stationary phase (2.0 OD600nm) culture 
supernatants of B. theta and B. ovatus growth with pustulan revealed the accumulation 
of a glycan the growth media (Figure 5.26), confirmed to be the disaccharide β1,6-
glucobiose by HPAEC-PAD analysis. The potential significance for the accumulation 
of the disaccharide is explored in the Discussion.   
 
Analysis of culture supernatants of B. theta growth with pustulan revealed a large 
number of β1,6-oligosaccharides during  the exponential phase (Figure 5.27). This is 







Figure 5.26. Thin layer chromatography (TLC) of culture supernatants of B. theta and 
B. ovatus grown on pustulan and glucose to stationary phase. Culture supernatants 
from stationary phase cultures were subjected to TLC using the following markers: glucose 




Figure 5.27. TLC analysis of  culture supernatants of B. theta and B. ovatus grown on the β1,6-
polysaccharide, pustulan.  Overnight grown minimal media with glucose (5 mg/ mL)) were used to inoculate 
minimal media (5 mL) containing pustulan (5 mg/mL). Anaerobic growth was measured spectrophotometrically 
(OD600nm), which is representative of different stages of bacterial growth. Samples of the culture supernatant 
were taken at various optical densities and analysed by TLC. Samples are labelled according to the optical 
density (OD600nm) at which they were taken. EARLY/LATE represent stationary phase samples taken 
immediately when stationary phase was reached or ~6 h into stationary phase respectively. Glucose and β1,4-
glucooligosaccharides (d.p. 2 to 4) were used as standards (denoted by G -> G4). Panel A and B displays 
growth of  B. theta and B. ovatus, respectively,with pustulan. 
B. ovatus  
A  





This chapter provides evidence that the PULbtPUS targets the utilization of  β1,6-
glucans. This PUL appears to be widespread amongst a number of Bacteroides 
species, suggesting that β1-6-glucans are a viable energy source. Whilst β1,6-glucans 
upregulate PULbtPUS and PULboPUS the exact signalling molecule which activates these 
loci has not been elucidated. Owing to the observation that B. theta and B. ovatus cells 
cultured with glucose as a sole carbon source display no increase in gene expression, 
it can be concluded with a high degree of certainty that monomeric glucose does not 
activate the β1,6-glucan PUL. Instead, the activating molecule is most likely a β1,6-
oligosaccharide, the D.P of which was not explored.  
The data presented in this chapter attempts to construct a model of β1,6-glucan 
utilization in Bacteroides through the characterisation of the proteins encoded by 
PULbtPUS. The surface binding proteins encoded by PULbtPUS, and by inference the 
equivalent proteins derived from PULboPUS, target the β1,6-glucan pustulan 
preferentially, and display similar affinities for β1,6-glucooligosaccharides with a D.P 
> 7 as shown by ITC. β1,6-glucans have been shown to adopt a hook-like 
conformation in solution, with four β-D-1,6-glucopyranose residues forming one hook 
(Lowman et al., 2011). It is possible that the two surface binding proteins not only 
recognise and interact with the individual glucopyranose residues of the β1,6-glucan, 
but also the secondary structure formed by the target glycan. Previously characterised 
SusDh proteins have been observed to recognise glycan structures (Koropatkin et al., 
2009);(Koropatkin et al., 2008). The binding specificities of both SusDh, BT3311, and 
the SGBP, BT3313, are consistent with the activity of the surface GH30 endo-β1,6-
glucanase. Complementary to the biological function of SGBPs, sequestering target 
glycans to the cell surface, a number of SGBPs have been observed to bind to target 
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polysaccharides and their constituent oligosaccharides following surface enzyme 
degradation (Cuskin et al., 2015b). Indeed, this is consistent with the longer 
oligosaccharide products generated by the surface GH30 endo-β1,6-glucanase 
generated during the initial stages of degradation as observed in vivo. SusDh proteins 
bind oligosaccharides for transportation through their cognate outer membrane SusCh 
into the periplasmic space where further enzymatic deconstruction occurs, reiterating 
the hypothesis that both extracellular binding proteins target long chain 
oligosaccharides and is complemented by studies of other PUL systems (Rogowski et 
al., 2015). 
Genomic data indicate that the core enzymatic machinery necessary to fully degrade 
β1,6-glucans is seemingly conserved amongst Bacteroides species, and consists 
solely of a GH30 endo-β1,6-glucanase and a GH3 β-glucosidase. As such, PULbtPUS 
presents a relatively simple model of polysaccharide utilization by a PUL system. 
Indeed, the complexity of a PUL (complexity meaning the number of protein encoding 
ORFs required to fully degrade and utilize the target substrate) correlates to the 
complexity and accessibility of the target substrate (Rogowski et al., 2015). The GH30 
endo-β1,6-glucanase, predicted to be localised to the cell surface, targets extracellular 
polysaccharides initially, cleaving the sugar polymer into β1,6-olgiosaccharides. The 
presence of an endo-acting enzyme on the cell surface, generating oligosaccharides 
which can be further processed (usually following transportation into the periplasm), is 
typical of other PULs which target ‘less-complex’ substrates (galactan. Jonathon 
Briggs personal communication).  
The capability of the surface GH30 endo-β1,6-glucanase to hydrolyse short chain 
oligosaccharides to a D.P of three (not quantified) is interesting. Previously 
characterised surface endo-acting enzymes preferentially target longer 
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oligosaccharides and display little/no catalytic activity against oligosaccharides with a 
d.p < 5, owing to weak binding at sub-sites proximal to the active site of the enzyme 
(Cuskin et al., 2014, Rogowski et al., 2015), and perhaps suggests a significant 
proportion of oligosaccharides are degraded at the cell surface. The observation that 
culture supernatants of B. theta and B. ovatus grown in the presence of pustulan 
results in the accumulation of β1,6-glucobiose in the growth media, suggests that the 
bulk of degradation does indeed occur extracellularly and is concurrent with the activity 
of the recombinant GH30 enzyme. It has recently been proposed that Bacteroides 
utilizes a ‘selfish’ mechanism of polysaccharide utilization when presented with a 
complex glycan, which would require a significant energy investment by the bacterium 
to degrade.  The bulk of depolymerisation occurs within the bacterial cell and therefore 
reduces the quantity of depolymerised products released extracellularly for potential 
scavenging by competitors (Cuskin et al., 2014, Rogowski et al., 2015). Conversely, 
Bacteroides has been shown to employ strategies which liberate oligosaccharides 
extracellularly during degradation, to the extent of being able to sustain the growth of 
co-cultured bacterial  species in vivo (Rogowski et al., 2015). The abundance of 
extracellular β1,6-oligosaccharides released by the surface GH30 during growth 
suggest that the bacterium has not evolved to utilize β1,6-glucans in an overtly selfish 
manner. The significance of this is not clear, although a ‘self-less’ model of 
polysaccharide utilization in B. theta is usually utilized for high-abundance/low-
complexity substrates (unpublished data). Interestingly, β1,6-glucans would not be 
abundant, although the complexity of this glucan fraction can vary drastically. 
The exo-acting GH3 β-glucosidase, predicted to reside within the perisplasm, most 
likely further depolymerises β1,6-linked oligosaccharides by liberating glucose from 
imported GH30 endo-glucanase products, which can be transported into the 
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cytoplasm and catabolized by the bacterium. However, the necessity for this enzyme 
can be questioned owing to the ability of the surface GH30 glucanase to generate 
glucose from the polysaccharide.  The B. theta GH3,  BT3314, has been shown to 
target a number of β-linked disaccharides, and displayed the greatest preference for 
the β1,6-linkage, albeit with a severely reduced efficiency when compared to the B. 
ovatus GH3 β-glucosidase. The difference in catalytic activity observed between the 
recombinant GH3 enzymes of B. theta and B. ovatus is surprising owing to the high 
degree of amino acid sequence homology shared between the two enzymes (91 %). 
It should be noted, however, that due to availability of substrate, the activity of the GH3 
enzymes could not be tested against β-oligosaccharides with a D.P > 2. It is plausible 
that the B. theta enzyme, or indeed both enzymes, may be catalytically more efficient 
against the tri or tetrasaccharide, accommodating additional β-D-glucose moieties in 
potential +2/+3 catalytic sub-sites, lowering the affinity constant (Km). Regardless, the 
need for the GH3 enzyme in the model of β1,6-glucan degradation can be questioned; 
the low catalytic activity of the B. theta GH3 enzyme in conjunction with the ability of 
the surface GH30 to produce glucose suggests a level of redundancy in the B. theta 
β1,6-glucan PUL system. To reiterate, gene up-regulation data suggest that the 
activating molecule of the β1,6-glucan PUL is a β1,6-linked gluco-oligosaccharide. 
Catalytically low levels of β-glucosidase activity would therefore be necessary to 
degrade the signalling molecule, preventing continuous up-regulation of the PUL, 
providing one potential reason for the lack of total-redundancy of the GH3 enzyme in 
B. theta.  
The degree of β1,3-linked glucose side-chains of the β1,6-glucan fraction of the yeast 
cell wall can vary significantly amongst yeast species. Studies report branching of up 
to 75 % in Schizosaccharomyces pombe, a yeast utilized in the brewing industry. 
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BT3314, the endo-β1,6-glucanase can tolerate a degree of decoration of the β1,6-
backbone and can hydrolyse purified yeast β1,6-glucans from Saccharomyces 
cerevisiae, which on average has β1,3-linked glucose decorations every 19 glucose 
residues (Aimanianda et al., 2009). The degree of tolerance the GH30 endo-β1,6-
glucanase possesses for highly decorated β1,6-glucans is not known.  It can be 
speculated that a highly decorated β1,6-glucan, such as the β-glucans possessed by 
S. pombe (B. theta targets the α-mannan of S. pombe (Cuskin et al., 2015b)), would 
result in a lower frequency of cuts making it a less-accessible backbone, potentially 
altering the proposed model of β1,6-glucan degradation dramatically. Whilst highly 
speculative, it can be hypothesised that when Bacteroides is challenged with highly 
decorated β 1,6-glucans, the GH3 β-glucosidase would play a much more pivotal role 
and may even provide a competitive advantage to B. ovatus which encodes for a 
significantly more active GH3 β-glucosidase owing to the enzyme’s ability to remove 
the β1,3-linked glucose decorations of imported oligosaccharides more efficiently. 
Indeed, B. theta is capable of degrading and utilizing yeast α-mannan, whilst B. ovatus 
cannot, lacking the PULs necessary to target the highly complex glycan (Cuskin et al., 
2015b). B. theta requires a significant energy investment to target the highly complex 
α-mannans of the yeast cell wall. In vivo studies have shown that wild-type B. theta is 
outcompeted by a mutant lacking the PULs needed to target α-mannan when fed a 
non-mannan diet, thereby suggesting α-mannan utilization is only ‘cost-effective’ when 
the target substrate is available. The evolutionary persistence of the α-mannan PULs 
in B. theta therefore suggests that α-mannans are valuable target substrates for the 
gut bacterium, despite the ‘risk’. Due to the role of β1,6-glucans in the  structural 
integrity of the yeast cell wall, it can be speculated that enzymatic disruption of this 
glucan may potentially liberate other structural polysaccharides. Tentatively, B. theta 
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may have evolved a strategy to disrupt the yeast cell wall, gaining access to a 
preferential, more abundant, substrates as a nutrient sources. This view is supported 
by the proposed redundancy of the B. theta GH3 glucosidase and its similarity with 
GH3 enzymes from other B. theta strains. B. ovatus, which is unable to utilize yeast 
α-mannans and encodes for a significantly more active GH3 β-glucosidase may be a 
more efficient β1,6-glucan utilizer as a result, due to the organism’s requirement to 
access β1,6-glucans solely as an energy source. 
5.8 Further Work. 
Future work is necessary to further explore the observed differences in GH3 
glucosidase activity between the B. theta and B. ovatus enzyme, in order to fully 
ascertain if such discrepancies in activity extend to in vivo, and to fully elucidate the 
biological rationale for such differences in activity. To achieve this goal, competition 
experiments must be performed to see if the more active GH3 of B. ovatus provides a 
competitive advantage over B. theta when cultured with pustulan and yeast β1,6-
glucans of various species to investigate if the degree of side-chains affects β1,6-
glucan utilization. Assessing the ability of Bacteroides species to degrade the β1,6-
glucans of other yeast species would help to inform our knowledge of complex glycan 
utilization and sharing with the gut.  
Yeasts, such as Candida albicans are commensal members of the gut, and can be 
pathogenic in immunocompromised patients. The ability of B. theta to degrade yeast 
cell wall glycans, and the potential of the organism to disrupt yeast cell walls may help 
to modulate yeast levels within the gut, preventing opportunistic yeast infections and 
pathogenesis. The ability of the bacterium to access and degrade intact yeast cell 
walls must be assessed.  
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Further health implications may arise from the release of yeast cell wall molecules into 
the gut lumen, induced by B. theta hydrolysis. Both β1,3 and β1,6 glucans have been 
observed to be immunostimulatory and may interact with the immune system of the 
host. Indeed, β1,6 glucans are potent cytokine inducers in human blood (Noss et al., 
2013). As such, the degradation of yeast cell wall polysaccharides by Bacteroides may 


















Chapter 6.0: Final Discussion 
 
The data presented in this study provides example mechanisms by which organisms 
that inhabit the highly competitive environments of both the rumen and the human 
distal gut have evolved unique strategies to facilitate the degradation and utilization of 
complex carbohydrates.  
Bacteria which inhabit the rumen have evolved to target plant biomass primarily 
through deploying glycoside hydrolases which often encode for non-catalytic CBMs. 
CBMs enhance the activity of their parent catalytic domain (As described in the 
Introduction, Section 1.2). Understanding the molecular basis of CBM-ligand 
interactions informs enzyme based saccharification strategies to disrupt and degrade 
the highly complex and heterogeneous plant cell wall. As such, engineering the 
specificity of enzymes and CBMs is of industrial relevance. Chapter 3 describes the 
continued structural and biochemical characterisation of a non-catalytic binding 
module of the CBM65 family, derived from an endoglucanase encoded by 
Eubacterium cellulosolvens, an organism which is consistently dominant in the rumen 
(Prins et al., 1972). The CBM65 family uniquely displays specificity for the side-chains 
of the decorated β1,4-glucan xyloglucan, over linear β1,4-glucans. The crystal 
structure of CBM65B in complex with ligand provides insight into side-chain specificity, 
revealing that specificity for the decorated xyloglucan is conferred through an 
extended hydrophobic platform, consisting of five aromatic residues, forming 
interactions between both the glucan backbone and xylose decorations of the 
polysaccharide. ITC revealed that the CBM65s displayed a higher affinity for the 
decorated XXXG oligosaccharide than the undecorated equivalent oligosaccharide, 
cellotetraose. Substituting the back-bone specific residue in CBM65A abrogated 
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cellulose recognition but did not impact upon xyloglucan affinity, therefore 
emphasising the importance of side-chain recognition, which is in contrast to other 
previously characterised CBMs (Najmudin et al., 2006). Surprisingly, mutating the 
structurally equivalent residue in CBM65B did not impact upon cellulose recognition, 
despite no other obvious candidate residues being apparent in the ligand binding cleft. 
The mechanism by which CBM65B recognises linear β1,4-glucans is some-what 
unclear. A co-complexed structure of CBM65B with cellooligosaccharides is 
necessary to elucidate whether CBM65A and 65B recognise cellulose via differening 
mechanisms or to identify a functionally equivalent residue in the CBM65B which 
provides a polar contact with the glucose backbone of linear β1,4-glucans. 
 X-2 L110F, a CBM variant engineered from a xylan specific Rhodothermus marinus 
CBM, has recently been shown to bind xyloglucan via interactions with both the 
backbone and decorations of xyloglucan (von Schantz et al., 2014).  X-2 L110F 
displays similarities in xyloglucan recognition to CBM65B, both displaying a preference 
for the branched polysaccharide over linear β1,4-glucans. Likewise, the aromatic 
amino acid residues housed within the ligand binding cleft have a crucial impact on 
ligand binding in both CBM65 and X-2 L110F. The binding interface of X-2 L110F is 
rich in aromatic side chains, forming hydrophobic interactions with XXXG. However, 
whilst CBM65 binding of XXXG is primarily mediated by apolar and hydrophobic 
contacts, X-2 L110F binding of XXXG requires substantial binding site plasticity in 
order to achieve polar contacts between the xylose decorations of XXXG, with several 
amino acids undergoing conformational changes in the ligand binding cleft. In contrast, 
the ligand binding site of CBM65 is pre-arranged and undergoes little rearrangement 
of amino acid chains upon ligand binding. CBM65B-XXXG complex reveals only one 
polar contact between the protein and xylose decorations of XXXG, whilst up to nine 
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polar contacts are formed between X-2 L110F and the xylose sidechains,  
Interestingly,  X02 L110F and CBM65s recognise differing faces of the XXXG 
oligosaccharide. Whilst the CBM65 display no binding to xylans, X-2 L110F displays 
higher affinity for oat-spelt xylan over tamarind seed xyloglucan, again suggesting 
differing mechanism of ligand recognition. Such differences observed in xyloglucan 
recognition between the CBM65s and X-2 L110F, as well as differences in ligand 
binding cleft architecture, may enable the targeting of xyloglucan in differing plant cell 
wall contexts and be of industrial benefit. Indeed, CBMs can recognise identical 
ligands in solution, but demonstrate differing specificities for cell walls (McCartney et 
al., 2006). Likewise, whilst the primary role of CBMs is to increase enzyme substrate 
proximity, some CBMs may enable targeting to accessible regions of the plant cell wall 
(Montanier et al., 2009). The multiple binding specificities demonstrated by the 
CBM65s may enable more efficient targeting in heterogeneous plant cell walls. The 
structure of xyloglucan can vary between cell type and plant species (Fry et al., 1993). 
The mechanism of ligand recognition displayed by CBM65 may allow for subtle 
variations in ligand structure and may accommodate the xyloglucans of taxonomically 
diverse cell walls. These data presented in Chapter 3 provides a model by which 
decorated polysaccharides are recognised by CBMs, and how a CBM can 
demonstrate a distinct preference for xyloglucan over β-glucans (Luis et al., 2013). 
Chapters 4 and 5 provides insight into yeast cell wall polysaccharide utilization by B, 
theta through the biochemical characterisation of the molecular machinery encoded 
by the respective PUL systems. The ability of Bacteroides to utilize yeast cell 
polysaccharides is entirely consistent with the organisms perceived role as a ‘glycan 
generalist’ (Martens et al., 2009), enabling Bacteroides to flourish in a highly-
competitive eco-system. The strategies utilized by B. theta to target different fractions 
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of the yeast cell wall, α-mannan and β1,6-glucans respectively, are in stark contrast. 
Indeed, α-mannan utilization appears to be restricted to limited Bacteroides species, 
(Cuskin et al., 2015b), whilst PULPUS is seemingly wide-spread. β1,6 glucan utilization 
represents a seemingly simple model of polysaccharide utilization. Extracellular 
deconstruction is dominated by an endo-acting β1,6-glucanase, with a high efficiency 
against the polysaccharide and high d.p β1,6-oligosaccharides. This is reminiscent of 
xyloglucan utilization by B. ovatus (Larsbrink, 2014), whereby extracellular metabolism 
of the polysaccharide is mediated by endo-acting enzymes. Likewise, the SusDh and 
SGPB encoded by PULPUST bind polysaccharide and β1,6-oligosaccharides with a d.p 
>6 preferentially.  Further parallels can be drawn between the xyloglucan system and 
pustulan utilization by B. theta, due to the speculated redundancy of exo-acting 
enzymes encoded by the respective PULs. The periplasmic GH3 β-glucosidase of 
PULbtPUS is catalytically feeble. The surface endo-glucanase can generate glucose 
from the polysaccharide and so the necessity of this enzyme for β1,6-glucan utilization 
is unknown. It can be speculated that this enzyme may serve to hydrolyse the 
molecular cues which up-regulate the PUL. The significance of the GH3 needs to be 
elucidated by assessing the ability of GH3 deficient B. theta strains to utilize β1,6 
glucans. Such observations are further emphasised by the fact that the homologous 
GH3 β-glucosidase encoded by PULboPUS displays significantly greater activity against 
tested disaccharides.   
Evidence provided in Chapter 4 shows that B. theta as evolved to utilize the α-mannan 
of different yeast species. An α-galactosidase encoded by PUL-Man1 was able to 
sufficiently remove the α-galactosyl residues appended to the backbone of S. pombe 




Numerous attempts to manipulate the composition of the human gut microbiota have 
been attempted. However, the lack of knowledge of complex glycan utilization and 
sharing within the gut environment by key glycan degraders has slowed such efforts 
(Hooper et al., 2002). Evidence provided in Chapter 4 demonstrates how the α-
mannan apparatus of B. theta is tailored to minimise substrate loss to the environment, 
and by extension, the gut lumen. Conversely, oligosaccharides are freely liberated 
during β1,6-glucan utilization by B. theta.  Extracellular side chain removal of α-
mannan is mediated by a constitutively expressed α-mannosidases, not encoded by 
PUL-Man1-3. Extracellular mannose-side chain removal is severely limited, but 
sufficient enough to enable GH76 endo-α1,6-mannanase access to the sterically 
restricted α1,6-mannanase back-bone. Mannose liberated during B. theta α-mannan 
deconstruction could not support the growth of other Bacteroides species. Indeed, 
biochemical characterisation of the surface GH76 endo-α1,6-mannanases reveals that 
they are adapted to hydrolyse longer α1,6-oligosaccharides, and are slower than their 
periplasmically located counterparts. This strategy would reduce loss of substrate to 
the gut lumen, synergising substrate cleavage with importation. The periplasmic α-
mannosidases were ~20-50-fold more efficient at mannose side-chain deconstruction 
than the enzyme believed to facilitate extracellular debranching. These data suggest 
B. theta has adopted a selfish mechanism of α-mannan degradation, owing the 
significant energy investment targeting α-mannan entails (Cuskin et al., 2015b). Such 
observations resonate with the findings of (Rogowski et al., 2015), where-by the by 
products of B. ovatus complex xylan utilization were unable to support the growth of 
co-cultured xylooligosaccharide users. Conversely, the products liberated during B. 
ovatus degradation of simpler xylans were able to the support growth of co-cultured 
species.  These findings suggest that glycan complexity dictates the strategy of 
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utilization and contributes to our understanding of bacterial interactions within the gut 
microbiota, potentially informing prebiotic strategies. 
The data presented in Chapter 4 also shows how B. theta has evolved to target the α-
mannan of differing yeast species. The α-galactosidase encoded by PUL-Man1 was 
able to sufficiently remove the α-galactosyl residues appended to the backbone of S. 
pombe yeast mannan to enable GH76 endo-mannanase attack. PUL-Man2 encodes 
a GH130 glycoside hydrolase which targets the β1,2-mannosidic linkages that cap the 
mannose side-chains of Candida albicans α-mannan, a pathogenic yeast and 
commensal member of the gut microbiota (Cuskin et al., 2015b). The ability of B. theta 
to target alternate fungal mannans most likely arose due to exposure to dietary 
mannans or commensal yeasts in the gut.   
To conclude, evidence presented in this thesis demonstrates that Bacteroides has 
evolved the ability the target yeast cell wall polysaccharides, and exploits α-mannans 
and β1,6-glucans through differing strategies. B. theta encodes for PUL-Man1-3 and 
PULPUS. It can be speculated that B. theta may disrupt yeast cell walls through β1,6-
glucan hydrolysis, thereby providing access to a niche and preferential substrate (α-
mannan). Conversely, B. ovatus does not encode for PUL-Man, but encodes PULPUS. 
B. ovatus may potentially solely target β1,6-glucans as an energy source, a hypothesis 
which may be supported by the greater activity displayed by the GH3 encoded by 
PULboPUS than the B. theta homologue. This needs to be assessed by competition 
experiments. Nevertheless, the impact of yeast modulation within the gut (especially 
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Protein GH Family 








SpII  18/19 
BT1878 SpII  23/24 
BT2199 SpII  18/19 
BT3130 SpI 20/21 
BT3773 SpI 22/23 
BT3858 SpII  23/24 
BT3990 SpI 19/20 
BT3991 SpII  19/20 
BT3994 SpII  16/17 
BT4072 GH38 SpI 20/21 
    
BT4073 GH92 SpII  19/20 
lipoP analysis of B. theta encoded, putative extracellular α-mannosidases used to determine 






























Data collection CBM65B-XXXG 
Source  I04 
Wavelength (Å) 0.9795 
Space group P43 21 2 
Cell dimensions  
    a, b, c (Å) 57.9, 57.9, 116.7 
 ()  90.0, 90, 90.0 
No. of unique 
observations 
8,856 
Multiplicity 6.2 (4.7) 
Resolution (Å) 58.37-2.35 (2.48-
2.35) 
Rmerge (%) 7.8 (66.1) 
I/I 13.4 (2.0) 
Completeness (%) 100.0 (100.0) 
  
Refinement  
Rwork/ Rfree 22.44 (28.03) 
No. atoms  
    Protein 955 
    Ligand 72. 
    Water 1 
B-factors  
    Protein 50.4 
    Ligand 47.6 
    Water 39.5 
R.m.s deviations  
    Bond lengths (Å)  0.012 
    Bond angles (º) 1.56 




































Data collection BT3312 BT3312-Inhibitor 
Source  I02 I03 
Wavelength (Å) 0.9794 0.7749 
Space group P21 P21 
Cell dimensions   
    a, b, c (Å) 62.4, 156, 78.0 62.4, 78.8, 145.5 
 ()  90.0, 100.4, 90.0 90.0, 94.9, 90.0 
No. of measured 
reflections 
429705 (10374) 445926 (22895) 
No. of independent 
reflections 
114209 (4871) 116665 (5762) 




Rmerge (%) 6.7 (57.8) 9.9 (78.4) 
CC1/2 1.00 (0.47) 1.00 (0.64) 
I/I 9.0 (1.8) 7.8 (1.6) 
Completeness (%) 99.2 (86.2) 97.4 (97.6) 
Redundancy 3.8 (2.1) 3.8 (4.0) 
   
Refinement   
Rwork/ Rfree 19.8 (24.8) 18.7 (23.2) 
No. atoms   
    Protein 10497 10675 
    Ligand N.A. 66 
    Water 705 616 
B-factors   
    Protein 34.3 30.6 
    Ligand N.A. 29.15 
    Water 39.6 39.9 
R.m.s deviations   
    Bond lengths (Å)  0.017 0.018 
    Bond angles (º) 1.82 1.79 




Appendix B – Chemicals, media and enzymes used in this study 
B1 Chemicals 
Biogene 
 Electrophoresis grade Agarose 
British Drug Houses (BDH) 
 Acetic acid (glacial) 


















46/48% (w/v) NaOH 
Sodium acetate trihydrate 
Megazyme 



















GE Health Care 
Agarose (ultrapure) 
Sigma 
3,5-Dinitrosalasylic acid (DNSA) 
4-nitophenyl substrates (pNP) 
Ammonium persulphate 
Ampicillin 
Bovine serum albumin (BSA) 





di-Sodium hydrogen phosphate 























Bacteriological Agar No. 1 
B3 Enzymes 
MBI Fermentas 
DNA restriction endonucleases 
Invitrogen 







KOD HotStart DNA polymerase 
Stratagene 








Plasmid mini kit 
Plasmid midi kit 
Qiaquick Gel extraction kit 
Qiaquick PCR purification kit 
 
 
 
 
 
 
 
